CAR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Avis Budget Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Avis Budget Group, Inc. (“Avis Budget” or “the Company”) (NASDAQ: CAR) and certain of its officers.
- 06/13/2025
|
Class Action Lawsuit Filed: Avis Budget Group, Inc. (CAR) - Join by June 24, 2025 - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / June 13, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=153053&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq.
- 06/13/2025
|
CAR DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Avis Budget Group, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important June 24 Deadline in Securities Class Action - CAR
- NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / WHY: New York, N.Y., June 13, 2025.
- 06/13/2025
|
Levi & Korsinsky Notifies Avis Budget Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – CAR
- NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Avis Budget Group, Inc. ("Avis Budget" or the "Company") (NASDAQ: CAR) of a class action securities lawsuit.
- 06/13/2025
|
Levi & Korsinsky Notifies Avis Budget Group, Inc. (CAR) Shareholders of Class Action Lawsuit and June 24, 2025 Deadline
- NEW YORK, NY / ACCESS Newswire / June 13, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=153035&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq.
- 06/13/2025
|
Pomerantz Law Firm Announces the Filing of a Class Action Against Avis Budget Group, Inc. and Certain Officers - CAR
- NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Avis Budget Group, Inc.("Avis Budget" or the "Company") (NASDAQ:CAR) and certain officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed under 25-cv-03332 , is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Avis Budget securities between February 16, 2024 and February 10, 2025, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 ("Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
- 06/13/2025
|
Johnson & Johnson's dual-targeting CAR T-cell therapy shows encouraging first results in large B-cell lymphoma
- Phase 1b study suggests a promising safety profile and highlights the potential of a novel dual-targeting CD19/CD20 CAR T in patients with relapsed or refractory disease 75-80% complete response rate among evaluable patients at the recommended Phase 2 dose MILAN , June 13, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today the first clinical data from an ongoing Phase 1b study for JNJ-90014496 (JNJ-4496), an investigational dual-targeting anti-CD19/CD20 bispecific autologous chimeric antigen receptor (CAR) T-cell therapy, being studied in patients with relapsed or refractory large B-cell lymphoma (R/R LBCL) who have not been previously treated with CAR T-cell therapy.1 Findings demonstrate the potential of JNJ-4496 in the treatment of patients with R/R LBCL, including R/R diffuse large B-cell lymphoma (DLBCL) – the most common type of aggressive lymphoma, a blood cancer that originates in the lymphatic system.1,2 These data were presented as an oral presentation at the 2025 European Hematology Association (EHA) Congress (Abstract #S239).1 JNJ-4496, formerly known as C-CAR039, is a dual-targeting CAR T designed to bind to both CD19 and CD20 antigens — two cell surface proteins commonly expressed on malignant B-cells. This design, including a 4-1BB costimulatory domain, is intended to enhance binding strength and persistence, also potentially addressing common mechanisms of resistance in relapsed or refractory disease.
- 06/13/2025
|
Class Action Lawsuit Filed: Avis Budget Group, Inc. (CAR) – Join by June 24, 2025 - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / June 13, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=152993&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq.
- 06/13/2025
|
Investors Urged to Contact Levi & Korsinsky for Information Before June 24, 2025 - Avis Budget Group, Inc. (CAR)
- NEW YORK, NY / ACCESS Newswire / June 13, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=152916&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq.
- 06/13/2025
|
CAR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Avis Budget Group, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ:CAR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Avis Budget securities between February 16, 2024 and February 10, 2025, both dates inclusive (the "Class Period").
- 06/13/2025
|
Levi & Korsinsky Notifies Avis Budget Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - CAR
- NEW YORK , June 13, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Avis Budget Group, Inc. ("Avis Budget" or the "Company") (NASDAQ: CAR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Avis Budget investors who were adversely affected by alleged securities fraud between February 16, 2024 and February 10, 2025.
- 06/13/2025
|
Levi & Korsinsky Notifies Avis Budget Group, Inc. (CAR) Investors - Lead Plaintiff Deadline on June 24, 2025
- NEW YORK, NY / ACCESS Newswire / June 12, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=152871&wire=1&utm_campaign=14 or contact Joseph E. Levi, Esq.
- 06/12/2025
|
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avis Budget Group
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Avis To Contact Him Directly To Discuss Their Options
- 06/12/2025
|
CAR Investors Have Opportunity to Lead Avis Budget Group, Inc. Securities Fraud Lawsuit
- NEW YORK , May 22, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Avis Budget Group, Inc. (NASDAQ: CAR) between February 16, 2024 and February 10, 2025, both dates inclusive (the "Class Period"), of the important June 24, 2025 lead plaintiff deadline. So What: If you purchased Avis Budget securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 05/22/2025
|
Levi & Korsinsky Notifies Avis Budget Group, Inc. (CAR) Shareholders of Class Action Lawsuit and June 24, 2025 Deadline
- NEW YORK, NY / ACCESS Newswire / May 22, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=149697&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq.
- 05/22/2025
|
Securities Fraud Class Action Filed Against Avis Budget Group, Inc. (CAR) - Levi & Korsinsky Reminds Investors of June 24, 2025
- NEW YORK CITY, NY / ACCESS Newswire / May 21, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=149678&wire=1&utm_campaign=27 or contact Joseph E. Levi, Esq.
- 05/21/2025
|
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 24, 2025 in Avis Budget Group, Inc. Lawsuit – CAR
- NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Avis Budget Group, Inc. (NASDAQ: CAR).
- 05/21/2025
|
Lost Money on Avis Budget Group, Inc. (CAR)? Contact Levi & Korsinsky to Join Class Action Before June 24, 2025
- NEW YORK, NY / ACCESS Newswire / May 21, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=149607&wire=1&utm_campaign=20 or contact Joseph E. Levi, Esq.
- 05/21/2025
|
Class Action Lawsuit Filed Against Avis Budget Group, Inc. (CAR) - Recover Losses - Contact Levi & Korsinsky Before June 24, 2025
- NEW YORK, NY / ACCESS Newswire / May 21, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=149592&wire=1&utm_campaign=9 or contact Joseph E. Levi, Esq.
- 05/21/2025
|
Pomerantz Law Firm Announces the Filing of a Class Action Against Avis Budget Group, Inc. and Certain Officers - CAR
- NEW YORK CITY, NY / ACCESS Newswire / May 21, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Avis Budget Group, Inc.("Avis Budget" or the "Company") (NASDAQ:CAR) and certain officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed under 25-cv-03332 , is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Avis Budget securities between February 16, 2024 and February 10, 2025, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 ("Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
- 05/21/2025
|
Class Action Lawsuit Filed Against Avis Budget Group, Inc. (CAR) - Recover Losses - Contact Levi & Korsinsky Before June 24, 2025
- NEW YORK, NY / ACCESS Newswire / May 21, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=149496&wire=1&utm_campaign=9 or contact Joseph E. Levi, Esq.
- 05/21/2025
|
CAR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Avis Budget Group, Inc. to Contact the Firm Today!
- NEW YORK CITY, NY / ACCESS Newswire / May 21, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ:CAR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Avis Budget securities between February 16, 2024 and February 10, 2025, both dates inclusive (the "Class Period").
- 05/21/2025
|
CAR ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Avis Budget Group, Inc. - June 24, 2025 Deadline
- NEW YORK, NY / ACCESS Newswire / May 21, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=149479&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq.
- 05/21/2025
|
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Avis Budget Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAR
- NEW YORK CITY, NY / ACCESS Newswire / May 21, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Avis Budget Group, Inc. (NASDAQ:CAR) between February 16, 2024 and February 10, 2025, both dates inclusive (the "Class Period"), of the important June 24, 2025 lead plaintiff deadline. SO WHAT: If you purchased Avis Budget securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
- 05/21/2025
|
Class Action Lawsuit Filed: Avis Budget Group, Inc. (CAR) - Join by June 24, 2025 - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=149421&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq.
- 05/20/2025
|
Securities Lawsuit Alert: Avis Budget Group, Inc. (CAR) - Contact Levi & Korsinsky Before June 24, 2025
- NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=149390&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq.
- 05/20/2025
|
Avis Budget Group, Inc. (CAR) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before June 24, 2025
- NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=149383&wire=1&utm_campaign=4 or contact Joseph E. Levi, Esq.
- 05/20/2025
|
Pomerantz Law Firm Announces the Filing of a Class Action Against Avis Budget Group, Inc. and Certain Officers - CAR
- NEW YORK , May 20, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Avis Budget Group, Inc. ("Avis Budget" or the "Company") (NASDAQ: CAR) and certain officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed under 25-cv-03332 , is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Avis Budget securities between February 16, 2024 and February 10, 2025, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 ("Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
- 05/20/2025
|
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Avis Budget Group, Inc. (CAR) Investors of June 24, 2025 Deadline
- NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=149334&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq.
- 05/20/2025
|
CAR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Avis Budget Group, Inc. to Contact the Firm Today!
- NEW YORK CITY, NY / ACCESS Newswire / May 20, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ:CAR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Avis Budget securities between February 16, 2024 and February 10, 2025, both dates inclusive (the "Class Period").
- 05/20/2025
|
Levi & Korsinsky Notifies Shareholders of Avis Budget Group, Inc.(CAR) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK , May 20, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Avis Budget Group, Inc. ("Avis Budget" or the "Company") (NASDAQ: CAR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Avis Budget investors who were adversely affected by alleged securities fraud between February 16, 2024 and February 10, 2025.
- 05/20/2025
|
Lost Money on Avis Budget Group, Inc. (CAR)? Join Class Action Before June 24, 2025 - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / May 19, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=149292&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq.
- 05/19/2025
|
ROSEN, A TOP RANKED LAW FIRM, Encourages Avis Budget Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAR
- NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Avis Budget Group, Inc. (NASDAQ: CAR) between February 16, 2024 and February 10, 2025, both dates inclusive (the “Class Period”), of the important June 24, 2025 lead plaintiff deadline.
- 05/19/2025
|
Securities Lawsuit Alert: Avis Budget Group, Inc. (CAR) - Contact Levi & Korsinsky Before June 24, 2025
- NEW YORK, NY / ACCESS Newswire / May 19, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=149267&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq.
- 05/19/2025
|
CAR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Avis Budget Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Avis Budget Group, Inc. (“Avis Budget” or “the Company”) (NASDAQ: CAR) and certain of its officers.
- 05/19/2025
|
The Gross Law Firm Reminds Avis Budget Group, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 24, 2025 - CAR
- NEW YORK , May 19, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Avis Budget Group, Inc. (NASDAQ: CAR). Shareholders who purchased shares of CAR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
- 05/19/2025
|
Levi & Korsinsky Notifies Shareholders of Avis Budget Group, Inc. (CAR) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Avis Budget Group, Inc. ("Avis Budget" or the "Company") (NASDAQ: CAR) of a class action securities lawsuit.
- 05/19/2025
|
Class Action Filed Against Avis Budget Group, Inc. (CAR) Over Securities Violations - Contact Levi & Korsinsky Today
- NEW YORK, NY / ACCESS Newswire / May 19, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=149209&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq.
- 05/19/2025
|
Pomerantz Law Firm Announces the Filing of a Class Action Against Avis Budget Group, Inc. and Certain Officers - CAR
- NEW YORK, NY / ACCESS Newswire / May 19, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Avis Budget Group, Inc.("Avis Budget" or the "Company") (NASDAQ:CAR) and certain officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed under 25-cv-03332 , is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Avis Budget securities between February 16, 2024 and February 10, 2025, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 ("Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
- 05/19/2025
|
Levi & Korsinsky Urges Avis Budget Group, Inc. (CAR) Shareholders to Act Before Lead Plaintiff Deadline June 24, 2025
- NEW YORK, NY / ACCESS Newswire / May 19, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=149159&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq.
- 05/19/2025
|
Avis Budget Group, Inc. (CAR) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of June 24, 2025 Deadline
- NEW YORK, NY / ACCESS Newswire / May 19, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=149157&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq.
- 05/19/2025
|
CAR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Avis Budget Group, Inc. to Contact the Firm Today!
- NEW YORK CITY, NY / ACCESS Newswire / May 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ:CAR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Avis Budget securities between February 16, 2024 and February 10, 2025, both dates inclusive (the "Class Period").
- 05/19/2025
|
June 24, 2025 Deadline Approaching: Join Class Action Against Avis Budget Group, Inc. (CAR) - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=149095&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq.
- 05/18/2025
|
Did You Lose Money on Avis Budget Group, Inc. (CAR)? Levi & Korsinsky Urges Investors to Act Before June 24, 2025
- NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=149080&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq.
- 05/18/2025
|
Investor Alert: Deadline Approaching to Join Avis Budget Group, Inc. (CAR) Class Action - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=149050&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq.
- 05/18/2025
|
Class Action Alert: Levi & Korsinsky Reminds Avis Budget (CAR) Investors of June 24, 2025 Deadline
- NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=149045&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq.
- 05/18/2025
|
TOP RANKED ROSEN LAW FIRM Encourages Avis Budget Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CAR
- NEW YORK CITY, NY / ACCESS Newswire / May 18, 2025 / WHY: New York, N.Y., May 18, 2025.
- 05/18/2025
|
CAR Investors Have the Opportunity to Lead the Avis Budget Group Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
- Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Avis To Contact Him Directly To Discuss Their Options
- 05/18/2025
|
Investor Alert: Deadline Approaching to Join Avis Budget Group, Inc. (CAR) Class Action - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=149022&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq.
- 05/18/2025
|
CAR Stockholders Have Opportunity to Lead Avis Budget Group, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
- NEW YORK CITY, NY / ACCESS Newswire / May 18, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ:CAR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Avis Budget securities between February 16, 2024 and February 10, 2025, both dates inclusive (the "Class Period").
- 05/18/2025
|
Lost Money on Avis Budget Group, Inc. (CAR)? Join Class Action Before June 24, 2025 - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / May 17, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=148980&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq.
- 05/17/2025
|
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Avis Budget Group, Inc.(CAR) Shareholders
- NEW YORK, NY / ACCESS Newswire / April 30, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=146307&wire=1 or contact Joseph E. Levi, Esq.
- 04/30/2025
|
ROSEN, A LONGSTANDING LAW FIRM, Encourages Avis Budget Group, Inc. to Secure Counsel Before Important Deadline in Securities Class Action - CAR
- NEW YORK, NY / ACCESS Newswire / April 30, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Avis Budget Group, Inc. (NASDAQ:CAR) between February 16, 2024 and February 10, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.
- 04/30/2025
|
Levi & Korsinsky Notifies Shareholders of Avis Budget Group, Inc. (CAR) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / April 30, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=146297&wire=1 or contact Joseph E. Levi, Esq.
- 04/30/2025
|
Avis Budget Group, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the Securities Fraud Class Action Lawsuit Against CAR
- Robbins LLP is Investigating Allegations that Avis Budget Group, Inc. (CAR) Misled Investors Regarding the Company's Strategy to Accelerate Fleet Rotations
- 04/30/2025
|
Levi & Korsinsky Notifies Shareholders of Avis Budget Group, Inc. (CAR) of a Class Action Lawsuit and an Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / April 30, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=146276&wire=1 or contact Joseph E. Levi, Esq.
- 04/30/2025
|
Securities Fraud Investigation Into Avis Budget Group, Inc. (CAR) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
- LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Avis Budget Group, Inc. (“Avis” or the “Company”) (NASDAQ: CAR) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON AVIS BUDGET GROUP, INC. (CAR), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On F.
- 04/30/2025
|
Earnings Preview: Avis Budget Group (CAR) Q1 Earnings Expected to Decline
- Avis Budget (CAR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/30/2025
|
CAR LAWSUIT ALERT: Levi & Korsinsky Notifies Avis Budget Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
- NEW YORK, NY / ACCESS Newswire / April 30, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=146223&wire=1 or contact Joseph E. Levi, Esq.
- 04/30/2025
|
Pomerantz Law Firm Announces the Filing of a Class Action Against Avis Budget Group, Inc. and Certain Officers - CAR
- NEW YORK CITY, NY / ACCESS Newswire / April 30, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Avis Budget Group, Inc.("Avis Budget" or the "Company") (NASDAQ:CAR) and certain officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed under 25-cv-03332 , is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Avis Budget securities between February 16, 2024 and February 10, 2025, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 ("Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
- 04/30/2025
|
Shareholders That Lost Money on Avis Budget Group, Inc. (CAR) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- NEW YORK, NY / ACCESS Newswire / April 30, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=146143&wire=1 or contact Joseph E. Levi, Esq.
- 04/30/2025
|
CAR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Avis Budget Group, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
- NEW YORK CITY, NY / ACCESS Newswire / April 30, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ:CAR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Avis Budget securities between February 16, 2024 and February 10, 2025, both dates inclusive (the "Class Period").
- 04/30/2025
|
Shareholders that Lost Money on Avis Budget Group, Inc. (CAR) Should Contact Levi & Korsinsky about Pending Class Action - CAR
- NEW YORK, NY / ACCESS Newswire / April 29, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=146104&wire=1 or contact Joseph E. Levi, Esq.
- 04/29/2025
|
AVIS BUDGET ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Avis Budget Group, Inc. and Encourages Investors to Contact the Firm
- NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Avis Budget Group, Inc. (“Avis Budget” or the “Company”) (NASDAQ:CAR) in the United States District Court for the District of New Jersey on behalf of all persons and entities who purchased or otherwise acquired Avis Budget securities between February 16, 2024 and February 10, 2025, both dates inclusive (the “Class Period”). Investors have until June 24, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
- 04/29/2025
|
Avis Budget Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before June 24, 2025 to Discuss Your Rights - CAR
- NEW YORK, NY / ACCESS Newswire / April 29, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=146100&wire=1 or contact Joseph E. Levi, Esq.
- 04/29/2025
|
Levi & Korsinsky Reminds Avis Budget Group, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 24, 2025 - CAR
- NEW YORK, NY / ACCESS Newswire / April 29, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=146092&wire=1 or contact Joseph E. Levi, Esq.
- 04/29/2025
|
Investors Who Lost Money on Avis Budget Group, Inc. (CAR) Should Contact Levi & Korsinsky About Pending Class Action - CAR
- NEW YORK, NY / ACCESS Newswire / April 29, 2025 / If you suffered a loss on your Avis Budget Group, Inc. (NASDAQ:CAR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/avis-budget-lawsuit-submission-form?prid=146066&wire=1 or contact Joseph E. Levi, Esq.
- 04/29/2025
|
Avis Budget Group, Inc. (CAR) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
- BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Avis Budget Group, Inc. (“Avis” or the “Company”) (NASDAQ: CAR) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN AVIS BUDGET GROUP, INC. (CAR), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights b.
- 04/29/2025
|
ROSEN, A TOP-RANKED LAW FIRM, Encourages Avis Budget Group, Inc. to Secure Counsel Before Important Deadline in Securities Class Action - CAR
- NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Avis Budget Group, Inc. (NASDAQ: CAR) between February 16, 2024 and February 10, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 24, 2025.
- 04/29/2025
|
CAR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Avis Budget Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
- NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Avis Budget Group, Inc. (“Avis Budget” or “the Company”) (NASDAQ: CAR) and certain of its officers.
- 04/29/2025
|
Securities Fraud Investigation Into Avis Budget Group, Inc. (CAR) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
- LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Avis Budget Group, Inc. (“Avis” or the “Company”) (NASDAQ: CAR) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON AVIS BUDGET GROUP, INC. (CAR), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On February 11, 2025, Avis released its fourth quarter and ful.
- 04/29/2025
|
CAR INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Avis Budget Group, Inc. Investors with Substantial Losses Have Opportunity to Lead the Avis Budget Class Action Lawsuit
- SAN DIEGO, April 25, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that the Avis Budget class action lawsuit seeks to represent purchasers or acquirers of Avis Budget Group, Inc. (NASDAQ: CAR) securities between February 16, 2024 and February 10, 2025, inclusive (the “Class Period”). Captioned Merriam v. Avis Budget Group, Inc., No. 25-cv-03332 (D.N.J.), the Avis Budget class action lawsuit charges Avis Budget and certain of Avis Budget's top executives with violations of the Securities Exchange Act of 1934.
- 04/25/2025
|
5 Broker-Loved Stocks to Keep a Tab on Amid Signs of Easing Trade Woes
- Investors would do well to monitor broker-loved stocks like CAR, ABM, CVI, DK and ABG for high returns.
- 04/24/2025
|
Avis Budget Group to Announce First Quarter 2025 Results on May 7th
- PARSIPPANY, N.J., April 17, 2025 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) announced today that it plans to report its first quarter 2025 results after the market close on Wednesday, May 7th, 2025, and to host a conference call for institutional investors to discuss these results on Thursday, May 8th, 2025 at 8:30 a.m.
- 04/17/2025
|
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
- SAN JOSE, Calif. , April 14, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a new patent application covering its chimeric antigen receptor-T cell (CAR-T) technology.
- 04/14/2025
|
CAR Benefits From Demand in North America Despite Rising Fleet Costs
- Avis Budget Group's stock is benefiting from strategic fleet management, enabling it to deal with a turbulent supply chain.
- 04/08/2025
|
Chase the Rebound in Avis (CAR) Stock Amid Trump's Auto Tariff Boost?
- Avis (CAR) shares have risen more than +20% over the last week as President Trump's 25% tariffs on all imported vehicles are likely to boost the fleet value for the leading rental car operator.
- 04/02/2025
|
Avis Budget Is A Prime Beneficiary From Auto Tariffs (Upgrade)
- Shares of Avis Budget Group, Inc. have gained 20% recently due to President Trump's tariffs on new cars, which should benefit CAR's used car holdings. The 25% tariff on imported vehicles is expected to increase new car prices by 5-8%, driving up used car prices by 5-15%. Avis's financials are closely tied to used car prices, with potential gains of $3-4 billion from higher used car prices over the next 12-18 months.
- 03/28/2025
|
Avis and Hertz Could Be Winners Amid Trump's Auto Tariffs
- President Trump's auto tariffs are bad news for much of the auto industry—but not rental car companies.
- 03/28/2025
|
Hertz, Avis stocks surge as Trump auto tariffs could make used rental car fleets look shinier
- On Thursday, stocks of car rental companies Hertz and Avis saw their values unexpectedly take off. As of midday, shares of Hertz Global Holdings were trading at around $4.15, an intraday increase of more than 20%.
- 03/28/2025
|
Hertz and Avis surge as Trump's auto tariffs spark rental boom
- Shares of Hertz (HTZ) and Avis Budget Group (CAR) surged on Thursday after US President Donald Trump announced a plan to impose a 25% tariff on imported vehicles. The proposed levies are expected to increase car prices, potentially driving more consumers toward rental services instead of purchasing new vehicles.
- 03/27/2025
|
Why Car Rental Stocks Are Surging Today
- Geopolitical news is providing a lift to the auto rental sector.
- 03/27/2025
|
Hertz, Avis Budget Shares Surge Following Looming Auto Tariffs
- Hertz Global Holding and Avis Budget Group shares surged after President Trump announced tariffs that would bring fresh complications to auto manufacturers.
- 03/27/2025
|
Car rental firms Hertz, Avis zoom as tariffs seen hurting new-vehicle demand
- Shares of highly shorted Hertz and Avis Budget Group surged on Thursday as U.S. President Donald Trump's plan to slap a 25% tariff on imported vehicles raised prospects of consumers opting for car rentals instead of buying expensive new cars.
- 03/27/2025
|
Alviona who wants to be my Alviona Avis partner Weight Loss Results
- ALMERE, Netherlands, March 25, 2025 (GLOBE NEWSWIRE) -- The foundation of weight reduction therapy, which was discovered a century ago, is the utilization of the body's innate mechanism for energy production. Due to its propensity to produce quick and long-lasting weight loss, a weight-loss diet has become a popular therapeutic approach. It improves your exercise outcomes and helps you become a healthier, thinner version of yourself. While some people lack the time or motivation to follow the rigorous guidelines of a weight loss program, others are searching for a means to avoid unappealing diets. Without any advice or recommendations, the majority of people take weight reduction supplements and frequently wind up purchasing phony goods.
- 03/25/2025
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avis Budget Group, Inc. - CAR
- NEW YORK, NY / ACCESS Newswire / March 19, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Avis Budget Group, Inc ("Avis Budget" or the "Company") (NASDAQ:CAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 03/19/2025
|
AVIS AUX MÉDIAS : Les travailleurs réclament des soutiens gouvernementaux immédiats et décisifs face aux licenciements et à l'incertitude
- HAWKESBURY, Ontario, March 18, 2025 (GLOBE NEWSWIRE) -- Des soutiens gouvernementaux sont indispensables face aux nouvelles pertes d'emplois découlant des tarifs douaniers imposés par les États-Unis sur les exportations canadiennes d'acier et d'aluminium. Le Syndicat des Métallos et le Congrès du travail du Canada (CTC) organisent un point de presse à Hawkesbury, dans l'est de l'Ontario, auquel participeront les sections locales des Métallos touchées par les licenciements permanents et temporaires annoncés par Ivaco Rolling Mills ces deux dernières semaines.
- 03/18/2025
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avis Budget Group, Inc. - CAR
- NEW YORK , March 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Avis Budget Group, Inc ("Avis Budget" or the "Company") (NASDAQ: CAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 03/17/2025
|
Avis Budget (CAR) Surges 11.6%: Is This an Indication of Further Gains?
- Avis Budget (CAR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- 03/17/2025
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avis Budget Group, Inc. - CAR
- NEW YORK, NY / ACCESS Newswire / March 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Avis Budget Group, Inc ("Avis Budget" or the "Company") (NASDAQ:CAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 03/15/2025
|
Why Avis Budget Group Stock Was Stalling This Week
- The auto industry is currently in a state of nervous anticipation, and that's not good for associated companies. One striking case in point is auto rental mainstay Avis Budget Group (CAR -11.41%), whose share price according to data compiled by S&P Global Market Intelligence was down by more than 25% week to date as of early Friday morning.
- 03/14/2025
|
Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma
- PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Breyanzi--BMS Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma.
- 03/14/2025
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avis Budget Group, Inc. - CAR
- NEW YORK CITY, NY / ACCESS Newswire / March 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Avis Budget Group, Inc ("Avis Budget" or the "Company") (NASDAQ:CAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 03/13/2025
|
Avis de convocation aux AGE et AGO du 28 mars 2025
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avis Budget Group, Inc. - CAR
- NEW YORK , March 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Avis Budget Group, Inc ("Avis Budget" or the "Company") (NASDAQ: CAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 03/11/2025
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avis Budget Group, Inc. - CAR
- NEW YORK CITY, NY / ACCESS Newswire / March 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Avis Budget Group, Inc ("Avis Budget" or the "Company") (NASDAQ:CAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 03/09/2025
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avis Budget Group, Inc. - CAR
- NEW YORK, NY / ACCESS Newswire / March 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Avis Budget Group, Inc ("Avis Budget" or the "Company") (NASDAQ:CAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 03/07/2025
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avis Budget Group, Inc. - CAR
- NEW YORK, NY / ACCESS Newswire / March 5, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Avis Budget Group, Inc ("Avis Budget" or the "Company") (NASDAQ:CAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 03/05/2025
|
Autolus Therapeutics: Beaten Down, Cash Rich, Poised To Launch A CAR-T Cell Therapy
- Autolus Therapeutics' main focus is on obe-cel, a CAR T-cell therapy for B-cell ALL, with a strong likelihood of approval. AUTL has $657.1 million in cash, providing a cash runway of approximately 3 years, alleviating immediate financial concerns. The company faces significant competition in the CD19 CAR T-cell therapy market, making sales execution crucial for success.
- 03/04/2025
|
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Avis Budget Group, Inc. for potential violations of securities laws
- PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION NEW YORK , March 4, 2025 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avis Budget Group, Inc. ("ABG") (NASDAQ: CAR). The investigation concerns whether Avis Budget Group, Inc. and certain of its officers and/or directors have engaged in securities fraud.
- 03/04/2025
|
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Avis Budget Group, Inc. for potential violations of securities laws
- PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION
- 03/03/2025
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avis Budget Group, Inc. - CAR
- NEW YORK , March 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Avis Budget Group, Inc ("Avis Budget" or the "Company") (NASDAQ: CAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 03/03/2025
|
CARsgen's Claudin18.2 CAR-T Therapy Satri-cel Granted Breakthrough Therapy Designation by the NMPA
- SHANGHAI , March 2, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation (BTD) to satricabtagene autoleucel ("satri-cel", CT041) for the treatment of Claudin18.2-positive advanced gastric/gastroesophageal junction cancer (G/GEJ) in patients who have failed at least two prior lines of therapy. The company plans to submit a New Drug Application (NDA) for satri-cel to the NMPA in the first half of 2025.
- 03/02/2025
|
The Schall Law Firm Invites Shareholders With Losses In Avis Budget Group, Inc. To Join A Securities Fraud Investigation
- LOS ANGELES, CA / ACCESS Newswire / March 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ:CAR) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 03/02/2025
|
An Investigation Has Been Launched Into Avis Budget Group, Inc. For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / March 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ:CAR) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 03/01/2025
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avis Budget Group, Inc. - CAR
- NEW YORK, NY / ACCESS Newswire / March 1, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Avis Budget Group, Inc ("Avis Budget" or the "Company") (NASDAQ:CAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 03/01/2025
|
The Schall Law Firm Invites Shareholders With Losses In Avis Budget Group, Inc. To Join A Securities Fraud Investigation
- LOS ANGELES, CA / ACCESS Newswire / February 28, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ:CAR) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 02/28/2025
|
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avis Budget Group, Inc. (CAR) And Encourages Shareholders to Reach Out
- NEW YORK, NY / ACCESS Newswire / February 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ:CAR). Investors who purchased Avis Budget securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CAR.
- 02/28/2025
|
CARsgen's Allogeneic CD19/CD20 CAR-T Therapy Administers First Dose in a Patient with Autoimmune Disease
- SHANGHAI , Feb. 27, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that KJ-C2219, an allogeneic CAR-T therapy targeting CD19/CD20, has administered at the starting dose specified in the clinical protocol to the first patient with systemic lupus erythematosus (SLE) in an investigator-initiated trial (IIT). KJ-C2219 is developed using THANK-u Plus™ platform.
- 02/27/2025
|
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avis Budget Group, Inc. (CAR) and Encourages Shareholders to Learn More About the Investigation
- NEW YORK, NY / ACCESS Newswire / February 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ:CAR). Investors who purchased Avis Budget securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CAR.
- 02/27/2025
|
An Investigation Has Commenced on Behalf of Avis Budget Group, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your CAR Losses.
- NEW YORK, NY / ACCESS Newswire / February 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Avis Budget Group, Inc. ("Avis Budget") (NASDAQ:CAR) concerning possible violations of federal securities laws. Avis Budget issued a press release on February 11, 2025, reporting its financial results for the fourth quarter and full year 2024.
- 02/26/2025
|
FIX-IT DAY 2025: FREE CAR REPAIRS FOR LOS ANGELES RESIDENTS IN NEED
- CarParts.com, Safe Parking LA & Partners Unite to Provide Critical Auto Repairs For Individuals and Families Facing Hard Times TORRANCE, Calif. , Feb. 26, 2025 /PRNewswire/ -- CarParts.com, Inc. (NASDAQ: PRTS), a leading eCommerce destination for automotive parts and accessories, is launching Fix-It Day 2025, a community-driven initiative providing free car repairs to struggling individuals and families.
- 02/26/2025
|
Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial
- SAN JOSE, Calif. , Feb. 26, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced has it has dosed its final patient in the third cohort of its ongoing Phase 1 clinical trial evaluating its novel chimeric antigen receptor-T cell (CAR-T) therapy for recurrent ovarian cancer.
- 02/26/2025
|
Levi & Korsinsky Announces an Investigation on Behalf of Avis Budget Group, Inc. (CAR) Shareholders Who May Have Been Affected by Fraud
- NEW YORK, NY / ACCESS Newswire / February 25, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Avis Budget Group, Inc. ("Avis Budget") (NASDAQ:CAR) concerning possible violations of federal securities laws. Avis Budget issued a press release on February 11, 2025, reporting its financial results for the fourth quarter and full year 2024.
- 02/25/2025
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avis Budget Group, Inc. - CAR
- NEW YORK , Feb. 25, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Avis Budget Group, Inc ("Avis Budget" or the "Company") (NASDAQ: CAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 02/25/2025
|
Avis Budget Group, Inc. (CAR) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
- NEW YORK, NY / ACCESS Newswire / February 25, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Avis Budget Group, Inc. ("Avis Budget") (NASDAQ:CAR) concerning possible violations of federal securities laws. Avis Budget issued a press release on February 11, 2025, reporting its financial results for the fourth quarter and full year 2024.
- 02/25/2025
|
An Investigation Has Been Launched Into Avis Budget Group, Inc. For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / February 25, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ:CAR) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 02/25/2025
|
Bronstein, Gewirtz & Grossman, LLC Encourages Avis Budget Group, Inc. (CAR) Shareholders to Inquire about Securities Investigation
- NEW YORK, NY / ACCESS Newswire / February 25, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ:CAR). Investors who purchased Avis Budget securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CAR.
- 02/25/2025
|
CARsgen Therapeutics Introduced Zhuhai SB Xinchuang to Accelerate Allogeneic CAR-T Cell Products Development in Mainland China
- SHANGHAI , Feb. 25, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK, "CARsgen Therapeutics"), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces reaching agreements with an investment fund managed by Zhuhai Hengqin SB Xinchuang Equity Investment Management Enterprise (Limited Partnership) ("Zhuhai SB Xinchuang") to jointly invest in UCARsgen Biotech Limited ("UCARsgen"), a China-based new drug discovery biotechnology company focused on allogeneic CAR-T cell therapies for the treatment of hematologic malignancies. Under the agreements, UCARsgen has secured the exclusive rights in mainland China for the research, development, manufacture, and commercialization of the following allogeneic CAR-T products from CARsgen Therapeutics: the BCMA-targeted allogeneic CAR-T cell therapy for the treatment of multiple myeloma and plasma cell leukemia and the CD19/CD20 dual-targeted allogeneic CAR-T cell therapy for the treatment of B-cell malignancies.
- 02/25/2025
|
Allogene Therapeutics: Disrupting CAR-T With A Scalable Model
- Allogene Therapeutics: Disrupting CAR-T With A Scalable Model
- 02/24/2025
|
Avis Budget Group, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - CAR
- NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Avis Budget Group, Inc. ("Avis Budget") (NASDAQ:CAR) concerning possible violations of federal securities laws. Avis Budget issued a press release on February 11, 2025, reporting its financial results for the fourth quarter and full year 2024.
- 02/24/2025
|
Avis Budget Group, Inc. (CAR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
- NEW YORK, NY / ACCESS Newswire / February 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ:CAR). Investors who purchased Avis Budget securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CAR.
- 02/24/2025
|
Anixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer
- SAN JOSE, Calif. , Feb. 24, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today is pleased to announce that its pioneering CAR-T therapy for ovarian cancer, developed in collaboration with Moffitt Cancer Center ("Moffitt"), was prominently featured in Breaking Cancer News in an article titled "Navigating Uncharted Territory: CAR-T for Ovarian Cancer.
- 02/24/2025
|
Hemogenyx shares jump 13% as first-in-human trial of CAR-T therapy begins
- Shares in Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) surged 13% in the first hour of trading after the company announced it had administered the first human dose of its experimental CAR-T cell therapy, HG-CT-1. The treatment is designed for adults with relapsed or treatment-resistant acute myeloid leukaemia, a condition with few options and a poor prognosis.
- 02/24/2025
|
Avis Budget Group, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details- CAR
- NEW YORK, NY / ACCESS Newswire / February 23, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Avis Budget Group, Inc. ("Avis Budget") (NASDAQ:CAR) concerning possible violations of federal securities laws. Avis Budget issued a press release on February 11, 2025, reporting its financial results for the fourth quarter and full year 2024.
- 02/23/2025
|
An Investigation Has Been Launched Into Avis Budget Group, Inc. For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm
- LOS ANGELES, CA / ACCESS Newswire / February 23, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ:CAR) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 02/23/2025
|
Lost Money on Avis Budget Group, Inc. (CAR)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
- NEW YORK CITY, NY / ACCESS Newswire / February 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Avis Budget Group, Inc. ("Avis Budget") (NASDAQ:CAR) concerning possible violations of federal securities laws. Avis Budget issued a press release on February 11, 2025, reporting its financial results for the fourth quarter and full year 2024.
- 02/18/2025
|
The Schall Law Firm Invites Shareholders With Losses In Avis Budget Group, Inc. To Join A Securities Fraud Investigation
- LOS ANGELES, CA / ACCESS Newswire / February 18, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ:CAR) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
- 02/18/2025
|
ATTENTION Avis Budget Group, Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights
- NEW YORK, NY / ACCESS Newswire / February 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Avis Budget Group, Inc. ("Avis Budget") (NASDAQ:CAR) concerning possible violations of federal securities laws. Avis Budget issued a press release on February 11, 2025, reporting its financial results for the fourth quarter and full year 2024.
- 02/18/2025
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avis Budget Group, Inc. - CAR
- NEW YORK , Feb. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Avis Budget Group, Inc ("Avis Budget" or the "Company") (NASDAQ: CAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 02/18/2025
|
CAR Investors Have Opportunity to Join Avis Budget Group, Inc. Fraud Investigation with the Schall Law Firm
- LOS ANGELES--(BUSINESS WIRE)--CAR Investors Have Opportunity to Join Avis Budget Group, Inc. Fraud Investigation with the Schall Law Firm.
- 02/18/2025
|
Shareholders that lost money on Avis Budget Group, Inc.(CAR) should contact Levi & Korsinsky about Securities Fraud Investigation - CAR
- NEW YORK, NY / ACCESS Newswire / February 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Avis Budget Group, Inc. ("Avis Budget") (NASDAQ:CAR) concerning possible violations of federal securities laws. Avis Budget issued a press release on February 11, 2025, reporting its financial results for the fourth quarter and full year 2024.
- 02/18/2025
|
Avis Budget Group, Inc. (CAR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
- NEW YORK, NY / ACCESS Newswire / February 18, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ:CAR). Investors who purchased Avis Budget securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CAR.
- 02/18/2025
|
Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial
- Amendment expands the potential benefits of CAR-T therapy allowing a second dose and includes more ovarian cancer histologies SAN JOSE, Calif. , Feb. 18, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer today announced that it, along with its partner Moffitt Cancer Center ("Moffitt"), has received approval for an amendment to the protocol governing its ongoing clinical trial using CAR-T therapy for the treatment of ovarian cancer (NCT05316129).
- 02/18/2025
|
ATTENTION CAR SHAREHOLDERS: Investors who lost money on Avis Budget Group, Inc. are urged to contact Levi & Korsinsky about an ongoing investigation
- NEW YORK, NY / ACCESS Newswire / February 17, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Avis Budget Group, Inc. ("Avis Budget") (NASDAQ:CAR) concerning possible violations of federal securities laws. Avis Budget issued a press release on February 11, 2025, reporting its financial results for the fourth quarter and full year 2024.
- 02/17/2025
|
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avis Budget Group, Inc. (CAR) and Encourages Stockholders to Learn More About the Investigation
- NEW YORK, NY / ACCESS Newswire / February 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ:CAR). Investors who purchased Avis Budget securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CAR.
- 02/17/2025
|
Levi & Korsinsky Reminds Shareholders of an Investigation into Avis Budget Group, Inc. (CAR) Regarding Potential Securities Fraud Allegations
- NEW YORK, NY / ACCESS Newswire / February 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Avis Budget Group, Inc. ("Avis Budget") (NASDAQ:CAR) concerning possible violations of federal securities laws. Avis Budget issued a press release on February 11, 2025, reporting its financial results for the fourth quarter and full year 2024.
- 02/16/2025
|
Bronstein, Gewirtz & Grossman, LLC Encourages Avis Budget Group, Inc. (CAR) Investors to Inquire about Securities Investigation
- NEW YORK, NY / ACCESS Newswire / February 16, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ:CAR). Investors who purchased Avis Budget securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CAR.
- 02/16/2025
|
Avis Budget Group, Inc. (CAR) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates
- NEW YORK, NY / ACCESS Newswire / February 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Avis Budget Group, Inc. ("Avis Budget") (NASDAQ:CAR) concerning possible violations of federal securities laws. Avis Budget issued a press release on February 11, 2025, reporting its financial results for the fourth quarter and full year 2024.
- 02/15/2025
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avis Budget Group, Inc. - CAR
- NEW YORK, NY / ACCESS Newswire / February 15, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Avis Budget Group, Inc ("Avis Budget" or the "Company") (NASDAQ:CAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 02/15/2025
|
Canadian Apartments: You Have To Step Up To Buy Here
- CAPREIT reported strong Q4-2024 results. Notable items included a 3% distribution hike and a very substantial buyback. We go over the results and tell you why we are upgrading to a strong buy.
- 02/14/2025
|
Canadian Apartment Properties Real Estate Investment Trust (CDPYF) Q4 2024 Earnings Call Transcript
- Canadian Apartment Properties Real Estate Investment Trust (OTC:CDPYF) Q4 2024 Earnings Conference Call February 14, 2025 9:00 AM ET Company Participants Nicole Dolan - Investor Relations Mark Kenney - President & Chief Executive Officer Julian Schonfeldt - Chief Investment Officer Stephen Co - Chief Financial Officer Conference Call Participants Jonathan Kelcher - TD Cowen Brad Sturges - Raymond James Kyle Stanley - Desjardins Matt Kornack - National Bank Financial Jimmy Shan - RBC Capital Markets Mike Markidis - BMO Capital Markets Mario Saric - Scotiabank Dean Wilkinson - CIBC Operator Hello, everyone, and welcome to Canadian Apartment Properties REIT Fourth Quarter 2024 Results Conference Call. My name is Lydia, and I will be your operator today.
- 02/14/2025
|
Lost Money on Avis Budget Group, Inc. (CAR)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
- NEW YORK, NY / ACCESS Newswire / February 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Avis Budget Group, Inc. ("Avis Budget") (NASDAQ:CAR) concerning possible violations of federal securities laws. Avis Budget issued a press release on February 11, 2025, reporting its financial results for the fourth quarter and full year 2024.
- 02/14/2025
|
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avis Budget Group, Inc. (CAR) And Encourages Investors to Reach Out
- NEW YORK, NY / ACCESS Newswire / February 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Avis Budget Group, Inc. ("Avis Budget" or "the Company") (NASDAQ:CAR). Investors who purchased Avis Budget securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CAR.
- 02/14/2025
|
Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview
- SAN JOSE, Calif. , Feb. 14, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its Chairman and CEO, Dr. Amit Kumar, was featured in an interview with Alpha Wolf Trading.
- 02/14/2025
|
Shareholder Rights Advocates at Levi & Korsinsky Investigate Avis Budget Group, Inc. (CAR) Regarding Possible Securities Fraud Violations
- NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Avis Budget Group, Inc. ("Avis Budget") (NASDAQ:CAR) concerning possible violations of federal securities laws. Avis Budget issued a press release on February 11, 2025, reporting its financial results for the fourth quarter and full year 2024.
- 02/13/2025
|
Allogene Therapeutics Announces Publication of Durable Response Data from Phase 1 ALPHA/ALPHA2 Trials of the Allogeneic CAR T Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma in the Journal of Clinical Oncology
- SOUTH SAN FRANCISCO, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today announced the publication of data from its Phase 1 ALPHA and ALPHA2 clinical studies of cemacabtagene ansegedleucel (cema-cel; formerly ALLO-501/A) in relapsed/refractory (R/R) large B-cell lymphoma (LBCL) as a Rapid Communication in the Journal of Clinical Oncology. These results represent the largest dataset of LBCL patients treated with an allogeneic CAR T product and, with a minimum of two years of follow-up, the longest follow-up to date.
- 02/13/2025
|
Avis Budget Stock Price Decreases 7% Since Reporting Loss in Q4
- CAR's top line in the fourth quarter of 2024 takes a hit as revenues in the Americas decline.
- 02/13/2025
|
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avis Budget Group, Inc. - CAR
- NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Avis Budget Group, Inc ("Avis Budget" or the "Company") (NASDAQ:CAR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
- 02/13/2025
|
Avis Budget Group, Inc. (CAR) Q4 2024 Earnings Call Transcript
- Avis Budget Group, Inc. (NASDAQ:CAR ) Q4 2024 Earnings Conference Call February 12, 2025 8:30 AM ET Company Participants David Calabria - SVP, Corporate Finance and Treasurer Joseph Ferraro - President and CEO Izilda Martins - EVP and CFO Brian Choi - Executive VP and Chief Transformation Officer Conference Call Participants John Babcock - Bank of America Christopher Stathoulopoulos - Susquehanna Financial Harold Antor - Jefferies Jash Patwa - J.P. Morgan Chase Dan Levy - Barclays Bank Chris Woronka - Deutsche Bank Operator Greetings, and welcome to the Avis Budget Group's Fourth Quarter and Full Year 2024 Conference Call.
- 02/12/2025
|
Avis Budget (CAR) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
- The headline numbers for Avis Budget (CAR) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 02/11/2025
|
Avis Budget Group (CAR) Reports Q4 Loss, Misses Revenue Estimates
- Avis Budget Group (CAR) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.96. This compares to earnings of $7.10 per share a year ago.
- 02/11/2025
|
Avis Budget Group Reports Fourth Quarter and Full Year Results
- PARSIPPANY, N.J., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) announced financial results for the fourth quarter and full year ended December 31, 2024 today.
- 02/11/2025
|
CARsgen's First Enrolled Subject in the THANK-u Plus™ Platform-Based Allogeneic CAR-T Trial Achieves sCR at Week 4
- SHANGHAI , Feb. 9, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the first subject treated with an allogeneic BCMA CAR-T therapy developed on the THANK-u Plus™ platform, has achieved stringent complete response (sCR) and minimal residual disease (MRD) negativity at the Day-28 assessment. The patient, diagnosed with relapsed/refractory multiple myeloma, IgA-λ type (R-ISS Stage II), had previously undergone three lines of combination therapy along with autologous hematopoietic stem cell transplantation.
- 02/09/2025
|
Avis Budget Group to Announce Fourth Quarter 2024 Results on February 11th
- PARSIPPANY, N.J., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) announced today that it plans to report its fourth quarter 2024 results after the market close on Tuesday, February 11th, 2025, and to host a conference call for institutional investors to discuss these results on Wednesday, February 12th, 2025 at 8:30 a.m.
- 02/07/2025
|
5 Broker-Favorite Stocks to Keep an Eye on Amid Current Volatility
- Investors should keep a tab on stocks like General Motors, Dana, Valero Energy, National Vision and Avis Budget for high returns.
- 02/03/2025
|
Avis Budget Group (CAR) Expected to Beat Earnings Estimates: Should You Buy?
- Avis Budget (CAR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 02/03/2025
|
Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma
- PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Breyanzi--Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma.
- 01/31/2025
|
BROAD ARROW WELCOMES RENOWNED CAR SPECIALISTS TO EUROPEAN TEAM
- PHILIP KANTOR, GREGORY TUYTENS, AND PAUL GAUCHER JOIN BROAD ARROW AND BRING A COMBINED 50 YEARS OF EXPERIENCE IN THE COLLECTOR CAR AUCTION INDUSTRY | VALÉRIE SIMONET, RYAN CIGANA, AND SIMON DRAKE TO LEAD EUROPEAN OPERATIONS, CLIENT DEVELOPMENT, AND MARKETING PHILIP KANTOR, GREGORY TUYTENS, AND PAUL GAUCHER JOIN BROAD ARROW AND BRING A COMBINED 50 YEARS OF EXPERIENCE IN THE COLLECTOR CAR AUCTION INDUSTRY | VALÉRIE SIMONET, RYAN CIGANA, AND SIMON DRAKE TO LEAD EUROPEAN OPERATIONS, CLIENT DEVELOPMENT, AND MARKETING
- 01/30/2025
|
Billionaire Investor Sold These 5 Stocks And Loading Up On These Companies Instead
- According to LCH Investments, over 200 hedge funds are Tiger Cubs, funds started by former employees of Tiger Management, the iconic hedge fund founded by Julian Robertson in 1980.
- 01/29/2025
|
BROAD ARROW OFFERS 1954 JAGUAR D-TYPE 'OKV 2' WORKS COMPETITION CAR WITHOUT RESERVE AT 2025 AMELIA AUCTION
- AMONG THE MOST IMPORTANT SPORTS RACING CARS OF ALL TIME | D-TYPE OFFERED WITHOUT RESERVE, ESTIMATED TO BRING $6.5-8.5M AT MARCH 7-8 AUCTION AMONG THE MOST IMPORTANT SPORTS RACING CARS OF ALL TIME | D-TYPE OFFERED WITHOUT RESERVE, ESTIMATED TO BRING $6.5-8.5M AT MARCH 7-8 AUCTION
- 01/27/2025
|
CARsgen's Allogeneic CD38 CAR-T Therapy Administers First Dose in an Investigator-Initiated Trial
- SHANGHAI , Jan. 20, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that KJ-C2320, an allogeneic CAR T-cell therapy targeting CD38, has administered the first dose to a patient in an investigator-initiated trial (IIT). KJ-C2320 is developed based on CARsgen's THANK-uCAR® platform.
- 01/20/2025
|
CARsgen's Allogeneic CD19/CD20 CAR-T Therapy Administers First Dose in an Investigator-Initiated Trial
- SHANGHAI , Jan. 13, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that KJ-C2219, an allogeneic CAR T-cell therapy targeting CD19/CD20, has administered the first dose to a patient in an investigator-initiated trial (IIT). KJ-C2219 is developed based on CARsgen's THANK-u Plus platform and is designed for the treatment of hematologic malignancies and autoimmune diseases.
- 01/13/2025
|
Lyell to Highlight Vision for its Next-Generation CAR T-Cell Therapy Pipeline at 43rd Annual JP Morgan Healthcare Conference
- SOUTH SAN FRANCISCO, Calif., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer, today announced pipeline updates, including its plans to advance IMPT-314, a potentially best-in-class therapy for aggressive large B-cell lymphoma, into pivotal trials. IMPT-314 is an autologous dual-targeting CD19/CD20 chimeric antigen receptor (CAR) T-cell product candidate designed to increase complete response rates and prolong the duration of the responses as compared to the approved CD19‑targeted CAR therapies for the treatment of large B-cell lymphoma.
- 01/09/2025
|
Credit Agricole Nord de France - Avis de mise à disposition du bilan de contrat de liquidité
- Lille, le 3 janvier 2025 Avis de mise à disposition du bilan semestriel 2024 du contrat de liquidité du Crédit Agricole Nord de France La Caisse régionale du Crédit Agricole Nord de France annonce avoir mis à disposition du public et déposé auprès de l'Autorité des Marchés Financiers son bilan semestriel du contrat de liquidité contracté avec Oddo Corporate Finance. Le bilan semestriel 2024 du contrat de liquidité peut être consulté sur le site de présentation du Crédit Agricole Nord de France à l'adresse http://communication.ca-norddefrance.fr/ rubrique Publications.
- 01/03/2025
|
CARsgen Announces the Initiation of an Investigator-Initiated Trial for an Allogeneic CD19/CD20 CAR-T Therapy
- SHANGHAI , Dec. 31, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces the initiation of an investigator-initiated trial (IIT) in China for KJ-C2219, an allogeneic CAR T-cell therapy, targeting CD19/CD20. The trial will evaluate KJ-C2219 for the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma (R/R B-NHL).
- 12/31/2024
|
CARsgen Announces Positive Topline Results from China GC/GEJ Pivotal Phase II Clinical Trial of Claudin18.2 CAR-T (Satri-cel)
- SHANGHAI , Dec. 30, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces the positive results from the pivotal Phase II clinical trial CT041-ST-01(NCT04581473). This study is an open-label, multicenter clinical trial evaluating the safety and efficacy of satricabtagene autoleucel ("satri-cel", CT041) (an autologous CAR T-cell product candidate against Claudin18.2) in subjects with Claudin18.2 expression-positive, advanced gastric/gastroesophageal junction cancers that have failed at least 2 prior lines therapy.
- 12/30/2024
|
Crown88 Renews Partnership with Taiwanese Influencer Avis for Year 2025
- Singapore, Singapore--(Newsfile Corp. - December 29, 2024) - Crown88 , Singapore's largest online gaming platform since 2010, is pleased to announce the renewal of its successful partnership with Taiwanese influencer, "Avis 小哥哥艾理", for the year 2025. The collaboration, which began in 2024, has seen tremendous success, and both parties are excited to continue working together on new and innovative projects in the coming year.
- 12/29/2024
|
Why You Should Hold Avis Budget Stock in Your Portfolio Now
- CAR benefits from strong demand, fleet management and technology investments, which boost profitability. However, lack of dividends and low liquidity pose risks.
- 12/27/2024
|
Marker Therapeutics Announces $16.1 Million Private Placement
- Strategic financing supports clinical advancement in Phase 1 APOLLO study investigating MT-601 in patients with lymphoma who relapsed after anti-CD19 CAR-T cells Strategic financing supports clinical advancement in Phase 1 APOLLO study investigating MT-601 in patients with lymphoma who relapsed after anti-CD19 CAR-T cells
- 12/19/2024
|
Hemogenyx Pharmaceuticals partners with Kure.ai for ultrafast CAR-T manufacturing
- Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF). the UK-listed biopharmaceutical company focused on treatments for blood cancers, has entered a collaboration with Kure.ai to develop an ultrafast manufacturing process for its CAR-T cell therapies.
- 12/19/2024
|
Immix Biopharma Announces 75% Complete Response Rate (n=16); 31.5 months Best Response Duration (ongoing) for CAR-T NXC-201 in Relapsed/Refractory AL Amyloidosis Patients at ASH 2024
- 75% (12/16) complete response (CR) rate observed in standard of care (Dara-CyBorD) relapsed/refractory AL Amyloidosis patients with median 4 lines of prior therapy in updated Phase 1/2 data as of December 9, 2024 Best responder duration of response was 31.5 months with complete response ongoing as of December 9, 2024 Conference call to discuss results Tuesday, December 10, 2024 4:30 p.m. ET at https://zoom.us/j/94736340854?pwd=LTBtu2LuvwSb6S6ISuH5yKTDLsI2vt.1 LOS ANGELES, CA, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and select immune-mediated diseases, today announced that new NXC-201 NEXICART-1 clinical data in relapsed/refractory AL Amyloidosis has been presented at 66th American Society of Hematology (ASH) Annual Meeting being held in San Diego, California.
- 12/10/2024
|
Kite's Yescarta® Only CAR T-Cell Therapy to Show Durable Response and Long-Term Survival After Five Years in Patients With Relapsed/Refractory Non-Hodgkin Lymphomas at ASH 2024
- SANTA MONICA, Calif.--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), today announced results from a five-year follow-up analysis of ZUMA-5, a Phase 2 study of Yescarta® (axicabtagene ciloleucel) in patients with relapsed/refractory non-Hodgkin lymphomas (NHL) including follicular lymphoma (FL) or marginal zone lymphoma (MZL). The analysis demonstrated that after a median follow-up of more than five years, patients treated with Yescarta continued to experience durable response and long-.
- 12/09/2024
|
Longest Follow-Up Data Reported for Kite's Tecartus® CAR T-Cell Therapy at ASH 2024 Reinforce Durable Efficacy and Survival Benefits
- SANTA MONICA, Calif.--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), announced results today from four analyses that continue to demonstrate the durability of response of Tecartus® (brexucabtagene autoleucel) in patients with relapsed/refractory mantle cell lymphoma (R/R MCL) and relapsed/refractory B-cell precursor acute lymphoblastic leukemia (R/R B-ALL) during the 66th American Society of Hematology (ASH) Annual Meeting and Exposition. The data presented include an oral presentation.
- 12/09/2024
|
Fate Therapeutics Presents New Phase 1 Clinical Data of FT819 Off-the-shelf, CAR T-cell Product Candidate for Systemic Lupus Erythematosus
- All Three Patients Treated in First Dose Cohort Administered Fludarabine-free Conditioning and Show Rapid, Deep, and Sustained B-cell Depletion with Favorable Safety Profile
- 12/09/2024
|
Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma
- Mechelen, Belgium; December 7, 2024, 18:30 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced additional data from the ongoing Phase 1/2 ATALANTA-1 study of its CD19 CAR T-cell therapy, GLPG5101. The results, featured in an oral presentation at the 66 th American Society of Hematology (ASH) Annual Meeting and Exposition, demonstrate an encouraging efficacy and safety profile in patients with relapsed/refractory non-Hodgkin lymphoma (R/R NHL). Most patients in the study received GLPG5101 as a fresh, fit, stem-like, early memory CD19 CAR T-cell therapy, with a median vein-to-vein time of seven days.
- 12/07/2024
|
New Highs for Dow Transports: Top 3 Stocks Driving the Surge
- The Dow Jones Transportation Average rose more than 8.4% in November to set a new high. Most components saw gains, with only two moving lower.
- 12/04/2024
|
Clinical trials for HEMO-CAR-T: What's next? ICYMI
- Hemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) CEO Dr.Vladislav Sandler and non-executive director Peter Redmond talked with Proactive about key developments, including its EGM. Redmond explained the reasoning behind share consolidation, aimed at attracting institutional investors and enhancing the company's capital structure as it moves closer to clinical trials for its HEMO-CAR-T product.
- 11/30/2024
|
Xenetic Biosciences, Inc. Presents Positive Preclinical Data Highlighting the Potential of Co-Administration of DNase I with CAR T Cells in a Murine Model of Melanoma Lung Metastasis
- Data presented at the AACR Special Conference in Cancer Research: Tumor-body Interactions: The Roles of Micro- and Macroenvironment in Cancer Results bolster Company's rationale for incorporating DNase I as an adjunctive treatment to improve therapeutic responses in patients undergoing CAR T cell therapy FRAMINGHAM, MA / ACCESSWIRE / November 21, 2024 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immune-oncology technologies addressing hard to treat cancers, today announced the presentation of preclinical data investigating the potential of co-administration of deoxyribonuclease I (DNase I) with chimeric antigen receptor (CAR) T cells in a syngeneic B16 melanoma murine model of lung metastasis. The poster titled, " The synergistic action of DNase I and CAR T cells enhances the therapeutic efficacy of adoptive immunotherapy in the syngeneic murine metastasis model ," was presented on behalf of the Company by Alexey Stepanov, PhD, Institute Investigator at The Scripps Research Institute, at the AACR Special Conference in Cancer Research: Tumor-body Interactions: The Roles of Micro- and Macroenvironment in Cancer, held November 17-20, 2024, in Boston.
- 11/21/2024
|
AUCATZYL's Approval Positions Autolus Therapeutics Favorably In The CAR-T Market
- Autolus Therapeutics' AUCATZYL, approved by the FDA for relapsed/refractory B-cell ALL, shows strong potential despite safety concerns. The Company's Obe-cel family and oncology pipeline include multiple catalysts for 2025, expanding potential indications in autoimmune diseases and hematologic malignancies. AUTL's cash runway of 1.9 years and no financial debt provide a solid financial foundation to support AUCATZYL's commercialization and future growth.
- 11/21/2024
|
Of 63 Fortune 500 Industry Leaders, 57 Pay Dividends, 38 Are Cash Rich And 1 Is A Buy
- AT&T, Altria Group, and Energy Transfer are top buys with dividends from $1K invested exceeding single share prices, meeting the dogcatcher ideal. Analysts forecast 15.47% to 28.33% net gains by November 2025 for top-ten F500IL dogs, with Energy Transfer as the standout “safer” choice. Eight F500IL stocks show negative free cash flow margins, making them unsafe buys; price drops or dividend increases could make top-yield F500IL fair-priced.
- 11/20/2024
|
MOTORTREND NAMES MERCEDES-BENZ E-CLASS 2025 CAR OF THE YEAR
- – Mercedes-Benz's elegant midsize luxury car has outdone its competitors to secure MotorTrend's Golden Calipers for the second time in five years – LOS ANGELES , Nov. 20, 2024 /PRNewswire/ -- MotorTrend Group , a Warner Bros. Discovery company, announced today the Mercedes-Benz E-Class as its 2025 Car of the Year award winner.
- 11/20/2024
|
Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases
- Over the weekend, Bristol Myers Squibb & Co BMY shared preliminary data from a Phase 1 study of CC-97540 (BMS-986353), a CD19-directed CAR T Cell Therapy Manufactured Using a Next-generation Process for severe, refractory autoimmune diseases.
- 11/18/2024
|
Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial
- Third cohort dose is one million CAR positive cells; ten times higher than the first cohort dose SAN JOSE, Calif. , Nov. 18, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it has dosed its first patient in the third cohort in the ongoing Phase 1 clinical trial of its novel chimeric antigen receptor-T cell (CAR-T) therapy for recurrent ovarian cancer.
- 11/18/2024
|
Fate Therapeutics Presents 6-Month Follow-up Data on First Patient Treated in Phase 1 Autoimmunity Study with Fludarabine-free Conditioning and FT819 Off-the-shelf, 1XX CAR T-cell Product Candidate at ACR Convergence
- 27-year-old African American-Asian Woman with Active Lupus Nephritis Achieved DORIS Clinical Remission; Patient Remains On-study, in Clinical Remission, and Free of All Immunosuppressive Therapies
- 11/18/2024
|
Poseida Therapeutics Hosts Cell Therapy R&D Day Highlighting Its Innovative Clinical and Preclinical Pipeline
- Emerging leadership in allogeneic CAR-T for hematologic malignancies demonstrated by recent P-BCMA-ALLO1 Phase 1 data and new preclinical findings for P-CD19CD20-ALLO1 and P-CD70-ALLO1 Latest preclinical data on P-BCMACD19-ALLO1 demonstrates its potential as a next-generation allogeneic TSCM-rich CAR-T for both autoimmune diseases and oncology Advancing innovative strategies to overcome the unique challenges of applying CAR-T to solid tumors Virtual R&D Day featuring partner Astellas Pharma and Poseida's leadership and scientific teams to be held today at 10:00am ET / 7:00am PT SAN DIEGO , Nov. 14, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advancing differentiated non-viral treatments for patients with cancer, autoimmune and rare diseases, today announced plans to share progress across its clinical- and earlier-stage pipeline of differentiated T stem cell memory cells (TSCM)-rich allogeneic CAR-T therapies in oncology and autoimmune diseases during a virtual R&D Day to be held today at 10:00am ET / 7:00am PT. "We believe Poseida is well positioned to be a cell therapy leader based on the unique capabilities of our proprietary non-viral technology platform and our allogeneic TSCM-rich CAR-T approach," said Kristin Yarema, Ph.D.
- 11/14/2024
|
Avis Budget Stock Appreciates 12% Despite Earnings Miss in Q3
- CAR's third-quarter 2024 top line witnesses a decline due to a fall in revenues from the Americas.
- 11/11/2024
|
Fate Therapeutics Highlights Cancer-selective, HER2-Targeting Profile of FT825 / ONO-8250 CAR T-cell Product Candidate for Treatment of Advanced Solid Tumors at 2024 SITC Annual Meeting
- Novel H 2 CasMab-2 Antigen Binding Domain Shown to Preferentially Target HER2 Expressed on Tumor Cells in Preclinical Studies
- 11/09/2024
|
Fate Therapeutics Presents Pan-tumor Targeting Preclinical Data for FT836 MICA/B-targeted CAR T-cell Product Candidate at 2024 SITC Annual Meeting
- Multiplexed-engineered, iPSC-derived CAR T Cell Targets Proteins Expressed on Cancer Cells in Response to Cellular Stress and Malignant Transformation
- 11/08/2024
|
Canadian Apartment Properties Real Estate Investment Trust (CDPYF) Q3 2024 Earnings Call Transcript
- Canadian Apartment Properties Real Estate Investment Trust (OTC:CDPYF) Q3 2024 Earnings Conference Call November 8, 2024 9:00 AM ET Company Participants Nicole Dolan - IR Mark Kenney - President and CEO Julian Schonfeldt - CIO Stephen Co - CFO Conference Call Participants Fred Blondeau - Green Street Dean Wilkinson - CIBC Jonathan Kelcher - TD Cowen Brad Sturges - Raymond James Jimmy Shan - RBC Capital Markets Kyle Stanley - Desjardins Mario Saric - Scotiabank Matt Kornack - National Bank Financial Michael Markidis - BMO Capital Markets Operator Good morning and thank you for attending today's Canadian Apartment Properties RIET Third Quarter 2024 Results Conference Call. My name is Alisa, and I'll be your moderator today's.
- 11/08/2024
|
Canadian Apartment Properties: Immigration Changes Spook Investors
- We had downgraded CAPREIT to a hold in September as valuation looked average. The stock has dropped sharply, and two factors are to blame. We examine the setup and give you our outlook.
- 11/08/2024
|
Poseida Therapeutics to Present Clinical and Preclinical Data on Investigational Allogeneic CAR-T Cell Therapies at SITC 2024 and ASH 2024
- New preclinical data on allogeneic CAR+TCR-T cells rich in stem cell memory T cells (TSCM) and enhanced potency to better target solid tumors will be presented at SITC Additional profiling of patient responses in P-BCMA-ALLO1 Phase 1 Arm C and preclinical P-CD19CD20-ALLO1 to be presented at ASH SAN DIEGO , Nov. 5, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advancing differentiated non-viral treatments for patients with cancer, autoimmune and rare diseases, today announced new preclinical data on allogeneic CAR+TCR-T cells rich in stem cell memory T cells (TSCM), along with platform enhancements aimed at enhancing potency and improving targeting of solid tumors, will be presented at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting in Houston, November 6-10. Additionally, the Company announced presentations at the 66th American Society of Hematology (ASH) Annual Meeting & Exposition, which will be held December 7-10 in San Diego.
- 11/05/2024
|
Kite to Highlight Industry-Leading CAR T-Cell Therapy Portfolio at ASH 2024, Including Positive Survival Outcomes in Both Clinical Trials and the Real-World
- SANTA MONICA, Calif.--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), will share 18 presentations, including six oral presentations, demonstrating the strength of its CAR T-cell therapy portfolio across a spectrum of blood cancers during the 66th American Society of Hematology (ASH) Annual Meeting and Exposition (December 7-10). “Our data underscore our commitment to helping people with blood cancers live longer and demonstrate the benefit of CAR T-cell therapy as a mainstay of blood ca.
- 11/05/2024
|
Why Avis Budget Stock Soared 17% After Earnings
- Avis Budget didn't grow earnings in 2024, but 2025 looks better.
- 11/01/2024
|
Avis Budget Group, Inc. (CAR) Q3 2024 Earnings Call Transcript
- Avis Budget Group, Inc. (NASDAQ:CAR ) Q3 2024 Earnings Conference Call November 1, 2024 8:30 AM ET Company Participants David Calabria - SVP, Corporate Finance and Treasurer Joe Ferraro - President and CEO Izzy Martins - EVP and CFO Conference Call Participants Chris Woronka - Deutsche Bank John Babcock - Bank of America Elizabeth Dove - Goldman Sachs Ryan Brinkman - J.P. Morgan Chase Christopher Stathoulopoulos - Susquehanna Financial John Healy - Northcoast Research Dan Levy - Barclays Bank Operator Greetings and welcome to the Avis Budget Group Third Quarter 2024 Earnings Conference Call.
- 11/01/2024
|
CARsgen® U.S. Clinical Holds Lifted by FDA
- SHANGHAI , Oct. 31, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the U.S. Food and Drug Administration ("FDA") lifted the clinical holds on clinical trials of zevorcabtagene autoleucel (zevor-cel, CT053, an autologous CAR-T product against BCMA), satricabtagene autoleucel (satri-cel, CT041, an autologous CAR-T product against Claudin18.2), and CT071 (an autologous CAR-T product against GPRC5D) in the United States. About CARsgen Therapeutics Holdings Limited CARsgen is a biopharmaceutical company with operations in China and the U.S., focusing on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors.
- 10/31/2024
|
Compared to Estimates, Avis Budget (CAR) Q3 Earnings: A Look at Key Metrics
- The headline numbers for Avis Budget (CAR) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 10/31/2024
|
Avis Budget Group (CAR) Q3 Earnings and Revenues Miss Estimates
- Avis Budget Group (CAR) came out with quarterly earnings of $6.65 per share, missing the Zacks Consensus Estimate of $8.55 per share. This compares to earnings of $16.78 per share a year ago.
- 10/31/2024
|
Avis's stock slides after third-quarter earnings fall short of estimates
- Avis Budget Group's stock was falling in after-hours trade Thursday, after the car-rental company's third-quarter earnings fell short of estimates.
- 10/31/2024
|
Avis Budget Group Reports Third Quarter Results
- PARSIPPANY, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) announced financial results for third quarter 2024 today.
- 10/31/2024
|
Avis Budget Group to Announce Third Quarter 2024 Results on October 31st
- PARSIPPANY, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) announced today that it plans to report its third quarter 2024 results after the market close on Thursday, October 31st, 2024, and to host a conference call for institutional investors to discuss these results on Friday, November 1st, 2024 at 8:30 a.m.
- 10/25/2024
|
Lyell Immunopharma: Oversold And Poised For A Turning Point To Growth
- Lyell Immunopharma, Inc.'s financials show reduced losses and efficient cash management, with a strong cash position supporting operations through 2027 despite a challenging biotech environment. The company's innovative CAR T-cell therapies, particularly LYL119 and IMPT-314, target critical oncology challenges with promising early clinical results expected by late 2025. Lyell's acquisition of ImmPACT Bio expands its pipeline into hematologic cancers, enhancing its portfolio with dual-targeting CAR T-cell therapies and broadening therapeutic options.
- 10/25/2024
|
Lyell Immunopharma to Acquire ImmPACT Bio and Prioritizes its Pipeline to Focus on Next-Generation CAR T-cell Therapies
- SOUTH SAN FRANCISCO, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL) announced today that it has entered into a definitive agreement to acquire ImmPACT Bio USA Inc. (“ImmPACT”), a privately-owned clinical-stage biotechnology company. ImmPACT's lead program, IMPT-314, is a CD19/20-targeting chimeric antigen receptor (CAR) T-cell product candidate that Lyell will continue to develop for hematologic malignancies, including large B-cell lymphoma. IMPT-314 was designed to outperform the efficacy of approved CD19 CAR T-cell therapies via a dual-targeting CAR T-cell design and to improve CAR T-cell persistence by enriching for naïve and central memory T cells during manufacturing. The acquisition of ImmPACT is expected to significantly strengthen Lyell's clinical-stage pipeline of next- generation CAR T-cell therapies and complement its suite of proprietary technologies designed to generate longer-lasting, functional T cells to achieve more durable outcomes for patients with solid tumors and hematologic malignancies.
- 10/24/2024
|
Spain Car Rental Market Trends, Analysis, and Opportunity Forecast (2024-2029) Featuring Profiles of Key Players - Centauro Rent a Car, Rentspain, GoldCar Spain, Avis Car Rental, Budget Rent a Car System & More
- Dublin, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The "Spain Car Rental - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024-2029)" report has been added to ResearchAndMarkets.com's offering. The Spain Car Rental Market size is estimated at USD 5.95 billion in 2024, and is expected to reach USD 7.47 billion by 2029, growing at a CAGR of 10.13% during the forecast period (2024-2029). Over the long term, the rising number of tourists in the country and the increasing car rental fleet size are driving the car rental market in Spain. The country has 47 UNESCO World Heritage Sites, numerous beaches on the Atlantic & Mediterranean, and many ongoing festivals across the year, which aid in gathering millions of international tourists, along with domestic tourists. In June 2022, the Spanish government's announcement of EUR 110 million investment in tourism competitiveness indirectly benefited the car rental market by attracting more potential investors. People's attitudes toward traveling light are changing, and they prefer renting a car to owning one, especially when traveling. This social mindset shift has contributed to an unusually high demand for rented cars. Spain is no longer a destination for visitors who arrive by car. Tourists are looking for car rentals for their vacations. As a result, the country is experiencing a car rental crisis. The electric rental fleets in the country are also expected to grow in the coming years, encouraging the rental services offered across the country to attract customers and curb greenhouse emissions. Some of the prominent players in the Spanish airport car rental market are Europcar Mobility Group, Hertz Corporation, and Avis Budget Group. However, tourist travel behavior and vacation expectations have been reset following the pandemic. Following three years of revenue decline (due to the pandemic), the car rental industry is expected to see an increase and a healthy profit. Spain Car Rental Market Trends
- 10/21/2024
|
Poseida Therapeutics Announces Nomination of New CAR-T Development Candidate Under Collaboration with Roche
- Allogeneic, TSCM-rich dual CAR-T for the treatment of hematologic malignancies, including multiple myeloma Nomination triggers $15 million milestone payment to Poseida, extending cash runway into early 2026 Poseida Cell Therapy R&D Day to take place on Thursday, November 14 at 7 am PT / 10 am ET SAN DIEGO , Oct. 17, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advancing differentiated non-viral treatments for patients with cancer, autoimmune, and rare diseases, today announced the nomination of a new development candidate under its collaboration with Roche. The nomination triggered a $15 million milestone payment from Roche to Poseida.
- 10/17/2024
|
Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial
- Patient showed clinical activity after initial treatment, with necrosis, inflammation, and T cell infiltration observed in tumor biopsy from the lowest dose SAN JOSE, Calif. , Oct. 15, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it has administered the second dose of its CAR-T therapy to an individual patient.
- 10/15/2024
|
New Strong Sell Stocks for October 15th
- AMTB, CAR and BSET have been added to the Zacks Rank #24 (Strong Sell) List on October 15, 2024.
- 10/15/2024
|
New Strong Sell Stocks for October 11th
- ALLY, CAR and DNOW have been added to the Zacks Rank #5 (Strong Sell) List on October 11, 2024.
- 10/11/2024
|
Aurigene Oncology Limited Announces Promising Results of Phase 1 Study for India's First Trial for Novel Autologous CAR-T Cell Therapy for Multiple Myeloma
- BENGALURU, India & HYDERABAD, India--(BUSINESS WIRE)-- #AurigeneOncology--Aurigene Oncology announces promising results of Phase 1 study for India's first trial for novel autologous CAR-T cell therapy for multiple myeloma.
- 10/08/2024
|
EV Nickel Intersects 3 New Zones of Mineralization on the Carlang Trend Including Highest Nickel Grades to Date & Significantly Extends Strike Length by 7km
- Maiden diamond drill program on CarLang B, C and E Zones intersected significant near surface mineralization CarLang C encountered highest grades to date on the CarLang Trend and covers an area approximately twice the size as the Company's CarLang A Deposit EV24-CAR06 intersected 241.70m grading 0.30% Ni, incl.7.5m grading 0.56% Ni and 1.5m at 0.96% Ni EV24-CAR08 intersected 234.00m grading 0.28% Ni, incl.37.50m grading 0.37% Ni, 13.50m grading 0.39% Ni and 19.50m at 0.37% Ni Mineralization intersected in EV24-CAR08 appears to be magmatic in origin with 1-5% disseminated sulphide observed in drill core 7 of 10 holes bottomed in targeted mineralization Drilling identifies 3 new zones of large-scale nickel mineralization over 7 kilometres of strike and remains open for expansion in multiple directions TORONTO, ON / ACCESSWIRE / October 8, 2024 / EV NICKEL INC. (TSXV:EVNI) ("EVNi" or the "Company") ") is pleased to announce exploration results for its recently completed diamond drill program on the CarLand trend.
- 10/08/2024
|
Immix Biopharma Advances CAR-T NXC-201 to Expansion Cohort Dose Level in U.S. AL Amyloidosis Trial NEXICART-2
- Now dosing at dose expansion level of 450 million NXC-201 CAR+T cells. First cohort at 150 million CAR+T cells already successfully completed Each of these two doses have produced complete responses in prior clinical studies Lead site Memorial Sloan Kettering Cancer Center (MSKCC); 4 disclosed clinical sites so far NXC-201 is the only one-time CAR-T treatment option being studied for relapsed/refractory AL Amyloidosis in U.S. clinical trials AL Amyloidosis, a disorder of plasma cells that leads to progressive damage to the heart, kidney and liver, affects approximately 33,000 patients in the U.S. LOS ANGELES, CA, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us”, “IMMX”) (Nasdaq: IMMX), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and select immune-mediated diseases, today announced advances in the NEXICART-2 clinical study of its CAR-T NXC-201 for relapsed/refractory AL Amyloidosis, a plasma cell disorder that leads to progressive damage to the heart, kidney and liver, which currently affects approximately 33,000 patients in the U.S. Immix Biopharma's sterically-optimized CAR-T NXC-201 is the only one-time CAR-T treatment option being studied for relapsed/refractory AL Amyloidosis in U.S. clinical trials.
- 10/02/2024
|
Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial
- Amendment will allow a second dose of CAR-T therapy to suitable patients SAN JOSE, Calif. , Sept. 30, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it and partner Moffitt Cancer Center ("Moffitt") have submitted an amendment to the current protocol that governs its ongoing clinical trial utilizing a CAR-T therapy to treat ovarian cancer (NCT05316129).
- 09/30/2024
|
Poseida Therapeutics Reports Positive Interim Phase 1 Results for Allogeneic CAR-T Therapy P-BCMA-ALLO1 with High Overall Response Rates in Heavily Pretreated Relapsed/Refractory Multiple Myeloma Patients
- Data showed a 91% ORR with P-BCMA-ALLO1 in an optimized lymphodepletion arm, including a 100% ORR in BCMA-naïve patients, and an 86% ORR in those who had received at least one prior BCMA- and/or GPRC5D-targeting treatment modality Differentiated P-BCMA-ALLO1 safety results with no dose-limiting toxicities, low rates of CRS and ICANS all Grade 2 or less and no graft vs. host disease or Parkinsonism P-BCMA-ALLO1 was recently granted Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA and is being evaluated in a Phase 1/1b clinical trial in patients with relapsed/refractory multiple myeloma who have previously received three or more prior lines of therapy Company to host webcast and conference call tomorrow at 1 p.m.
- 09/27/2024
|
Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer Conference
- SAN JOSE, Calif. , Sept. 18, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it will present at the Ovarian Cancer Research Alliance's ("OCRA") International Gynecologic Cancer Conference taking place online September 25-27, 2024.
- 09/18/2024
|
Verismo Therapeutics Awarded a ScaleReady™ G-Rex® Grant
- PHILADELPHIA , Sept. 17, 2024 /PRNewswire/ -- Verismo Therapeutics, a clinical-stage CAR T company developing the novel KIR-CAR platform technology, today announced that it has been awarded a $150,000 G-Rex Grant by ScaleReady™.
- 09/17/2024
|
Phio Pharmaceuticals Announces Presentation at the 9th Annual CAR-TCR Summit in Boston, MA
- Phio's INTASYL self-delivering RNAi technology enhances cell potency and yield in Adoptive Cell Therapy Marlborough, Massachusetts--(Newsfile Corp. - September 16, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary INTASYL® siRNA gene silencing technology is designed to make immune cells more effective in killing tumor cells, today announced that it is presenting data about its INTASYL technology platform which represents an innovative and flexible solution for adoptive cell therapy providing compounds designed specifically to enhance cell potency and improve overall yield, offering a more effective approach for treating cancer. The data will be presented at the CAR-TCR Summit taking place September 17-20 in Boston, MA.
- 09/16/2024
|
ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex® Manufacture of CAR-T and TCR Therapies
- ST. PAUL, Minn. , Sept. 16, 2024 /PRNewswire/ -- ScaleReady and Bio-Techne Corporation (NASDAQ: TECH) today announced the launch of the G-Rex optimized ProPakTM GMP Cytokines, ideally tailored to high efficiency closed system cell and gene-modified cell therapy (CGT) manufacturing.
- 09/16/2024
|
Top 3 Industrials Stocks That May Rocket Higher In Q3
- The most oversold stocks in the industrials sector presents an opportunity to buy into undervalued companies.
- 09/11/2024
|
Avis Budget Group Announces Pricing of $700 Million of Senior Notes
- PARSIPPANY, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) (the “Company”) announced today that its wholly-owned subsidiaries, Avis Budget Car Rental, LLC and Avis Budget Finance, Inc. (together, the “Issuers”), priced a private offering of $700 million aggregate principal amount of 8.250% senior notes due 2030 (the “Notes”), which represents a $200 million increase from the previously announced size of the offering. The Notes will have a maturity date of January 15, 2030. The closing of the offering of the Notes is expected to occur on September 13, 2024, subject to customary closing conditions. The Notes will be issued at par and guaranteed on a senior unsecured basis by the Company and certain of its U.S. subsidiaries.
- 09/10/2024
|
DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Avis Rent A Car System LLC Customers Whose Data May Have Been Compromised
- NEWTOWN, Pa., Sept. 10, 2024 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by Avis Rent A Car System LLC (“Avis”). Avis learned of suspicious activity on or about August 5, 2024. To join this case, go HERE .
- 09/10/2024
|
Avis Budget Group Announces Intention to Offer $500 Million of Senior Notes
- PARSIPPANY, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) (the “Company”) announced today that its wholly-owned subsidiaries, Avis Budget Car Rental, LLC and Avis Budget Finance, Inc. (together, the “Issuers”), intend, subject to market and other customary conditions, to offer $500 million aggregate principal amount of senior notes due 2030 (the “Notes”) in a private offering. The Notes will be guaranteed on a senior unsecured basis by Avis Budget Group, Inc. and certain of its U.S. subsidiaries.
- 09/10/2024
|
DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Avis Rent A Car System LLC Customers Whose Data May Have Been Compromised.
- Edelson Lechtzin LLP is investigating claims regarding data privacy violations by Avis Rent A Car System LLC ("Avis"). Avis learned of suspicious activity on or about August 5, 2024.
- 09/09/2024
|
Avis Rent A Car Data Breach Exposes Personal Information: Murphy Law Firm Investigates Legal Claims
- OKLAHOMA CITY, Okla., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Murphy Law Firm is investigating claims on behalf of all individuals whose personal and confidential information was compromised in the data breach involving Avis Rent A Car (“Avis”).
- 09/09/2024
|
Thousands of Avis car rental customers had personal data stolen in cyberattack
- Car rental giant Avis is notifying hundreds of thousands of people that their personal information and driver's license numbers were stolen in an August cyberattack.
- 09/09/2024
|
Canadian Apartment Properties: Crowd Comes Around To Our View
- Canadian Apartment Properties REIT's Q2 2024 results highlighted a small dip in occupancy, but strong rent growth offset that and pushed NOI margins higher. The sale of the MHC portfolio and a distribution hike were the other notable events. We update our thesis and tell you where we stand with this one.
- 09/05/2024
|
Poseida Therapeutics to Present New Clinical Data from Phase 1 Study of Allogeneic CAR-T P-BCMA-ALLO1 in Patients with Relapsed/Refractory Multiple Myeloma at 21st International Myeloma Society Annual Meeting
- Latest data from Poseida's lead investigational allogeneic CAR-T program, which is based on the Company's unique stem cell memory T cell (TSCM) platform Company to host conference call on Saturday, September 28, 2024, at 1 PM ET / 10 AM PT to review the P-BCMA-ALLO1 Phase 1 IMS oral presentation data Poseida initiates P-BCMA-ALLO1 Phase 1b clinical trial in patients with multiple myeloma, generating $20 million payment from Roche SAN DIEGO , Sept. 5, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advancing differentiated non-viral treatments for patients with cancer and rare diseases, announced today that new clinical data from an ongoing Phase 1 study of P-BCMA-ALLO1 in patients with relapsed/refractory multiple myeloma will be presented in an oral session at the 21st International Myeloma Society (IMS) Annual Meeting, which is being held in Rio de Janeiro from September 25-28, 2024.
- 09/05/2024
|
Poseida Therapeutics Presents New Case Study Demonstrating Reactivation of CAR-T Therapy with a T-Cell Engager in a Patient with Relapsed Multiple Myeloma
- Reactivation of P-BCMA-101 CAR-T cells and a repeat stringent complete response (sCR) more than 3 years after original CAR-T therapy Demonstrates potential of stem cell memory T cells (TSCM), a key differentiator for Poseida's CAR-T programs SAN DIEGO , Sept. 4, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advancing differentiated non-viral treatments for patients with cancer and rare diseases, highlighted new data from a case study of a patient with relapsed multiple myeloma treated in a clinical trial of P-BCMA-101, the Company's original investigational T stem cell memory (TSCM)-rich BCMA targeting autologous CAR-T cell therapy.
- 09/04/2024
|
Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium
- SAN JOSE, Calif. , Sept. 3, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the inventor of its ovarian cancer CAR-T technology, Jose R.
- 09/03/2024
|
Cartesian Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 Trial of Next-Generation mRNA CAR-T Cell Therapy Descartes-15
- Descartes-15 observed to achieve an approximately ten-fold increase relative to Descartes-08 in CAR expression and selective target-specific killing in preclinical studies
- 09/03/2024
|
Allogene Therapeutics: Cema-Cel Promising Among Innovative CAR T-Cell Therapies
- Allogene Therapeutics is a clinical-stage biotech developing allogeneic CAR T therapies for cancer and autoimmune diseases, with a focus on Cema-cel for LBCL. ALLO's advanced gene-editing platforms, like TALEN and CRISPR/Cas9, engineer donor-derived T cells to overcome autologous therapy limitations, enhancing treatment safety and effectiveness. Cema-cel, the company's flagship therapy, is in a pivotal Phase 2 trial (ALPHA3) for large B-cell lymphoma, with potential regulatory submission by 2027.
- 08/26/2024
|
Galapagos: CAR-T Biotech To Change Landscape With GLPG5101 And Beyond
- Galapagos NV achieved positive results from its European phase 1/2 ATLANTA-1 study using GLPG5101 for patients with relapsed/refractory NHL; phase 1 portion with 87.5% ORR and phase 2 portion with 93.3% ORR. The global non-Hodgkin Lymphoma market is expected to reach $16 billion by 2029; on average, between 30% to 40% of NHL patients have relapsed/refractory disease. IND clearance of U.S. phase 1/2 ATLANTA-1 study using GLPG5101 for patients with relapsed/refractory NHL achieved; this trial could speed up enrollment and further establish efficacy with newly added patients.
- 08/23/2024
|
Galapagos announces FDA clearance of IND application for Phase 1/2 ATALANTA-1 study of CD19 CAR-T, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma
- Mechelen, Belgium; August 23, 2024, 07:00 CET; regulated information – inside information – Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the U.S. Food and Drug Administration (FDA) has cleared Galapagos' Investigational New Drug (IND) application for ATALANTA-1, a Phase 1/2 multicenter study evaluating the feasibility, safety, and efficacy of GLPG5101 in patients with relapsed/refractory non-Hodgkin lymphoma (R/R NHL).
- 08/23/2024
|
Canadian Apartment Properties: We Still Prefer Northview When Playing The North
- CAPREIT's operational performance remains solid, but Northview Residential REIT offers a more attractive risk/return profile in the Canadian residential REIT sector. Earnings update shows solid AMR growth in the residential portfolio, NOI growth, and announcement of MHC portfolio sale. CAPREIT trades at a moderate discount to NAV but limited upside at current prices, with Northview Residential REIT offering better value.
- 08/21/2024
|
Marker Therapeutics Awarded $2 Million Grant from NIH in Support of Phase 1 Study Investigating MT-601 in CAR-Relapsed Patients with Non-Hodgkin's Lymphoma
- Marker Therapeutics to receive non-dilutive funding from NIH Small Business Innovation Research Program based on preliminary clinical results and non-clinical data in lymphoma Marker Therapeutics to receive non-dilutive funding from NIH Small Business Innovation Research Program based on preliminary clinical results and non-clinical data in lymphoma
- 08/12/2024
|
Canadian Apartment Properties Real Estate Investment Trust (CDPYF) Q2 2024 Earnings Call Transcript
- Canadian Apartment Properties Real Estate Investment Trust (OTC:CDPYF) Q2 2024 Earnings Conference Call August 8, 2024 9:00 AM ET Company Participants Nicole Dolan - Investor Relations Mark Kenney - President and Chief Executive Officer Julian Schonfeldt - Chief Investment Officer Stephen Co - Chief Financial Officer Conference Call Participants Fred Blondeau - Green Street Jonathan Kelcher - TD Cowen Mario Saric - Scotiabank Kyle Stanley - Jarden Jimmy Shan - RBC Matt Kornack - National Bank Sairam Srinivas - Cormark Securities Dean Wilkerson - CIBC Operator Good morning. Thank you for attending today's Canadian Apartment Properties Second Quarter 2024 Results Conference Call.
- 08/10/2024
|
Avis Budget (CAR) Stock Gains 6% Since Q2 Earnings Miss
- Avis Budget Group's (CAR) second-quarter 2024 earnings and revenues decrease on a year-over-year basis.
- 08/09/2024
|
Avis Budget Group, Inc. (CAR) Q2 2024 Earnings Call Transcript
- Avis Budget Group, Inc. (NASDAQ:CAR ) Q2 2024 Earnings Conference Call August 6, 2024 8:30 AM ET Company Participants David Calabria - Senior Vice President, Corporate Finance and Treasurer Joseph Ferraro - President and Chief Executive Officer Izzy Martins - Executive Vice President and Chief Financial Officer Conference Call Participants Chris Woronka - Deutsche Bank Ryan Brinkman - JPMorgan John Babcock - Bank of America Lizzie Dove - Goldman Sachs Stephanie Moore - Jefferies Operator Greetings. Welcome to the Avis Budget Group Second Quarter 2024 Earnings Conference Call.
- 08/06/2024
|
Here's What Key Metrics Tell Us About Avis Budget (CAR) Q2 Earnings
- The headline numbers for Avis Budget (CAR) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 08/05/2024
|
Avis Budget Group (CAR) Misses Q2 Earnings and Revenue Estimates
- Avis Budget Group (CAR) came out with quarterly earnings of $0.41 per share, missing the Zacks Consensus Estimate of $2.60 per share. This compares to earnings of $11.01 per share a year ago.
- 08/05/2024
|
Avis Budget Group Reports Second Quarter Results
- PARSIPPANY, N.J., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) announced financial results for second quarter 2024 today.
- 08/05/2024
|
Avis Budget Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
- Avis Budget Group, Inc. CAR is set to release earnings results for its second quarter, after the closing bell on Aug. 5, 2024.
- 08/05/2024
|
Analysts Estimate Avis Budget Group (CAR) to Report a Decline in Earnings: What to Look Out for
- Avis Budget (CAR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/29/2024
|
Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting
- SAN JOSE, Calif. , July 29, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced a presentation on its ovarian cancer CAR-T therapy clinical trial at the International Gynecologic Cancer Society (IGCS) 2024 Annual Global Meeting being held October 16-18, 2024, in Dublin, Ireland.
- 07/29/2024
|
7 Contrarian Plays That Wall Street Is Ignoring: July 2024
- With the recent stock market pullback, you may be taking a look at potential bargains among widely-followed stocks. However, instead of “buying the dip” in what's popular, you may want to take a look at the deep value opportunities among contrarian stocks instead.
- 07/29/2024
|
California Institute for Regenerative Medicine Awards Funding for CAR-T NXC-201 U.S. AL Amyloidosis Clinical Trial (NEXICART-2)
- $8 million grant funds development of NXC-201 in relapsed/refractory AL Amyloidosis $8 million grant funds development of NXC-201 in relapsed/refractory AL Amyloidosis
- 07/25/2024
|
California Institute for Regenerative Medicine Awards Funding for CAR-T NXC-201 U.S. AL Amyloidosis Clinical Trial (NEXICART-2)
- $8 million grant funds development of NXC-201 in relapsed/refractory AL Amyloidosis $8 million grant funds development of NXC-201 in relapsed/refractory AL Amyloidosis
- 07/25/2024
|
Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy
- IND follows encouraging findings of necrosis, inflammation and T cell infiltration in tumor biopsy of patient in lowest dose cohort SAN JOSE, Calif. , July 23, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its collaborator, Moffitt Cancer Center (Moffitt), has received approval by the U.S. Food and Drug Administration (FDA) of an individual patient Investigational New Drug Application (IND) to allow a second dose of its CAR-T therapy for a patient that may be demonstrating clinical activity to the initial treatment.
- 07/23/2024
|
Canadian Apartment Properties: A Story Of Three Tailwinds
- Canadian housing sector faces an affordability crisis due to demographic, regulatory, and economic conditions. Population growth outpaces housing supply, leading to rising rents and low vacancy rates. CAPREIT represents a sound investment opportunity with growth potential, a conservative debt profile, and a strategic capital recycling strategy.
- 07/16/2024
|
Canadian Apartment REIT: Bull Case Remains Firmly Intact
- After 18 months on the sidelines, we gave CAPREIT a buy on our last evaluation. The stock has outperformed the REIT Index ETF by a 2:1 margin since then. We tell you why we are staying with a Buy rating.
- 07/15/2024
|
Avis Budget Group to Announce Second Quarter 2024 Results on August 5th
- PARSIPPANY, N.J., July 11, 2024 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) announced today that it plans to report its second quarter 2024 results after the market close on Monday, August 5th, 2024, and to host a conference call for institutional investors to discuss these results on Tuesday, August 6th, 2024 at 8:30 a.m.
- 07/11/2024
|
Immix Biopharma Doses 1st Patient in U.S. AL Amyloidosis Trial with CAR-T NXC-201
- LOS ANGELES, July 08, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us”, “IMMX”) (Nasdaq: IMMX), a clinical-stage biopharmaceutical company trailblazing cell therapies in AL Amyloidosis and autoimmune disease, today announced that the 1st patient has been dosed at MSKCC in its U.S. NEXICART-2 trial with NXC-201, a sterically-optimized BCMA-targeted CAR-T cell therapy.
- 07/08/2024
|
Atara Biotherapeutics: An Underestimated Contender In Autoimmune Diseases CAR-T Cell Therapy
- Atara Biotherapeutics is a biotech company developing allogeneic EBV T cells for oncology and autoimmune indications, with a world-first allogeneic CAR-T approval in Europe and nearing FDA approval. Assuming no regulatory delays ATRA is well-funded to deliver proof-of-concept clinical data for its CAR-T platform in both B-cell malignancies and lupus, with an estimated cash runway into 2027. Despite fierce competition, ATRA's differentiated CAR-T platform combines all the best attributes of the competition, thus having a best-in-class potential.
- 07/03/2024
|
Cartesian Therapeutics Plummets Despite 'Watershed Moment' For CAR-T Drugs
- Cartesian Therapeutics reported a "watershed moment" for its autoimmune-disease drug on Tuesday, but the biotech stock plunged.
- 07/02/2024
|
Senti Bio Awarded California Institute for Regenerative Medicines (CIRM) Grant for Clinical Development of Logic Gated CAR-NK Cell Therapy
- SOUTH SAN FRANCISCO, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that the California Institute for Regenerative Medicines (“CIRM”) has awarded an $8 million grant to Senti Bio.
- 07/01/2024
|
Carisma Therapeutics Announces Nomination of First In Vivo CAR-M Development Candidate for Hepatocellular Carcinoma Under Collaboration with Moderna
- Development Candidate targets Glypican-3 for the treatment of solid tumors, including hepatocellular carcinoma Nomination triggers a $2 million milestone payment to Carisma PHILADELPHIA , June 27, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced the nomination of the first development candidate ("Development Candidate"), under its collaboration with Moderna, Inc. The Development Candidate is an in vivo CAR-M targeting Glypican-3 ("GPC3") and is designed to treat solid tumors, including hepatocellular carcinoma ("HCC"), the most prevalent type of liver cancer and the fastest-rising cause of cancer-related death in the U.S. This nomination triggers a $2 million milestone payment to Carisma. The nomination of this Development Candidate leverages Carisma's expertise in engineering chimeric antigen receptor monocytes and macrophages ("CAR-M") with Moderna's mRNA and lipid nanoparticle platform to create a novel in vivo cell therapy for oncology.
- 06/27/2024
|
Lyell Immunopharma Reports Dose-dependent Clinical Activity from Phase 1 Trial of LYL797, a ROR1-targeted CAR-T Cell Product Candidate Enhanced with its Proprietary Anti-exhaustion Technology
- SOUTH SAN FRANCISCO, Calif., June 26, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors, today announced initial clinical and translational data from its Phase 1 trial of LYL797, its first-generation reprogrammed ROR1 CAR T‑cell product candidate enhanced with proprietary anti-exhaustion technology. The initial dataset consists primarily of patients with triple-negative breast cancer (TNBC) and demonstrated dose-dependent antitumor clinical activity and the ability of LYL797 CAR T cells to proliferate, infiltrate tumors and kill cancer cells in patients with relapsed/refractory disease. Patients with TNBC treated with LYL797 had an objective response rate (ORR) of 40% and clinical benefit rate (CBR) of 60% at the 150 x 106 CAR T cell dose level, with a CBR of 38% across all dose levels evaluable to date. Common treatment-related adverse events in patients without lung metastases included Grade 1 and 2 cytokine release syndrome (CRS) and headache, and the expected cytopenia from lymphodepletion. There were no reports of immune effector cell-associated neurotoxicity syndrome (ICANS) attributed to LYL797. Pneumonitis occurred in patients with lung metastases and dose escalation is continuing separately and more gradually in those patients. No dose-limiting toxicities have been reported in patients without lung involvement. All patients are now receiving prophylactic steroids prior to LYL797 treatment.
- 06/26/2024
|
Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial
- This patient is expected to be the final patient in the second dosage cohort of the trial SAN JOSE, Calif. , June 24, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it has treated the sixth patient in the ongoing Phase 1 clinical trial of its novel chimeric antigen receptor T-cell (CAR-T) therapy for ovarian cancer.
- 06/24/2024
|
Kyverna's KYV-101 Receives U.S. FDA IND Clearance for Treatment of Patients With Treatment-Refractory Stiff-Person Syndrome in the KYSA-8 Phase 2 Trial
- This IND clearance expands the use of KYV-101 CAR T-cell therapy in a Phase 2, open-label KYSA-8 clinical trial targeting a devastating neuroimmunological autoimmune disease KYV-101 is a fully human anti-CD19 CAR T-cell therapy designed for use in patients with B cell-driven autoimmune diseases EMERYVILLE, Calif. , June 20, 2024 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Kyverna), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases, announced today the clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for its autologous, fully human anti-CD19 chimeric antigen receptor (CAR) T-cell product candidate, KYV-101, to be used for the treatment of stiff-person syndrome (SPS) in Kyverna's trial, named KYSA-8.
- 06/20/2024
|
Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel (cema-cel), an Allogeneic CAR T Product, as Part of First Line Treatment for Patients with Large B-Cell Lymphoma (LBCL) Likely to Relapse
- SOUTH SAN FRANCISCO, Calif. and BOULDER, Colo., June 20, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products, and Foresight Diagnostics (Foresight), a leader in ultra-sensitive liquid biopsy-based minimal residual disease (MRD) detection, today announced the initiation of the pivotal Phase 2 ALPHA3 trial evaluating the use of cemacabtagene ansegedleucel (cema-cel) as part of the first line (1L) treatment regimen for newly diagnosed LBCL patients who are likely to relapse after standard 1L treatment and need further therapy.
- 06/20/2024
|
Crown88, Asia's Premier Gaming Provider Collaborates with Taiwanese Influencer Avis in Expansion Endeavors
- Singapore, Singapore--(Newsfile Corp. - June 20, 2024) - Crown88, a pioneer in the Online Gaming Industry since its inception in 2010, has been steadily broadening its reputable services across multiple Asian territories, including Singapore, Malaysia, Thailand, Vietnam, Myanmar, and most recently, Australia. Now, marking a significant milestone in its journey, Crown88 proudly announces a strategic partnership with Avis, a prominent Taiwanese YouTuber renowned for captivating millions of followers with his compelling content.
- 06/20/2024
|
Avis Budget Group Digital Transformation Strategy Analysis Report 2024: Accelerators, Incubators, Technology Centers and Other Innovation Programs
- Dublin, June 17, 2024 (GLOBE NEWSWIRE) -- The "Avis Budget Group (Avis) - Digital Transformation Strategies" company profile has been added to ResearchAndMarkets.com's offering. The report provides comprehensive information and insights into Avis' tech activities, including its digital transformation strategies and innovation programs.
- 06/17/2024
|
Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T Therapy
- Overall response rate of 90% in cohort with durable responses observed; one patient remains in complete remission at 31 months
- 06/17/2024
|
Galapagos presents encouraging new data for CD19 CAR-T candidate GLPG5101 in non-Hodgkin lymphoma at EHA 2024
- Mechelen, Belgium; June 14, 2024, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present encouraging new data from the ongoing Phase 1/2 ATALANTA-1 study of CD19 CAR-T candidate, GLPG5101, in relapsed/refractory non-Hodgkin lymphoma (R/R NHL) at the annual European Hematology Association (EHA) 2024 Hybrid Congress. Galapagos' product candidate GLPG5101 is produced using the company's innovative, decentralized T-cell manufacturing platform.
- 06/14/2024
|
Allogene: Two End Of 2024 Data Readouts With Improved Allogeneic CAR-T Products
- Allogene Therapeutics, Inc. initiation of phase 2 ALPHA3 study, using cema-cel for the treatment of patients with 1st-line large B-cell lymphoma, expected in mid-2024 with two data analysis in 2026. Results from phase 2 ALPHA2 trial, using cema-cel for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia, expected by end of 2024. Results from phase 1 TRAVERSE trial, using ALLO-316 for the treatment of CD70 positive clear cell renal cell carcinoma patients, expected by the end of 2024.
- 06/12/2024
|
Kyverna Therapeutics and National Institutes of Health Co-Author Seminal Review on Cell Therapy for Autoimmunity in Nature Reviews Immunology
- Promising results from early clinical experience with anti-CD19 CAR T cells in patients with autoimmune diseases Optimal CAR construct design contributing to an acceptable safety profile, and potential for lasting immune reset are key for treatment adoption Kyverna is currently recruiting for multiple KYSA trials where the company's product candidate KYV-101 is used to treat patients suffering from myasthenia gravis, multiple sclerosis, and lupus nephritis EMERYVILLE, Calif. , June 10, 2024 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Kyverna), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases, announced today the publication in Nature Reviews Immunology of a manuscript co-authored with the National Institutes of Health titled "Chimeric antigen receptor T cell therapy for autoimmune disease"1.
- 06/10/2024
|
New Strong Sell Stocks for June 7th
- A, CAR and BGS have been added to the Zacks Rank #5 (Strong Sell) List on June 7, 2024.
- 06/07/2024
|
AbelZeta announces clinical data showing preliminary anti-tumor activity for C-CAR031, an armored autologous GPC3 CAR-T, in patients with advanced hepatocellular carcinoma, at ASCO Annual Meeting 2024
- CAR031 study at 9.03-mo median follow up achieves disease control rate (DCR) of 91.3% and objective response rate (ORR) of 56.5% for patients across all dose levels (DLs) and ORR of 75.0% at DL4 ROCKVILLE, Md. , June 4, 2024 /PRNewswire/ -- AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietary cell-based therapeutic products, today announced preliminary safety and efficacy results from its first time in human investigator-initiated trial (IIT) of C-CAR031 in connection with the Company's oral presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.
- 06/04/2024
|
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
- -- CB-010 allogeneic CAR-T cell therapy w ith partial HLA matching has potential to rival efficacy and safety profile of approved autologous CAR-T cell therapies -- -- 14.4 months median PFS in ANTLER patients with partial HLA matching (≥4 alleles) --
- 06/02/2024
|
U.S. Food and Drug Administration Approves Bristol Myers Squibb's Breyanzi as a New CAR T Cell Therapy for Relapsed or Refractory Mantle Cell Lymphoma
- PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Breyanzi--U.S. Food and Drug Administration Approves Bristol Myers Squibb's Breyanzi as a New CAR T Cell Therapy for Relapsed or Refractory Mantle Cell Lymphoma.
- 05/30/2024
|
Atara Biotherapeutics Presents Preclinical Data on ATA3219, an Allogeneic CD19-Targeted CAR T Therapy for the Treatment of B-Cell Driven Autoimmune Diseases, at the ISCT 2024 Annual Meeting
- THOUSAND OAKS, Calif.--(BUSINESS WIRE)---- $ATRA #CART--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced preclinical data supporting the potential of ATA3219, an allogeneic, anti-CD19 chimeric antigen receptor (CAR) T-cell therapy candidate for the treatment of B-cell driven autoimmune diseases. Findings demon.
- 05/29/2024
|
Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHA
- SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today that new and updated data from the CARTITUDE clinical development program evaluating CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) for patients with multiple myeloma will be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting and the 2024 European Hematology Association's (EHA) Hybrid Congress. Data from Cohort D of the Ph.
- 05/23/2024
|
Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial
- Novel and proprietary CAR-T approach holds potential to be first effective CAR-T therapy for solid tumors SAN JOSE, Calif. , May 21, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and prevention of cancer, today announced that treatment has commenced for the fifth patient in its ongoing Phase 1 clinical trial of its novel chimeric antigen receptor T-cell (CAR-T) therapy for ovarian cancer.
- 05/21/2024
|
Higher inflation in 2024 likely: NABE
- Inflation is likely to stick around at higher-than-desired levels for the rest of the year, according to a new survey by America’s top economists. "With the higher inflation expectations, panelists now anticipate the Federal Reserve’s Open Market Committee will cut rates by half a percentage point – down from three-quarters of a point and to occur later in the year than previously expected" wrote National Association of Business Economics President Ellen Zentner, who is also chief U.S. economist at Morgan Stanley. NABE’s May survey, which includes 43 professional forecasters, now pegs inflation to stall at 2.6%. While down from April’s consumer price index reading of 3.4%, it remains above the Fed’s preferred 2% target, a level expected to green-light interest rate cuts. Still, prices have come down sharply from the 9.1% peak. CONSUMER ETFs SHOW THE REAL INFLATION PICTURE About 48% of market participants see the Fed cutting rates for the first time in September to 5%-5.25%, according to the CME’s FedWatch Tool, which tracks the probability of rate moves. The Federal Funds rate is currently at 5.25%-5.5%. Still, Fed Chair Jerome Powell was a bit downtrodden about the inflation battle in his remarks last week. "We did not expect this to be a smooth road, but these were higher than I think anybody expected," he said. "What that has told us is that we will need to be patient and let restrictive policy do its work," he said during a panel discussion at the Foreign Bankers' Association in Amsterdam. His remarks followed a month-over-month 0.4% rise in the producer price index for April, which tracks prices at the wholesale level. Annually, prices rose 2.2%. Both were higher than previous reports. INFLATION BREAKDOWN: A LOOK PRICES RISING THE MOST Americans are paying more for everyday staples, especially food, compared to a year ago, including a 4.8% jump for canned vegetables, hot dogs are up 7.1%, butter 3.5% and sugar 4.3%, as reported in April’s CPI. CAR INSURANCE RATES KEEP RISING, FUELING INFLATION As a result, more consumers are loading up credit card debt to make ends meet. Consumers owe $1.02 trillion in credit card debt, according to the Federal Reserve Bank of New York. The average debt per borrower is north of $6,200 through the first quarter, up 8.5% from a year ago, TransUnion reported. FOX Business' Megan Henney contributed to this report.
- 05/20/2024
|
Meridian Wealth Management LLC Sells 3,300 Shares of PACCAR Inc (NASDAQ:PCAR)
- Meridian Wealth Management LLC trimmed its holdings in shares of PACCAR Inc (NASDAQ:PCAR – Free Report) by 49.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,368 shares of the company’s stock after selling 3,300 shares during the quarter. Meridian Wealth Management LLC’s holdings in PACCAR were worth $329,000 at the end of the most recent quarter. A number of other hedge funds and other institutional investors have also added to or reduced their stakes in PCAR. Raymond James Financial Services Advisors Inc. raised its holdings in PACCAR by 18.0% during the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 107,018 shares of the company’s stock valued at $10,450,000 after acquiring an additional 16,360 shares during the period. abrdn plc boosted its stake in PACCAR by 50.9% in the 4th quarter. abrdn plc now owns 264,756 shares of the company’s stock worth $25,853,000 after purchasing an additional 89,359 shares during the period. Aigen Investment Management LP purchased a new stake in PACCAR during the 3rd quarter valued at approximately $319,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. lifted its holdings in shares of PACCAR by 42.5% in the 3rd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 558,909 shares of the company’s stock valued at $47,518,000 after acquiring an additional 166,628 shares during the last quarter. Finally, Pacer Advisors Inc. raised its position in PACCAR by 29.6% during the fourth quarter. Pacer Advisors Inc. now owns 71,727 shares of the company’s stock valued at $7,004,000 after purchasing an additional 16,390 shares during the period. 64.90% of the stock is owned by hedge funds and other institutional investors. Insider Buying and Selling at PACCAR In other PACCAR news, VP Michael K. Walton sold 9,123 shares of PACCAR stock in a transaction on Monday, May 6th. The shares were sold at an average price of $105.11, for a total transaction of $958,918.53. Following the sale, the vice president now owns 1,468 shares of the company’s stock, valued at approximately $154,301.48. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other PACCAR news, VP Brice J. Poplawski sold 2,067 shares of PACCAR stock in a transaction dated Friday, May 10th. The shares were sold at an average price of $109.40, for a total transaction of $226,129.80. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Michael K. Walton sold 9,123 shares of the firm’s stock in a transaction on Monday, May 6th. The stock was sold at an average price of $105.11, for a total value of $958,918.53. Following the sale, the vice president now directly owns 1,468 shares of the company’s stock, valued at approximately $154,301.48. The disclosure for this sale can be found here. Insiders sold 45,040 shares of company stock valued at $4,779,241 over the last quarter. 2.02% of the stock is currently owned by insiders. Wall Street Analysts Forecast Growth PCAR has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. dropped their price objective on PACCAR from $140.00 to $130.00 and set an “overweight” rating for the company in a report on Wednesday, May 1st. The Goldman Sachs Group raised their price target on shares of PACCAR from $106.00 to $121.00 and gave the stock a “neutral” rating in a research note on Tuesday, April 16th. UBS Group raised shares of PACCAR from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $104.00 to $136.00 in a research report on Friday, March 15th. TD Cowen raised their target price on shares of PACCAR from $91.00 to $108.00 and gave the stock a “market perform” rating in a research report on Wednesday, January 24th. Finally, Evercore ISI increased their price objective on PACCAR from $94.00 to $101.00 and gave the stock an “in-line” rating in a research note on Tuesday, February 20th. Seven equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $112.62. Get Our Latest Analysis on PACCAR PACCAR Trading Up 0.1 % Shares of NASDAQ:PCAR opened at $106.00 on Monday. The company has a market capitalization of $55.56 billion, a PE ratio of 11.00, a PEG ratio of 1.64 and a beta of 0.96. PACCAR Inc has a 12-month low of $68.40 and a 12-month high of $125.50. The business has a 50 day moving average of $115.26 and a two-hundred day moving average of $104.48. The company has a current ratio of 2.73, a quick ratio of 2.49 and a debt-to-equity ratio of 0.54. PACCAR (NASDAQ:PCAR – Get Free Report) last posted its earnings results on Tuesday, April 30th. The company reported $2.27 EPS for the quarter, beating analysts’ consensus estimates of $2.20 by $0.07. PACCAR had a return on equity of 31.71% and a net margin of 14.30%. The firm had revenue of $8.24 billion for the quarter, compared to analysts’ expectations of $8.25 billion. During the same period last year, the firm earned $2.25 EPS. The company’s quarterly revenue was up 2.3% on a year-over-year basis. As a group, analysts forecast that PACCAR Inc will post 8.26 EPS for the current year. PACCAR Increases Dividend The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 5th. Shareholders of record on Wednesday, May 15th will be paid a dividend of $0.30 per share. This is a positive change from PACCAR’s previous quarterly dividend of $0.27. This represents a $1.20 annualized dividend and a yield of 1.13%. The ex-dividend date of this dividend is Tuesday, May 14th. PACCAR’s payout ratio is 12.45%. PACCAR Company Profile (Free Report) PACCAR Inc designs, manufactures, and distributes light, medium, and heavy-duty commercial trucks in the United States, Canada, Europe, Mexico, South America, Australia, and internationally. It operates through three segments: Truck, Parts, and Financial Services. The Truck segment designs, manufactures, and distributes trucks for the over-the-road and off-highway hauling of commercial and consumer goods.
- 05/20/2024
|
HaemaLogiX welcomes former Australian Federal Minister for Health Professor the Hon Greg Hunt to the company board as Non-Executive Director
- SYDNEY, May 20, 2024 /PRNewswire/ -- HaemaLogiX Ltd, a clinical stage biotech developing novel immunotherapies for patients with blood cancers and B-cell diseases, is pleased to announce the appointment of Professor the Hon Greg Hunt, former Australian Federal Minister for Health, to the HaemaLogiX Board as a Non-Executive Director. This appointment marks the first corporate directorship that Prof Hunt has accepted since completing his period as Minister for Health. As the Federal Minister for Health from 2017 to 2022, Prof Hunt oversaw Australia's response to the global COVID-19 pandemic. He established telehealth as a permanent and universal centrepiece of Medicare, Australia's publicly funded universal healthcare scheme. In addition, Prof Hunt reformed private health and established long-term plans for mental health, aged care, medical research and primary care and listed over 2,000 new and amended medicines for public access. As Minister for Industry, Innovation & Science, Prof Hunt laid the foundation for the Australian Space Agency. As Minister for the Environment, he established the Emissions Reduction Fund, the Green Army, the $1 billion Reef Trust and helped lead Australia's negotiations for the Montreal Protocol update and Paris Climate Change Accord. For his work as Environment Minister, Prof Hunt was named Best Minister in the World at the World Government Summit in 2016. Outside of his political career, Prof Hunt holds academic appointments with world-class institutions including the University of Melbourne and University College, London. Prof Hunt is also the Chair of the CARDIO4Cities Accelerator Steering Committee under Novartis Foundation, and Chair of the Turner Institute for Mental Health at Monash University. On his decision to join the Board, Professor Hunt said, "HaemaLogiX tackles an unmet treatment need through innovative science which is recognised by world-leading scientific voices. Through my career, I have seen first-hand the invaluable benefits that immunotherapy and other emerging therapies can bring to patients. As we continue to advance our clinical trials (and subject to those trials) there is great hope for safer and more effective treatments which may be made available for patients with multiple myeloma and other conditions," said Prof Hunt. "Working with this well-respected team was also a very exciting prospect. HaemaLogiX is led by an impressive senior executive and board. The Scientific Advisory Board is notable for its internationally-renowned researchers, medical professionals, and academics," said Prof Hunt. Established in 2014, HaemaLogiX is an Australian biotech company specialising in developing immune-based treatments to improve outcomes for patients battling blood cancers such as multiple myeloma, and B-Cell diseases. The company has identified unique therapeutic targets and developed antibody-based treatment strategies to change the course of related diseases. Damian Clarke-Bruce, CEO and Managing Director of HaemaLogiX, said that the synergy between the company's research focus and Prof Hunt's passion for enhanced patient outcomes and innovation in science, makes him a strong addition to the board. "We're thrilled to welcome Greg to our company. He brings a wealth of advisory experience and knowledge to HaemaLogiX, with an equal commitment to seeing new treatments reach patients and the market." HaemaLogiX is the first and only company, of which we are aware, developing antibody therapy focused on the novel targets kappa myeloma antigen (KMA) and lambda myeloma antigen (LMA). KMA and LMA are found on the surface of cancer cells and not on normal cells in patients with multiple myeloma and AL amyloidosis, two diseases with limited treatment success and no effective cure. The company's antibody clinical trial programs targeting KMA and LMA are conducted in partnership with global leaders in haematology at Alfred Health and the Peter MacCallum Cancer Centre (Peter Mac). Validated and guided by these pioneering research institutions, HaemaLogiX runs first-in-class clinical programs. Led by Professor Andrew Spencer from the Alfred, a published Phase 2b efficacy study for the KappaMab program demonstrated an 83% overall response rate in multiple myeloma patients, combined with a 46% reduction in risk of death compared to the matched case control group, without delivering any increased adverse effects for the patients. Two patients from this study have remained on therapy for more than 4 years following their initial treatment. Haemalogix and Peter Mac are actively progressing the manufacturing stage of their collaborative CAR-T development program. The team plans to initiate the first CAR-T Phase 1 clinical trial targeting KMA on malignant plasma cells. This trial is in relapsed/refractory myeloma patients with KMA-positive bone marrow plasma cells and whose disease is progressing in spite of prior standard of care treatments. "Science is always evolving. Through our identification of unique novel antigens, HaemaLogiX technology and multiple therapeutic vehicles provide new options for patients. Greg further links us internationally with key industry stakeholders. As we move to expand our presence into the US, we are excited by this and ready for the next step of our company's growth," said Clark-Bruce. Non-Executive Chairman, Dr John Cullity said: "Greg represents a significant addition to our Board. As we further our clinical achievements, we look forward to working closely with Greg to amplify our presence within the Australian life science sector in addition to accessing global audiences as we scale up HaemaLogiX." Media ContactJane Lowe+61 411 117 774[email protected] Evelyn Yang+61 432 871 726[email protected] About HaemaLogiX Ltd Formed in 2014, HaemaLogiX is a public unlisted biotech company researching antibody therapies for multiple myeloma. Multiple myeloma is a haematological (blood) cancer of plasma cells (B cells) that can cause focused damage to a patient's bone marrow. Multiple myeloma is considered treatable but generally incurable. The HaemaLogiX team has a wide range and depth of experience in antibody research, nonclinical & clinical development, manufacturing and commercialisation. The Scientific Advisory Board (SAB) members are internationally recognised experts in monoclonal antibody therapies and haematology. Our current research and clinical trial partners are global leaders in multiple myeloma and AL Amyloidosis therapy. HaemaLogiX is located in Sydney, Australia with clinical trials coordinated in Melbourne, Victoria and an evolving presence in the USA. www.haemalogix.com About Professor Greg Hunt Greg is a highly experienced former Cabinet Minister in the Australian Government, having served as Australia's Minister for the Environment, Innovation and Health across three major portfolios over almost nine years. He advises a wide range of businesses and not for profits in the areas of innovation, leadership, strategic planning, health and the environment. As Minister for Health from 2017 to 2022, Professor Hunt oversaw an annual budget of $132 billion, 17 portfolio agencies and 7,000 staff. Prior to that, Prof Hunt was Minister for Industry, Innovation & Science (2016-2017) and Minister for the Environment, Australian Government (2013-2016). He was first elected to the Parliament in 2001, serving as the Federal Member for Flinders, a seat that he went on holding for the subsequent two decades until his retirement in 2022. Professor Hunt was appointed Honorary Enterprise Professor in the Faculty of Medicine, Dentistry and Health Services and the Faculty of Business and Economics at the University of Melbourne in December 2022 and Honorary Professor at University College, London in February 2024. Greg is also the inaugural Chair of the Advisory Council for the Turner Institute for Brain and Mental Health at Monash University and Chair of the Novartis Foundation's CARDIO4Cities Accelerator Steering Committee.
- 05/20/2024
|
National Bank of Canada FI Grows Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
- National Bank of Canada FI boosted its position in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 200.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,500 shares of the company’s stock after buying an additional 1,000 shares during the period. National Bank of Canada FI’s holdings in Beam Therapeutics were worth $41,000 as of its most recent SEC filing. A number of other institutional investors and hedge funds also recently added to or reduced their stakes in BEAM. State Board of Administration of Florida Retirement System raised its position in Beam Therapeutics by 2.6% in the 3rd quarter. State Board of Administration of Florida Retirement System now owns 19,910 shares of the company’s stock valued at $479,000 after purchasing an additional 510 shares during the last quarter. First Horizon Advisors Inc. raised its holdings in shares of Beam Therapeutics by 125.9% in the fourth quarter. First Horizon Advisors Inc. now owns 994 shares of the company’s stock valued at $27,000 after buying an additional 554 shares during the last quarter. Allworth Financial LP boosted its stake in shares of Beam Therapeutics by 163.7% during the third quarter. Allworth Financial LP now owns 1,105 shares of the company’s stock worth $27,000 after buying an additional 686 shares during the period. Commonwealth Equity Services LLC grew its holdings in shares of Beam Therapeutics by 11.7% during the third quarter. Commonwealth Equity Services LLC now owns 9,812 shares of the company’s stock worth $236,000 after buying an additional 1,030 shares during the last quarter. Finally, Nisa Investment Advisors LLC increased its position in Beam Therapeutics by 70.0% in the 3rd quarter. Nisa Investment Advisors LLC now owns 3,312 shares of the company’s stock valued at $80,000 after acquiring an additional 1,364 shares during the period. Hedge funds and other institutional investors own 99.68% of the company’s stock. Beam Therapeutics Price Performance Shares of BEAM stock opened at $24.62 on Monday. The firm has a market cap of $2.03 billion, a P/E ratio of -13.83 and a beta of 1.88. Beam Therapeutics Inc. has a 1-year low of $16.95 and a 1-year high of $49.50. The firm’s 50-day simple moving average is $27.75 and its 200-day simple moving average is $28.40. Beam Therapeutics (NASDAQ:BEAM – Get Free Report) last posted its quarterly earnings results on Tuesday, May 7th. The company reported ($1.21) EPS for the quarter, beating the consensus estimate of ($1.42) by $0.21. Beam Therapeutics had a negative net margin of 37.33% and a negative return on equity of 15.46%. The firm had revenue of $7.40 million for the quarter, compared to analyst estimates of $17.09 million. During the same quarter last year, the firm posted ($1.33) earnings per share. Beam Therapeutics’s revenue for the quarter was down 69.4% compared to the same quarter last year. Analysts expect that Beam Therapeutics Inc. will post -4.68 earnings per share for the current fiscal year. Insider Activity at Beam Therapeutics In other Beam Therapeutics news, insider Amy Simon sold 7,157 shares of the business’s stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $32.13, for a total transaction of $229,954.41. Following the transaction, the insider now owns 86,590 shares in the company, valued at $2,782,136.70. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In other news, CEO John M. Evans sold 60,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 28th. The shares were sold at an average price of $33.86, for a total transaction of $2,031,600.00. Following the completion of the sale, the chief executive officer now owns 998,262 shares of the company’s stock, valued at $33,801,151.32. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Amy Simon sold 7,157 shares of the stock in a transaction on Monday, April 1st. The shares were sold at an average price of $32.13, for a total transaction of $229,954.41. Following the transaction, the insider now owns 86,590 shares in the company, valued at $2,782,136.70. The disclosure for this sale can be found here. In the last three months, insiders sold 95,239 shares of company stock worth $3,163,729. Corporate insiders own 4.20% of the company’s stock. Analysts Set New Price Targets A number of research firms have weighed in on BEAM. Royal Bank of Canada increased their price objective on Beam Therapeutics from $27.00 to $35.00 and gave the stock a “sector perform” rating in a research report on Wednesday, February 28th. TheStreet upgraded shares of Beam Therapeutics from a “d” rating to a “c-” rating in a research note on Monday, March 11th. Wedbush restated an “outperform” rating and issued a $57.00 price objective on shares of Beam Therapeutics in a research report on Tuesday, May 7th. BMO Capital Markets reiterated an “outperform” rating and set a $57.00 target price on shares of Beam Therapeutics in a research report on Wednesday, March 27th. Finally, JPMorgan Chase & Co. raised Beam Therapeutics from a “neutral” rating to an “overweight” rating and raised their price target for the company from $38.00 to $40.00 in a report on Monday, January 29th. Eight investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, Beam Therapeutics presently has an average rating of “Hold” and an average price target of $40.18. Get Our Latest Report on BEAM About Beam Therapeutics (Free Report) Beam Therapeutics Inc, a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 for the treatment of sickle cell disease or beta-thalassemia; and BEAM-302, a liver-targeting LNP formulation to treat severe alpha-1 antitrypsin deficiency; BEAM-201, an anti-CD7 CAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of refractory T-cell acute lymphoblastic leukemia/T cell lymphoblastic lymphoma; and BEAM-301, a liver-targeting LNP formulation for the treatment of glycogen storage disease 1a.
- 05/20/2024
|
HC Wainwright Analysts Lower Earnings Estimates for Mustang Bio, Inc. (NASDAQ:MBIO)
- Mustang Bio, Inc. (NASDAQ:MBIO – Free Report) – Analysts at HC Wainwright reduced their Q2 2024 earnings estimates for Mustang Bio in a research note issued to investors on Thursday, May 16th. HC Wainwright analyst J. Pantginis now forecasts that the company will post earnings of ($0.14) per share for the quarter, down from their previous estimate of ($0.13). HC Wainwright currently has a “Buy” rating and a $2.00 target price on the stock. The consensus estimate for Mustang Bio’s current full-year earnings is ($1.93) per share. HC Wainwright also issued estimates for Mustang Bio’s Q3 2024 earnings at ($0.13) EPS, Q4 2024 earnings at ($0.16) EPS, FY2024 earnings at ($0.61) EPS and FY2025 earnings at ($0.35) EPS. Mustang Bio Stock Up 4.0 % Shares of NASDAQ:MBIO opened at $0.31 on Monday. The company has a market capitalization of $3.24 million, a price-to-earnings ratio of -0.07 and a beta of 1.75. Mustang Bio has a 52 week low of $0.22 and a 52 week high of $8.17. The firm has a 50 day moving average of $0.61 and a 200 day moving average of $1.13. Mustang Bio (NASDAQ:MBIO – Get Free Report) last issued its quarterly earnings data on Monday, March 11th. The company reported ($0.71) EPS for the quarter, topping analysts’ consensus estimates of ($1.68) by $0.97. Hedge Funds Weigh In On Mustang Bio A hedge fund recently bought a new stake in Mustang Bio stock. Armistice Capital LLC acquired a new stake in shares of Mustang Bio, Inc. (NASDAQ:MBIO – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 435,764 shares of the company’s stock, valued at approximately $588,000. Armistice Capital LLC owned about 4.73% of Mustang Bio at the end of the most recent reporting period. Institutional investors and hedge funds own 9.95% of the company’s stock. About Mustang Bio (Get Free Report) Mustang Bio, Inc, a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
- 05/20/2024
|
Sorrento Therapeutics (OTCMKTS:SRNEQ) and bluebird bio (NASDAQ:BLUE) Financial Comparison
- Sorrento Therapeutics (OTCMKTS:SRNEQ – Get Free Report) and bluebird bio (NASDAQ:BLUE – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership. Profitability This table compares Sorrento Therapeutics and bluebird bio’s net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Sorrento Therapeutics N/A N/A N/A bluebird bio -419.64% -34.32% -14.44% Risk and Volatility Sorrento Therapeutics has a beta of 2.25, suggesting that its share price is 125% more volatile than the S&P 500. Comparatively, bluebird bio has a beta of 0.82, suggesting that its share price is 18% less volatile than the S&P 500. Analyst Ratings This is a breakdown of recent ratings and recommmendations for Sorrento Therapeutics and bluebird bio, as provided by MarketBeat.com. Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sorrento Therapeutics 0 0 0 0 N/A bluebird bio 1 6 4 0 2.27 bluebird bio has a consensus price target of $5.74, indicating a potential upside of 457.71%. Given bluebird bio’s higher possible upside, analysts plainly believe bluebird bio is more favorable than Sorrento Therapeutics. Institutional and Insider Ownership 0.0% of Sorrento Therapeutics shares are held by institutional investors. Comparatively, 87.4% of bluebird bio shares are held by institutional investors. 2.6% of Sorrento Therapeutics shares are held by company insiders. Comparatively, 2.1% of bluebird bio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Earnings & Valuation This table compares Sorrento Therapeutics and bluebird bio’s gross revenue, earnings per share and valuation. Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sorrento Therapeutics $62.84 million 0.26 -$572.84 million N/A N/A bluebird bio $21.73 million 5.18 -$266.58 million ($0.74) -1.39 bluebird bio has lower revenue, but higher earnings than Sorrento Therapeutics. Summary Sorrento Therapeutics beats bluebird bio on 6 of the 11 factors compared between the two stocks. About Sorrento Therapeutics (Get Free Report) Sorrento Therapeutics, Inc., a clinical and commercial stage biopharmaceutical company, develops a portfolio of next-generation treatments for three therapeutic areas: cancer, infectious disease,and pain. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy, and antibody drug conjugate, as well as bispecific antibody approach; and Sofusa, a drug delivery technology that deliver biologic directly into the lymphatic system. Its clinical programs in development include anti-CD38 CAR-T therapy for the treatment of multiple myeloma, as well as for amyloidosis and graft versus host disease. The company develops resiniferatoxin, a non-opioid-based TRPV1 agonist neurotoxin for late stage cancer and osteoarthritis pain treatment; and ZTlido, a lidocaine topical system for the treatment of post-herpetic neuralgia. It engages in the development of SEMDEXA, an injectable viscous gel formulation, which is Phase III trial for the treatment of sciatica, a pathology of low back pain; SP-103, an investigational non-aqueous lidocaine topical system undergoing clinical development in chronic low back pain condition; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation for the treatment of fibromyalgia. It has collaboration with SmartPharm Therapeutics Inc. to develop gene-encoded antibody vaccine to protect against COVID-19; and Mayo Clinic for Phase Ib pilot study using sofusa lymphatic drug delivery technology to deliver Ipilimumab in patient with melanoma. The company was founded in 2006 and is based in San Diego, California. On February 13, 2023, Sorrento Therapeutics, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas. The plan was later approved as Chapter 11 liquidation on November 30, 2023. About bluebird bio (Get Free Report) bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include ZYNTEGLO (betibeglogene autotemcel) for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and SKYSONA (elivaldogene autotemcel) to treat cerebral adrenoleukodystrophy. The company's clinical development programs include HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. It has license agreement with Orchard Therapeutics Limited. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Somerville, Massachusetts.
- 05/20/2024
|
Inflation flattens Americans' wealth gains under Biden: report
- Gains in American households' net worth have flattened during President Biden's administration because of inflation, a new analysis finds. A report by the Wall Street Journal analyzed changes in household net worth from the start of Biden's presidency in comparison to those seen during the tenure of his predecessor and presumptive opponent in the 2024 election, former President Donald Trump. It found that in nominal terms, total household net worth rose by 19% through Biden's first three years in office – a comparable figure to the 23% increase seen in Trump's first three years. However, when factoring inflation's impact on household net worth, the data is less favorable for Biden. After adjusting for inflation, household net worth is up by just 0.7% through Biden's first three years in office, whereas it was up 16% in Trump's first three years. At the time of Biden's inauguration in January 2021, year-over-year inflation in the U.S. economy was about 1.4%. However, inflation surged due to global supply chain disruptions related to the COVID pandemic as well as elevated levels of government spending, peaking at a 40-year high of 9.1% in June 2022. HOW IT STARTED … HOW IT'S GOING: HOME, ENERGY, CAR BILLS WAY UP THANKS TO INFLATION The U.S. spent trillions of dollars to stimulate the economy amid the pandemic at the end of Trump's administration and at the outset of Biden's term. Among those measures were the $1.9 trillion American Rescue Plan Act that was enacted in March 2021 and the Inflation Reduction Act, an $891 billion package enacted in August 2022. The two measures were approved by congressional Democrats on party-line votes using the budget reconciliation process. INFLATION INCREASES 3.4% IN APRIL AS PRICES REMAIN ELEVATED The Biden administration has blamed global supply chain disruptions as the main factor causing inflation and has defended those pieces of legislation as providing critical financial support to American households as the economy dealt with the pandemic's impact and addressing other pressing policy needs. The White House has also pointed to other actions, like releasing oil from the Strategic Petroleum Reserve to give energy markets a boost, as ways it has looked to ease the sting of inflation. The U.S. economy continues to experience elevated inflation, which came in at 3.4% in April. That's well above the Federal Reserve's target rate of 2%. To tamp down inflation, the Fed raised the benchmark federal funds rate, which influences interest rates across the economy, to a more than 20-year high target range of 5.25% to 5.50%. GET FOX BUSINESS ON THE GO BY CLICKING HERE With inflation remaining elevated, the central bank's policymakers have signaled that interest rates are likely to remain higher for longer than originally anticipated to allow more time for inflation to subside. FOX Business' Megan Henney contributed to this report.
- 05/19/2024
|
Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-Monocyte
- CT-0525 is the first CAR-Monocyte to be evaluated in humans in the solid tumor setting Initial data expected by year-end 2024 PHILADELPHIA , May 16, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the first patient was dosed in its Phase 1 clinical trial evaluating CT-0525, an ex vivo gene-modified autologous chimeric antigen receptor-monocyte (CAR-Monocyte) cellular therapy, for the treatment of patients with solid tumors that overexpress human epidermal growth factor receptor 2 (HER2). "Dosing of the first patient in the CT-0525 Phase 1 trial is a significant step in the development of engineered myeloid cells, marking the first time a CAR-Monocyte is tested in humans in the solid tumor setting," said Eugene P.
- 05/16/2024
|
Bristol Myers Squibb's CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma
- PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Breyanzi--Bristol Myers Squibb's CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma.
- 05/15/2024
|
Avis Budget Group Announces Pricing of €200 Million of Senior Notes
- PARSIPPANY, N.J., May 14, 2024 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) (the “Company”) announced today that its wholly-owned subsidiary, Avis Budget Finance plc (the “Issuer”), priced a private offering of €200 million aggregate principal amount of additional 7.25% Senior Notes due 2030 (the “Notes”). The Notes will be issued as additional notes under the Indenture, dated as of July 13, 2023, pursuant to which the Issuer previously issued €400 million aggregate principal amount of 7.25% Senior Notes due 2030. The Notes will have a maturity date of July 31, 2030. The closing of the offering of the Notes is expected to occur on May 21, 2024, subject to customary closing conditions. The Notes were priced at 100.25% of their face value and will be guaranteed on a senior unsecured basis by the Company and certain of its U.S. subsidiaries.
- 05/14/2024
|
Avis Budget Group Announces Intention to Offer €200 Million of Senior Notes
- PARSIPPANY, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) (the “Company”) announced today that its wholly-owned subsidiary, Avis Budget Finance plc (the “Issuer”), intends, subject to market and other customary conditions, to offer €200 million aggregate principal amount of additional 7.25% Senior Notes due 2030 (the “Notes”) in a private offering. The Notes will be issued as additional notes under the Indenture, dated as of July 13, 2023, pursuant to which the Issuer previously issued €400 million aggregate principal amount of 7.25% Senior Notes due 2030. The Notes will be guaranteed on a senior unsecured basis by Avis Budget Group, Inc. and certain of its U.S. subsidiaries.
- 05/13/2024
|
Canadian Apartment Properties Real Estate Investment Trust (CDPYF) Q1 2024 Earnings Call Transcript
- Canadian Apartment Properties Real Estate Investment Trust (OTC:CDPYF) Q1 2024 Earnings Conference Call May 9, 2024 9:00 AM ET Company Participants Nicole Dolan - Investor Relations Mark Kenney - President & Chief Executive Officer Julian Schonfeldt - Chief Investment Officer Stephen Co - Chief Financial Officer Conference Call Participants Jonathan Kelcher - TD Cowen Kyle Stanley - Desjardins Capital Markets Mike Markidis - BMO Capital Markets Jimmy Shan - RBC Capital Markets Sairam Srinivas - Cormark Securities Matt Kornack - National Bank of Canada Financial Markets Operator Good morning. Thank you for attending today's Canadian Apartment Properties REIT First Quarter 2024 Results conference call.
- 05/12/2024
|
Avis Budget (CAR) Gains 28% Despite Earnings Miss in Q1
- Avis Budget (CAR) witnesses a y/y decline in revenues from the Americas, while international revenues increase.
- 05/08/2024
|
Why Avis Budget Stock Surged Thursday
- Avis Budget topped revenue estimates in the first quarter. The company saw strong demand heading into the peak summer season.
- 05/03/2024
|
Canadian Apartment Properties REIT: Deep Value Embedded
- CAPREIT is a Canadian multifamily residential REIT with quality assets and high occupancy rates. Rent control in Ontario and British Columbia is a challenge, but CAPREIT can raise rents to market levels when tenants move out. We review the valuation and tell you how we are playing this.
- 05/02/2024
|
Avis's stock soars as robust demand and improved pricing fuel revenue beat
- Shares of Avis Budget Group Inc. rocketed Thursday, bouncing from a three-year low, after the car-rental company reported first-quarter revenue that beat expectations for the first time in a year as what it called continued robust travel demand led to record rental volume.
- 05/02/2024
|
Avis Budget Group, Inc. (CAR) Q1 2024 Earnings Call Transcript
- Avis Budget Group, Inc. (NASDAQ:CAR ) Q1 2024 Earnings Conference Call May 2, 2024 8:30 AM ET Company Participants David Calabria - Senior Vice President, Corporate Finance and Treasurer Joe Ferraro - President and Chief Executive Officer Izzy Martins - Executive Vice President and Chief Financial Officer Conference Call Participants Ryan Brinkman - J.P. Morgan John Babcock - Bank of America Chris Stathoulopoulos - Susquehanna Chris Woronka - Deutsche Bank Harold Antor - Jefferies John Healy - Northcoast Research Lizzie Dove - Goldman Sachs Operator Greetings.
- 05/02/2024
|
New Strong Sell Stocks for May 2nd
- DDD, ARR and CAR have been added to the Zacks Rank #5 (Strong Sell) List on May 2, 2023.
- 05/02/2024
|
Avis Budget (CAR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
- While the top- and bottom-line numbers for Avis Budget (CAR) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 05/01/2024
|
Avis Budget Group Reports First Quarter Results
- PARSIPPANY, N.J., May 01, 2024 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) announced financial results for first quarter 2024 today.
- 05/01/2024
|
Here's why the Hertz and Avis Budget stocks are tumbling
- Avis Budget Group (NASDAQ: CAR) and Hertz (NYSE: HTZ) stock prices tumbled on Thursday as investors focused on the latter's financial results. Hertz crashed by over 17%, bringing the year-to-date losses to over 54%.
- 04/25/2024
|
Analysts Estimate Avis Budget Group (CAR) to Report a Decline in Earnings: What to Look Out for
- Avis Budget (CAR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/24/2024
|
Avis Budget Group to Announce First Quarter 2024 Results on May 1st
- PARSIPPANY, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) announced today that it plans to report its first quarter 2024 results after the market close on Wednesday, May 1st, 2024, and to host a conference call for institutional investors to discuss these results on Thursday, May 2nd, 2024 at 8:30 a.m.
- 04/19/2024
|
Avis Budget Stock Swiftly Quadrupled Bears' Money
- Expiration Week Countdown subscribers just quadrupled their money in less than five days with our Avis Budget Group Inc (NASDAQ:CAR) April 115 put recommendation, which they received on Sunday, April 14.
- 04/18/2024
|
Avis Budget Group, Inc. (CAR) is Attracting Investor Attention: Here is What You Should Know
- Recently, Zacks.com users have been paying close attention to Avis Budget (CAR). This makes it worthwhile to examine what the stock has in store.
- 04/05/2024
|
Avis Budget Group (CAR) Stock Declines While Market Improves: Some Information for Investors
- In the latest trading session, Avis Budget Group (CAR) closed at $121.11, marking a -0.93% move from the previous day.
- 04/03/2024
|
The Spring Break Stock Surge: 3 Companies Ready to Cash In
- April is here, and spring break stocks are ready for takeoff. With robust consumer spending and pent-up travel demand, vacation bookings are skyrocketing.
- 04/02/2024
|
Avis Budget Group (CAR) Stock Slides as Market Rises: Facts to Know Before You Trade
- In the latest trading session, Avis Budget Group (CAR) closed at $122.46, marking a -0.62% move from the previous day.
- 03/28/2024
|
Avis Budget (CAR) Is Considered a Good Investment by Brokers: Is That True?
- Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
- 03/26/2024
|
Why Avis Budget Group (CAR) Dipped More Than Broader Market Today
- In the closing of the recent trading day, Avis Budget Group (CAR) stood at $113.47, denoting a -1.54% change from the preceding trading day.
- 03/22/2024
|
Avis Budget Group, Inc. (CAR) Is a Trending Stock: Facts to Know Before Betting on It
- Recently, Zacks.com users have been paying close attention to Avis Budget (CAR). This makes it worthwhile to examine what the stock has in store.
- 03/21/2024
|
Avis Budget Group (CAR) Rises But Trails Market: What Investors Should Know
- In the latest trading session, Avis Budget Group (CAR) closed at $108.12, marking a +0.39% move from the previous day.
- 03/18/2024
|
The 3 Most Undervalued Travel Stocks to Buy in March 2024
- For the last 18 months, finding undervalued travel stocks has been difficult. Despite concerns about a recession, consumers have been remarkably resilient and continue to prioritize spending on travel over accumulating things.
- 03/13/2024
|
Avis Budget Group (CAR) Beats Stock Market Upswing: What Investors Need to Know
- Avis Budget Group (CAR) closed at $113.11 in the latest trading session, marking a +1.21% move from the prior day.
- 03/12/2024
|
Investors Heavily Search Avis Budget Group, Inc. (CAR): Here is What You Need to Know
- Avis Budget (CAR) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- 03/07/2024
|
New Strong Sell Stocks for February 27th
- CAR, CCRN and ECPG have been added to the Zacks Rank #5 (Strong Sell) List on February 27, 2023.
- 02/27/2024
|
A Hedge Fund Made a Killing on Avis Stock. Now the Trade Is Backfiring.
- Karthik Sarma concentrates on a small number of stocks, and one has cost him more than $1 billion on paper in 2024.
- 02/26/2024
|
Canadian Apartment Properties: If You Like The North, Look At Northview
- Canadian Apartment Properties Real Estate Investment Trust's Q4 2023 results showed strong growth across the portfolio, but there's still no margin of safety. The Company initiated an inaugural $400MM ATM program, which we view as a potential risk with the units trading slightly below NAV. We maintain our Hold rating for CAPREIT, as we believe Northview Residential is still the clearest value play in Canadian multifamily.
- 02/26/2024
|
Canadian Apartment Properties Real Estate Investment Trust (CDPYF) Q4 2023 Earnings Call Transcript
- Canadian Apartment Properties Real Estate Investment Trust (CDPYF) Q4 2023 Earnings Call Transcript
- 02/23/2024
|
Here is What to Know Beyond Why Avis Budget Group, Inc. (CAR) is a Trending Stock
- Avis Budget (CAR) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
- 02/23/2024
|
New Strong Sell Stocks for February 21st
- CAR, CHX and CWST have been added to the Zacks Rank #5 (Strong Sell) List on February 21, 2024.
- 02/21/2024
|
Avis Budget (CAR) Stock Loses 6.7% Despite Q4 Earnings Beat
- Avis Budget's (CAR) earnings and revenues were down year over year in the fourth quarter of 2023.
- 02/16/2024
|
Hertz's stock headed for fresh closing low after being caught in downdraft created by Avis
- Hertz Global Holdings Inc.'s stock tumbled 12% Tuesday to put it on track for a record-low close, pulled down by bad news from its smaller rival, Avis Budget Group Inc.
- 02/13/2024
|
Avis's stock drops after company sells record number of cars into a tough used-car market
- Avis Budget Group Inc. investors were having their worst day in four years on Tuesday, after the car-rental company said it sold a record number of vehicles during the fourth quarter in a bad market for used cars, due to vehicle oversupply and a spike in interest costs.
- 02/13/2024
|
Avis Budget Group, Inc. (CAR) Q4 2023 Earnings Call Transcript
- Avis Budget Group, Inc. (CAR) Q4 2023 Earnings Call Transcript
- 02/13/2024
|
Avis Budget (CAR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
- While the top- and bottom-line numbers for Avis Budget (CAR) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 02/12/2024
|
Avis Budget Group (CAR) Q4 Earnings Surpass Estimates
- Avis Budget Group (CAR) came out with quarterly earnings of $7.10 per share, beating the Zacks Consensus Estimate of $4.36 per share. This compares to earnings of $10.46 per share a year ago.
- 02/12/2024
|
Avis Budget beats profit estimates in Q4
- Avis Budget Group Inc (NASDAQ: CAR) is trading down in extended hours even though it reported it better-than-expected financial results for its fiscal fourth quarter. Why is Avis Budget stock down in after-hours?
- 02/12/2024
|
Thursday's Market Data Deluge
- Perhaps it's better for many of us that the Monday morning following Super Bowl Sunday — especially one that went to the last play of overtime — is not rife with consequential stock market data ahead of the opening bell. We're down to our last couple busy weeks of Q4 earnings season, and have plenty of economic reports at the ready to help us move trading along this week.
- 02/12/2024
|
Wall Street Brunch: Retail Inflation In Focus
- This week, traders will have a lot of economic data to digest, including retail sales, manufacturing measures, jobless claims, and the consumer price index. The market is now pricing in a 16% chance of a March rate reduction by the Fed, but odds top 60% for a cut in May.
- 02/11/2024
|
Wall Street's Insights Into Key Metrics Ahead of Avis Budget (CAR) Q4 Earnings
- Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Avis Budget (CAR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.
- 02/07/2024
|
Earnings Preview: Avis Budget Group (CAR) Q4 Earnings Expected to Decline
- Avis Budget (CAR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 02/05/2024
|
Is Trending Stock Avis Budget Group, Inc. (CAR) a Buy Now?
- Avis Budget (CAR) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
- 02/01/2024
|
Avis Budget Group (CAR) Stock Falls Amid Market Uptick: What Investors Need to Know
- In the latest trading session, Avis Budget Group (CAR) closed at $166.90, marking a -0.63% move from the previous day.
- 01/24/2024
|
Avis Budget Group (CAR) Stock Falls Amid Market Uptick: What Investors Need to Know
- Avis Budget Group (CAR) reachead $167.95 at the closing of the latest trading day, reflecting a -1.04% change compared to its last close.
- 01/23/2024
|
Avis Budget Group (CAR) Rises As Market Takes a Dip: Key Facts
- Avis Budget Group (CAR) reachead $159.44 at the closing of the latest trading day, reflecting a +0.07% change compared to its last close.
- 01/17/2024
|
Avis Budget Group to Announce Fourth Quarter 2023 Results on February 12th
- PARSIPPANY, N.J., Jan. 12, 2024 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) announced today that it plans to report its fourth quarter 2023 results after the market close on Monday, February 12th, 2024, and to host a conference call for institutional investors to discuss these results on Tuesday, February 13th, 2024 at 8:30 a.m.
- 01/12/2024
|
Avis Budget Group (CAR) Falls More Steeply Than Broader Market: What Investors Need to Know
- In the closing of the recent trading day, Avis Budget Group (CAR) stood at $166.47, denoting a -1.46% change from the preceding trading day.
- 01/11/2024
|
Avis Budget Group (CAR) Increases Yet Falls Behind Market: What Investors Need to Know
- Avis Budget Group (CAR) closed at $166.04 in the latest trading session, marking a +0.04% move from the prior day.
- 01/05/2024
|
Reasons Why You Should Hold on to Avis Budget (CAR) For Now
- Avis Budget (CAR) operates in a diversified market and its shareholder-friendly attitude bodes well for the company.
- 01/05/2024
|
Avis Budget Group (CAR) Falls More Steeply Than Broader Market: What Investors Need to Know
- The latest trading day saw Avis Budget Group (CAR) settling at $175.65, representing a -0.91% change from its previous close.
- 01/02/2024
|
Avis Budget Group (CAR) Stock Dips While Market Gains: Key Facts
- In the most recent trading session, Avis Budget Group (CAR) closed at $179.51, indicating a -0.74% shift from the previous trading day.
- 12/27/2023
|
Avis Budget Group (CAR) Rises But Trails Market: What Investors Should Know
- In the closing of the recent trading day, Avis Budget Group (CAR) stood at $188.73, denoting a +0.05% change from the preceding trading day.
- 12/19/2023
|
Russell 2000 Leaders: 7 Stocks Outperforming the Index
- Russell 2000 stocks are some of the smallest companies by market capitalization in the market. Historically, small-cap and mid-cap stocks come with high beta values.
- 12/11/2023
|
Avis Stock Pops on Special Cash Dividend
- The car rental company says the dividend is payable on Dec. 21 to stockholders of record as of Dec. 15.
- 12/06/2023
|
Avis Budget Group announces special dividend of $10 per share
- The special dividend is payable on Dec. 21 to shareholders of record as of the close of business on Dec. 15, the company said Tuesday.
- 12/05/2023
|
Canadian Apartment Properties: Huge Rent Uplifts Offset NAV Pressures
- We had shifted to a hold on Canadian Apartment Properties Real Estate Investment Trust in our last update. The REIT has moved lower and delivered an excellent Q3 2023. We analyze the valuation and give you our take.
- 11/10/2023
|
Avis Budget (CAR) Q3 Earnings Beat Estimates, Revenues Miss
- Avis Budget's (CAR) earnings decline year over year in the third quarter of 2023.
- 11/06/2023
|
Dow transports have best week in a year, to snap longest weekly losing streak in 5 years
- The Dow Jones Transportation Average DJT, +1.78% rallied 1.7% in afternoon trading, with 18 of 20 components gaining ground, as part of a broader stock market rally. The index was headed for a fifth-straight gain as it has run up 7.2% this week.
- 11/03/2023
|
Avis Budget Group Inc. (CAR) Q3 2023 Earnings Call Transcript
- Avis Budget Group Inc. (NASDAQ:CAR ) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants David Calabria - SVP of Corporate Finance & Treasurer Joe Ferraro - CEO Brian Choi - CFO Conference Call Participants Hans Hoffman - Jefferies Chris Woronka - Deutsche Bank Ryan Brinkman - JP Morgan Operator Good day, everyone and welcome to the Avis Budget Group's Third Quarter 2023 Conference Call. [Operator Instructions] It is now my pleasure to turn today's call over to David Calabria, Treasurer and Senior Vice President of Corporate Finance.
- 11/02/2023
|
Avis Budget (CAR) Reports Q3 Earnings: What Key Metrics Have to Say
- Although the revenue and EPS for Avis Budget (CAR) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 11/01/2023
|
Here's Why Avis Budget Group (CAR) Fell More Than Broader Market
- The latest trading day saw Avis Budget Group (CAR) settling at $172.81, representing a -0.65% change from its previous close.
- 10/23/2023
|
Will Avis Budget (CAR) Beat Estimates Again in Its Next Earnings Report?
- Avis Budget (CAR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 10/23/2023
|
Avis Budget Group to Announce Third Quarter 2023 Results on November 1st
- PARSIPPANY, N.J., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) announced today that it plans to report its third quarter 2023 results after the market close on Wednesday, November 1st, 2023, and to host a conference call for institutional investors to discuss these results on Thursday, November 2nd, 2023 at 8:30 a.m.
- 10/09/2023
|
Don't Miss the Boom: 3 Nasdaq Stocks Set to Explode Higher
- When it comes to scouting potential high-growth opportunities, Nasdaq stocks often stand out as a top pick for many investors. Renowned for listing some of the most cutting-edge companies globally, the allure of significant returns is hard to ignore for those willing to tap into this innovation-driven marketplace.
- 09/26/2023
|
Avis Budget (CAR) Gains From Its Ability to Serve the Market
- Acquisitions and global brands help Avis Budget (CAR) prosper amid currency risks.
- 09/13/2023
|
Why Is Avis Budget (CAR) Down 3.3% Since Last Earnings Report?
- Avis Budget (CAR) reported earnings 30 days ago. What's next for the stock?
- 08/30/2023
|
New York fines Avis Budget for denying car rentals to people who lack credit cards
- New York state on Tuesday fined Avis Budget Group $275,000 for refusing to rent vehicles to customers who did not have credit cards.
- 08/15/2023
|
Avis Budget (CAR) Q2 Earnings Beat Estimates but Revenues Missed
- Avis Budget's (CAR) revenues and earnings down year over year in the second quarter of 2023.
- 08/08/2023
|
Canadian Apartment Properties: Solid Execution Despite Interest Rate Headwinds
- CAPREIT had a solid Q2-2023 with strong occupancies and a robust increase in operating revenues. Despite inflationary headwinds, CAPREIT managed to increase FFO per unit through unit repurchases. We look at the investment case based on historic multiples and outlook for growth.
- 08/07/2023
|
Is Avis Budget Group A Value Play? Earnings Have This To Say
- Avis Budget Group NASDAQ: CAR stock has been trading within a relatively tight channel for the past year; this can be taken as a sign of indecision from markets facing a directionless market. Despite these initial trends, the underlying transportation industry and its derivatives have shown promising growth in the past few months, aiding the results posted in Avis Budget's second quarter 2023 earnings results.
- 08/01/2023
|
Here's What Key Metrics Tell Us About Avis Budget (CAR) Q2 Earnings
- While the top- and bottom-line numbers for Avis Budget (CAR) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 07/31/2023
|
Markets Up, Yum China Beats, Avis Mixed
- The small-cap Russell 2000 led the way again today, +0.82%, followed by +0.32% from the Nasdaq, +0.16% on the Dow and +0.06% for the S&P.
- 07/31/2023
|
Avis Budget Group (CAR) Q2 Earnings Top Estimates
- Avis Budget Group (CAR) came out with quarterly earnings of $11.01 per share, beating the Zacks Consensus Estimate of $9.79 per share. This compares to earnings of $15.94 per share a year ago.
- 07/31/2023
|
Avis stock up 3% after rental-car company sees ‘robust' summer demand
- Shares of Avis Budget Group Inc. CAR, -0.97% rose more than 3% in the after-hours session Monday after the car-rental company's quarterly profit topped Wall Street expectations on strong demand for rentals amid “robust” summer travel. Avis earned $436 million, or $11.01 a share, in the second quarter, down from $774 million, or $15.71 a share, in the year-ago quarter.
- 07/31/2023
|
Best Value Stocks to Buy for July 26th
- VIRC, BSVN and CAR made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 26, 2023.
- 07/26/2023
|
Wall Street Analysts See Avis Budget (CAR) as a Buy: Should You Invest?
- When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
- 07/21/2023
|
Avis Budget's stock falls after analyst downgrades it just two months after turning bullish
- Shares of Avis Budget Group Inc. dropped Thursday, after Deutsche Bank's Chris Wronka downgraded the car-rental company, saying the stock nearly accomplished in just two months what he thought would take a year.
- 07/20/2023
|
2 Auto-Related Stocks to Buy for Value as Markets Move Higher
- Investors will continue to search for stocks that offer sound value as the broader market indexes have kept moving higher with the S&P 500 now up +17% this year and the Nasdaq up +35%.
- 07/13/2023
|
Avis Budget Group To Announce Second Quarter 2023 Results On July 31st
- Conference Call to Discuss Results Scheduled for August 1st, 2023 PARSIPPANY, N.J., July 07, 2023 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) announced today that it plans to report its second quarter 2023 results after the market close on Monday, July 31st, 2023, and to host a conference call for institutional investors to discuss these results on Tuesday, August 1st, 2023 at 8:30 a.m.
- 07/07/2023
|
3 Business Services Stocks to Consider From a Prospering Industry
- With rising demand and growing technology adoption, the Zacks Business Services industry is poised to prosper. CAR, BWMN and IBEX are three stocks that appear well-poised to ride this demand strength.
- 07/06/2023
|
Avis Budget (CAR) Is Attractively Priced Despite Fast-paced Momentum
- If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Avis Budget (CAR) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
- 07/06/2023
|
Best Momentum Stocks to Buy for July 5th
- CAR, ROAD and HRTG made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 5, 2023.
- 07/05/2023
|
New Strong Buy Stocks for July 5th
- RRGB, STNE, SSL, CIVI and CAR have been added to the Zacks Rank #1 (Strong Buy) List on July 5, 2023.
- 07/05/2023
|
Should You Invest in Avis Budget (CAR) Based on Bullish Wall Street Views?
- The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
- 07/04/2023
|
7 Best High-Growth Stocks to Buy if You're a Young Investor
- Generally speaking, financial advisors will often direct you to reliable enterprises though, for certain folks, high-growth stocks may make more sense. That's particularly true if you're part of the younger crowd.
- 06/29/2023
|
Avis Budget Is Too Cheap to Ignore
- Avis Budget Group Inc. ( CAR , Financial) is a mobility solutions provider with its business spread across most of the world. The company operates through several brands, including Avis Car Rental, Budget Rent a Car, Zipcar and Maggiore Group.
- 06/22/2023
|
Analyst Upgrades: 7 Stocks Wall Street Is Loving in June
- Perhaps one of the most controversial topics, on surface level, the concept of analyst upgraded stocks should seem a no-brainer. In our heads, we have fantastical ideas that analysts are nothing more than equity market nerds that eat and sleep publicly traded securities.
- 06/22/2023
|
Avis's stock gets ratings upgrade as demand for travel continues
- Avis Budget Group Inc.'s stock got a ratings upgrade from analysts at Morgan Stanley, who said they moved to a “relatively more constructive view” of the rental-car industry amid ongoing heated demand for travel.
- 06/22/2023
|
Avis Budget (CAR) Gains 34% in Year-to-Date Period: Here's How
- Avis Budget (CAR) benefits from its investment in technology and pursuit to improve offerings.
- 06/22/2023
|
Strength Seen in Avis Budget (CAR): Can Its 9.7% Jump Turn into More Strength?
- Avis Budget (CAR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
- 06/21/2023
|
Tesla's and Rivian's Tuesday Gains Paled Next to This Car Stock
- Markets were generally lower on Tuesday. Rivian and Tesla both saw their shares rise on their deal to adopt Tesla's charging standard and open access to its Supercharger network.
- 06/20/2023
|
Avis Budget's Ride Higher Continues
- The stock has fluctuated wildly since 2022, trading above $300 a share and as low as $138. Now with it settling in just above $200 per share, Avis Budget Group Inc. ( CAR , Financial) looks like a bargain.
- 06/16/2023
|
The 7 Most Undervalued Stocks to Buy in June 2023
- While acquiring high-momentum shares in the hopes of even greater returns may represent a sound tactic, arguably most investors prefer targeting the most undervalued stocks to buy. At the psychological level, a certain pioneering appeal exists about discovering the next big thing before the crowd arrives.
- 06/08/2023
|
Organic Growth Aids Avis Budget (CAR), Low Liquidity Prevails
- The ability to offer a wide variety of options targeting different market groups is boding well for Avis Budget (CAR). However, seasonality woes prevail.
- 06/05/2023
|
Canadian Apartment Properties: Exposure To Growing Markets Keeps The Stock Expensive
- The REIT owns 86% of properties in Canada and 14% in the Netherlands. Both of these are good markets which have seen some of the fastest growth, but also have record low levels of new supply.
- 05/26/2023
|
Avis Budget (CAR) Q1 Earnings and Revenues Beat Estimates
- Strong demand and proper pricing enable Avis Budget's (CAR) revenues to grow in the first quarter of 2023. Earnings surpass estimates by more than 100%.
- 05/02/2023
|
Avis Budget Group (CAR) Surpasses Q1 Earnings and Revenue Estimates
- Avis Budget Group (CAR) came out with quarterly earnings of $7.72 per share, beating the Zacks Consensus Estimate of $3.34 per share. This compares to earnings of $9.99 per share a year ago.
- 05/01/2023
|
Avis' Q1 profit, revenue top Wall Street expectations on ‘strong demand' for rental cars
- Shares of Avis Budget Group Inc. CAR dropped about 1% in the extended session Monday after the car-rental company posted a first-quarter profit and revenue beat. Avis earned $312 million, or $7.72 a share, in the quarter, compared with $519 million, or $9.71 a share, in the year-ago period.
- 05/01/2023
|
What's in the Cards for Avis Budget (CAR) in Q1 Earnings?
- Cost discipline and steady demand are likely to have bode well for Avis Budget (CAR) in the first quarter of 2023.
- 04/25/2023
|
Will Avis Budget (CAR) Beat Estimates Again in Its Next Earnings Report?
- Avis Budget (CAR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 04/21/2023
|
3 Business Services Stocks Benefiting From a Prospering Industry
- With rising demand and growing technology adoption, the Zacks Business Services industry is poised to prosper. CAR, APG AND BWMN are three stocks that appear well-poised to ride this demand strength.
- 04/18/2023
|
Are Business Services Stocks Lagging Avis Budget Group (CAR) This Year?
- Here is how Avis Budget Group (CAR) and International Money Express (IMXI) have performed compared to their sector so far this year.
- 04/12/2023
|
Are Investors Undervaluing Avis Budget Group (CAR) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 04/12/2023
|
Avis Budget (CAR) Shows Fast-paced Momentum But Is Still a Bargain Stock
- If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Avis Budget (CAR) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
- 04/12/2023
|
Wall Street Analysts Think Avis Budget (CAR) Could Surge 27.43%: Read This Before Placing a Bet
- The mean of analysts' price targets for Avis Budget (CAR) points to a 27.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
- 04/11/2023
|
At 3x Earnings, Avis Budget Is Worth Taking for a Spin
- Sixteen months removed from a wild short-squeeze rally, the rental car company's shares are trading at a paltry 3x trailing earnings. Among profitable S&P 400 stocks, only five are less expensive.
- 04/05/2023
|
Avis Budget Group to Announce First Quarter 2023 Results on May 1st
- Conference Call to Discuss Results Scheduled for May 2nd, 2023 Conference Call to Discuss Results Scheduled for May 2nd, 2023
- 04/04/2023
|
5 Value Stocks to Buy for Safety Amid Market Volatility
- We have narrowed our search to five value stocks. These are: CAR, RNR, RE, RS, CNO.
- 03/29/2023
|
Best Value Stocks to Buy for March 28th
- AMR, CAR and JRVR made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 28, 2023.
- 03/28/2023
|
New Strong Buy Stocks for March 28th
- CSTM, ATKR, CAR, BLMN and ICFI have been added to the Zacks Rank #1 (Strong Buy) List on March 28, 2023.
- 03/28/2023
|
Avis Budget Group: Today's Best Nearby Cap-Gain Transport Rental Stock Prospect
- A 3-5 month prospect from here of CAR share prices could reasonably range from a $172.43 low to a $215.91 high from its $185.77 present price, a gain of +16.2%. - source: blockdesk.com. 86 positions like today's in the past 5 years of 1,261 market days produced average net gains at 17.9% each during 31 market days (1 ½ months of 21 each).
- 03/16/2023
|
Are Business Services Stocks Lagging Avis Budget Group (CAR) This Year?
- Here is how Avis Budget Group (CAR) and DocuSign (DOCU) have performed compared to their sector so far this year.
- 03/09/2023
|
Canadian Apartment Properties Real Estate Investment Trust (CDPYF) Q4 2022 Earnings Call Transcript
- Canadian Apartment Properties Real Estate Investment Trust (OTC:CDPYF) Q4 2022 Results Conference Call February 23, 2023 9:00 AM ET Company Participants Nicole Dolan - Associate Director of Investor Relations Mark Kenney - President and CEO Stephen Co - CFO Julian Schonfeldt - Chief Investment Officer Conference Call Participants Mark Rothschild - Canaccord Dean Wilkinson - CIBC Jonathan Kelcher - TD Securities Mario Saric - Scotiabank Brad Sturges - Raymond James Kyle Stanley - Desjardins Jimmy Shan - RBC Capital Markets Matt Kornack - National Bank Financial Operator Good morning. Thank you for attending today's Canadian Apartment Properties REIT Fourth Quarter and Year-End 2020 Results Conference Call.
- 02/25/2023
|
Is Avis Budget Group (CAR) Stock Outpacing Its Business Services Peers This Year?
- Here is how Avis Budget Group (CAR) and Visa (V) have performed compared to their sector so far this year.
- 02/21/2023
|
All You Need to Know About Avis Budget (CAR) Rating Upgrade to Buy
- Avis Budget (CAR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- 02/20/2023
|
Are Investors Undervaluing Avis Budget Group (CAR) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 02/20/2023
|
Avis Budget's big stock rally give Dow transports a 99-point boost
- The Dow Jones Transportation Average DJT, +0.47% was rallying 66 points, or 0.4%, while its sister index, the Dow Jones Industrial Average DJIA, -0.37% , fell 122 points, or 0.4%, almost entirely because of one stock. Avis Budget Group Inc.'s stock CAR, +7.44% shot up 7.4% toward a three-month high, after the auto rental company beat fourth-quarter profit expectations by a wide margin.
- 02/14/2023
|
Avis Budget Group, Inc. (CAR) Q4 2022 Earnings Call Transcript
- Avis Budget Group, Inc. (NASDAQ:CAR ) Q4 2022 Earnings Conference Call February 14, 2023 8:30 AM ET Company Participants David Calabria - Treasurer and SVP, Corporate Finance Joe Ferraro - Chief Executive Officer Brian Choi - Chief Financial Officer Conference Call Participants Chris Woronka - Deutsche Bank Securities Inc. John Healy - Northcoast Research Diego Ortega Laya - Morgan Stanley Ryan Brinkman - JPMorgan Stephanie Moore - Jefferies Christopher Stathoulopoulos - Susquehanna Operator Greetings, and welcome to the Avis Budget Group's Fourth Quarter 2022 Conference Call. At this time, all participants are in a listen-only mode.
- 02/14/2023
|
Avis Budget (CAR) Q4 Earnings Beat Estimates, Revenues Up Y/Y
- Avis Budget (CAR) fourth-quarter 2022 earnings and revenues surge year over year.
- 02/14/2023
|
Avis Budget (CAR) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
- The headline numbers for Avis Budget (CAR) give insight into how the company performed in the quarter ended December 2022, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 02/14/2023
|
Avis Budget Group (CAR) Q4 Earnings and Revenues Surpass Estimates
- Avis Budget (CAR) delivered earnings and revenue surprises of 52.70% and 2.11%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 02/13/2023
|
Stocks moving in after hours: Palantir, Avis Budget Group, Denny's
- Yahoo Finance anchor Seana Smith checks out several stocks trending in the after-hours trading session.
- 02/13/2023
|
Avis Budget stock rallies after results beat, as travel rebound's momentum continues
- Shares of Avis Budget Group Inc. jumped after hours on Monday, after the car-rental chain reported fourth-quarter results that beat expectations, helped by a rebound in travel demand that it said has extended into the current quarter.
- 02/13/2023
|
Canadian Apartment Properties: Think Twice Before Buying
- Investing in the Canadian real estate sector could be a good way to diversify one's REIT and currency exposure. But with the real estate market completely detached from fundamentals and a new law now in effect prohibiting foreign investment into property, investors should demand an additional discount.
- 02/10/2023
|
Is a Surprise Coming for Avis Budget (CAR) This Earnings Season?
- Avis Budget (CAR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 02/09/2023
|
4 Service Stocks Poised to Beat Estimates This Earnings Season
- Here we pick four business service stocks, namely, Avis Budget Group, Inc. (CAR), Verisk Analytics, Inc. (VRSK), Gartner, Inc. (IT) and Aptiv PLC (APTV), which are likely to pull off earnings surprise this season.
- 01/30/2023
|
Will Avis Budget (CAR) Beat Estimates Again in Its Next Earnings Report?
- Avis Budget (CAR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 01/23/2023
|
5 Beaten-Down Stocks That Can Outperform This Year
- Evercore strategists screened for the beaten-down stocks that could be winners this year.
- 01/10/2023
|
Why Avis Budget (CAR) Has Gained 11.4% in the Past 6 Months
- Impressive investor-friendly measures and connected vehicles fleet boost Avis Budget (CAR).
- 01/09/2023
|
Why Avis Budget Group (CAR) is a Top Growth Stock for the Long-Term
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 01/09/2023
|
Avis Budget Group to Announce Fourth Quarter 2022 Results on February 13th
- Conference Call to Discuss Results Scheduled for February 14th, 2023 Conference Call to Discuss Results Scheduled for February 14th, 2023
- 01/06/2023
|
Why Avis Budget Group Might Be An Interesting Ride Long Term
- The car rental sector seems very attractive long term (3 to 4 years). Avis offers generally strong fundamentals and a low PE ratio.
- 01/02/2023
|
Top 5 Industrials Stocks That May Rally
- The most oversold stocks in the industrials sector presents an opportunity to buy into undervalued companies.
- 12/27/2022
|
Here's Why Avis Budget Group (CAR) is a Strong Growth Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 12/16/2022
|
Why Avis Budget (CAR) Stock Gained 40.2% in the Past 3 Months
- Enhanced technology, connected vehicles fleet & pro-investor steps boost Avis Budget (CAR) stock.
- 12/05/2022
|
Stocks to Be Thankful for and Stocks to Avoid
- Plus, we talk with Scott Galloway, author of "Adrift: America in 100 Charts."
- 12/03/2022
|
Canadian Apartment Properties REIT: A Rarer Entry Point At 25% Below NAV
- We identified Canadian Apartment REIT at an attractive point about a full-term baby ago. The thesis has not worked as the stock has been bludgeoned by interest rates and the general market malaise.
- 12/03/2022
|
Avis Budget (CAR) Up 2% Since Last Earnings Report: Can It Continue?
- Avis Budget (CAR) reported earnings 30 days ago. What's next for the stock?
- 11/30/2022
|
Are Business Services Stocks Lagging Avis Budget Group (CAR) This Year?
- Here is how Avis Budget Group (CAR) and Huron Consulting (HURN) have performed compared to their sector so far this year.
- 11/21/2022
|
Is Avis Budget Group (CAR) Stock Undervalued Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 11/21/2022
|
5 Stocks With Upgraded Broker Ratings to Fight Macro Challenges
- As brokers have more insight into stocks, one must follow rating upgrades before investing. We pick Conagra Brands (CAG), Medpace Holdings (MEDP), BP, Avis Budget Group (CAR) & Liberty Energy (LBRT), as these have seen rating upgrades.
- 11/21/2022
|
Stocks This Week: Buy Avis Budget And Landstar
- The markets are entering the most seasonally favorable period in any year. Here are S&P 400 stock selections.
- 11/21/2022
|
Here is Why Growth Investors Should Buy Avis Budget (CAR) Now
- Avis Budget (CAR) possesses solid growth attributes, which could help it handily outperform the market.
- 11/17/2022
|
6 Reasons Why You Must Add Avis Budget (CAR) to Your Portfolio
- Enhanced technology and shareholder-friendly measures boost Avis Budget (CAR) stock.
- 11/15/2022
|
Canadian Apartment Properties Real Estate Investment Trust (CDPYF) Q3 2022 Earnings Call Transcript
- Canadian Apartment Properties Real Estate Investment Trust (OTC:CDPYF) Q3 2022 Results Conference Call November 9, 2022 9:00 AM ET Company Participants David Mills - Investor Relations Mark Kenney - President and Chief Executive Officer Julian Schonfeldt - Chief Investment Officer Stephen Co - Chief Financial Officer Conference Call Participants Mark Rothschild - Canaccord Jonathan Kelcher - TD Securities Johann Rodrigues - Industrial Alliance Kyle Stanley - Desjardins Brad Sturges - Raymond James Mike Martinez - BMO Capital Khing Shan - RBC Capital Markets Matt Kornack - National Bank Financial Mario Saric - Scotiabank Operator Good morning. Thank you for attending today's Canadian Apartment Properties Brief Third Quarter 2022 Results Conference Call.
- 11/12/2022
|
Can Avis Budget (CAR) Run Higher on Rising Earnings Estimates?
- Avis Budget (CAR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
- 11/11/2022
|
Avis Budget (CAR) Stock Down 2.8% Since Q3 Earnings Beat
- Avis Budget's (CAR) third-quarter 2022 earnings and revenues increase year over year.
- 11/04/2022
|
Is Avis Budget Group (CAR) Stock Outpacing Its Business Services Peers This Year?
- Here is how Avis Budget Group (CAR) and Huron Consulting (HURN) have performed compared to their sector so far this year.
- 11/04/2022
|
Here Is Why Bargain Hunters Would Love Fast-paced Mover Avis Budget (CAR)
- Avis Budget (CAR) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
- 11/04/2022
|
Is Avis Budget Group (CAR) a Great Value Stock Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 11/03/2022
|
Avis stock plunges despite better-than-expected earnings
- Yahoo Finance Live anchors Brad Smith, Julie Hyman and Brian Sozzi discuss third-quarter earnings for Avis.
- 11/01/2022
|
Avis Budget Group, Inc. (CAR) Q3 2022 Earnings Call Transcript
- Avis Budget Group, Inc. (NASDAQ:CAR ) Q3 2022 Earnings Conference Call November 1, 2022 8:30 AM ET Company Participants David Calabria - Treasurer and SVP, Corporate Finance Joe Ferraro - CEO Brian Choi - CFO Conference Call Participants Ryan Brinkman - JPMorgan Adam Jonas - Morgan Stanley Chris Woronka - Deutsche Bank Stephanie Moore - Jefferies Operator Greetings, and welcome to the Avis Budget Group Third Quarter 2022 Conference Call. At this time, all participants are in listen-only mode.
- 11/01/2022
|
Avis Budget Stock Hits the Brakes Despite Quarterly Win
- The shares of Avis Budget Group Inc (NASDAQ:CAR) are down 10.9% to trade at $210.80 at last check, reversing premarket gains after the rental car company reported a third-quarter earnings and revenue beat.
- 11/01/2022
|
Avis Budget Group (CAR) Beats Q3 Earnings and Revenue Estimates
- Avis Budget (CAR) delivered earnings and revenue surprises of 46.62% and 0.66%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 10/31/2022
|
It's No Trick, All Treat for These 2 Stocks on Halloween Night
- Markets were lower, but these companies celebrated after hours.
- 10/31/2022
|
Avis Budget stock rallies 6% after company's Q3 earnings top views
- Shares of Avis Budget Group Inc. CAR, -2.83% rallied more than 6% in the extended session Monday after the car-rental company reported third-quarter earnings well above Wall Street expectations and said it expects the "strong" summer demand to carry through the end of the year. Avis earned $1.03 billion, or $21.67 a share, in the quarter, compared with $674 million, or $10.45 a share, in the year-ago period.
- 10/31/2022
|
What's in the Cards for Avis Budget (CAR) in Q3 Earnings?
- Avis Budget's (CAR) third-quarter 2022 earnings and revenues are likely to have surged from the respective year-ago reported figures.
- 10/25/2022
|
Will Avis Budget (CAR) Beat Estimates Again in Its Next Earnings Report?
- Avis Budget (CAR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 10/14/2022
|
Here's Why Investors Should Retain Avis Budget (CAR) Now
- Updated technology, connected fleets and stockholder-oriented moves boost Avis Budget (CAR).
- 10/11/2022
|
Canadian Apartment REIT: A 3.5% Dividend Yield With Residential Real Estate
- Canadian Apartment REIT saw its share price decrease by approximately 30% in the past year. The NAV is gradually decreasing, and I expect the REIT to lose an additional C$3B+ in book value.
- 10/08/2022
|
Avis Budget Group to Announce Third Quarter 2022 Results on October 31st
- Conference Call to Discuss Results Scheduled for Nov 1st, 2022 Conference Call to Discuss Results Scheduled for Nov 1st, 2022
- 10/07/2022
|
3 Reasons Why Growth Investors Shouldn't Overlook Avis Budget (CAR)
- Avis Budget (CAR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 09/29/2022
|
5 Value Stocks to Buy for Safety Amid Fed-Led Market Ruckus
- We have narrowed our search to five value stocks. These are: MPC, URI, UNM, DDS and CAR.
- 09/27/2022
|
Here's Why Investors Should Buy Avis Budget (CAR) Stock Now
- Pro-investor steps and fleet expansion bode well for Avis Budget (CAR) stock.
- 09/21/2022
|
5 Must-Buy Stocks With Solid Fundamentals Amid Market Mayhem
- We have narrowed our search to five U.S. corporate that have strong growth potential for the rest of 2022. These are: MPC, CAR, UNM, URI and CIVI.
- 09/21/2022
|
Here's Why Hold Strategy is Apt for WEX Stock Right Now
- Product and service quality and a deep understanding of customers' operational needs provide revenue stability to WEX.
- 09/14/2022
|
Is Avis Budget (CAR) a Solid Growth Stock? 3 Reasons to Think "Yes"
- Avis Budget (CAR) possesses solid growth attributes, which could help it handily outperform the market.
- 09/13/2022
|
ADP Shares Gain 20.4% in The Past Year: What's Aiding It?
- A strong business model, recurrent revenues and healthy margins boost the ADP stock.
- 09/09/2022
|
4 Stocks to Buy as Services Sector Activity Continues to Expand
- The services sector is expanding on higher orders, helping stocks like SPS Commerce, Inc. (SPSC), Avis Budget Group, Inc. (CAR), comScore, Inc. (SCOR) and ZipRecruiter, Inc. (ZIP).
- 09/09/2022
|
3 Momentum Anomaly Picks as Markets Shrug Off Rate Hike Fears
- Target Hospitality (TH), BancFirst (BANF) and Avis Budget (CAR) are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.
- 09/08/2022
|
Shrug Off Market Gyrations With These Top 5 Value Stocks
- We have narrowed our search to five value stocks. These are: UNM, URI, MPC, PPC and CAR.
- 09/07/2022
|
Avis Budget (CAR) Down 1.8% Since Last Earnings Report: Can It Rebound?
- Avis Budget (CAR) reported earnings 30 days ago. What's next for the stock?
- 08/31/2022
|
3 Momentum Anomaly Picks as Markets Remain Wary of Fed Hike
- Otter Tail (OTTR), Marten Transport (MRTN) and Avis Budget (CAR) are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.
- 08/24/2022
|
Avis Budget Group: Selloff Is A New Buying Opportunity
- Avis Budget reported its Q2 results which beat expectations, highlighted by strong demand for rental cars. The company is benefiting from higher rental rates while used car pricing dynamics support its vehicle sales business.
- 08/22/2022
|
Can Avis Budget (CAR) Climb 26% to Reach the Level Wall Street Analysts Expect?
- The average of price targets set by Wall Street analysts indicates a potential upside of 26.2% in Avis Budget (CAR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
- 08/22/2022
|
Here's Why You Should Hold WEX Stock in Your Portfolio for Now
- Acquisitions are contributing significantly to WEX's revenue growth and enhancing the company's scalability.
- 08/19/2022
|
Why Fast-paced Mover Avis Budget (CAR) Is a Great Choice for Value Investors
- If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Avis Budget (CAR) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
- 08/15/2022
|
Canadian Apartment Properties Real Estate Investment Trust's (CDPYF) CEO Mark Kenney on Q2 2022 Results - Earnings Call Transcript
- Canadian Apartment Properties Real Estate Investment Trust (OTC:CDPYF) Q2 2022 Earnings Conference Call August 11, 2022 9:00 AM ET Company Participants David Mills – Investor Relations Mark Kenney – President and Chief Executive Officer Julian Schonfeldt – Chief Investment Officer Stephen Co – Chief Financial Officer Conference Call Participants Jonathan Kelcher – TD Securities Kyle Stanley – Desjardins Johann Rodrigues – Industrial Alliance Jimmy Shan – RBC Capital Markets Matt Kornack – National Bank Financial Mario Saric – Scotiabank Jenny Ma – BMO Capital Markets Operator Good morning. Thank you for attending today's Canadian Apartment Properties REIT Second Quarter 2022 Results Conference Call.
- 08/11/2022
|
Avis Budget (CAR) is an Incredible Growth Stock: 3 Reasons Why
- Avis Budget (CAR) possesses solid growth attributes, which could help it handily outperform the market.
- 08/09/2022
|
Will Avis Budget (CAR) Gain on Rising Earnings Estimates?
- Avis Budget (CAR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
- 08/08/2022
|
Best Value Stocks to Buy for August 8th
- CAR, SATS and SVC made it to the Zacks Rank #1 (Strong Buy) value stocks list on August 8, 2022.
- 08/08/2022
|
Should Value Investors Buy Avis Budget Group (CAR) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 08/05/2022
|
The Best Stocks to Buy Now to Beat Monkeypox Mania
- Source: Viacheslav Lopatin / Shutterstock.com Just when we thought we were putting pandemics and public health crises behind us, “monkeypox” arises. Over the past few weeks, it's raised eyebrows and guards.
- 08/05/2022
|
Avis Budget Group (CAR) Q2 2022 Earnings
- Avis Budget Group, Inc. (NASDAQ: CAR) recently announced the financial results for the second quarter of 2022. These are the details.
- 08/03/2022
|
This “Unhinged” Recession Strategy Is Proven to Deliver Mega Gains
- Source: DesignRage / Shutterstock Last week, the U.S government confirmed what a lot of us already presumed. We are in a technical recession.
- 08/03/2022
|
Avis Budget Group (CAR) Q2 Earnings Beat Mark, Increase Y/Y
- Avis Budget Group's (CAR) second-quarter 2022 revenues surge year over year on higher revenues per day and strong demand.
- 08/02/2022
|
Avis Budget Group (CAR) CEO, Joe Ferraro on Q2 2022 Results - Earnings Call Transcript
- Avis Budget Group Inc. (NASDAQ:CAR ) Q2 2022 Earnings Conference Call August 2, 2022 8:30 AM ET Company Participants Joe Ferraro - President, Chief Executive Officer Brian Choi - Executive Vice President, Chief Financial Officer David Calabria - Senior Vice President, Corporate Finance, Treasurer Conference Call Participants John Healy - Northcoast Research Hans Hoffman - Jefferies Chris Woronka - Deutsche Bank Ryan Brinkman - JP Morgan Operator Greetings and welcome to Avis Budget Group second quarter 2022 conference call. At this time, all participants' lines are in a listen-only mode.
- 08/02/2022
|
Avis Budget Group (CAR) Q2 Earnings and Revenues Beat Estimates
- Avis Budget (CAR) delivered earnings and revenue surprises of 30.44% and 5.18%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- 08/01/2022
|
Avis Budget stock climbs after big earnings beat
- Shares of Avis Budget Group Inc. CAR, -0.52% were up more than 4% in after-hours trading Monday after the company easily topped profit expectations for its latest quarter. The rental-car company posted net income of $774 million, or $15.71 a share, compared with $398 million, or $5.63 a share, in the year-earlier period.
- 08/01/2022
|
Why Earnings Season Could Be Great for Avis Budget (CAR)
- Avis Budget (CAR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 07/29/2022
|
Why Avis Budget Is Stepping on the Gas Today
- The car rental outfit is set to report earnings next week.
- 07/28/2022
|
3 Top Stocks to Watch From the Business Services Industry
- With manufacturing and service activities remaining healthy, the Zacks Business Services industry is poised to prosper. WNS, CAR and BGSF are three stocks set to ride this demand strength.
- 07/19/2022
|
Will Avis Budget (CAR) Beat Estimates Again in Its Next Earnings Report?
- Avis Budget (CAR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 07/15/2022
|
Add These 4 Stocks With Remarkable Interest Coverage Ratio
- A company that is capable of generating earnings well above its interest expense can withstand financial hardship. Avis Budget (CAR), Stride (LRN), BorgWarner (BWA) and National Storage Affiliates (NSA) are strong enough to meet financial obligations.
- 07/15/2022
|
Top 5 Mid-Cap Momentum Stocks to Gain Defying Volatility
- We have narrowed our search to five mid-cap momentum stocks that have solid upside left for the rest of 2022. These are: WH, HHC, GEF, CVI and CAR.
- 07/13/2022
|
6 Reasons Why It is Worth Betting on WEX for Your Portfolio
- Solid revenue growth and strategic acquisitions boost WEX.
- 07/12/2022
|
Best Growth Stocks to Buy for July 12th
- WH, CAR and DELL made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 12, 2022.
- 07/12/2022
|
7 Wildly Oversold Nasdaq Stocks to Buy Now
- For speculators that are seeking the next big upside opportunity, you may consider these oversold Nasdaq stocks to buy now. The post 7 Wildly Oversold Nasdaq Stocks to Buy Now appeared first on InvestorPlace.
- 07/12/2022
|
Why Barclays Sees a Clear Winner Between Hertz and Avis
- There has always been a distinct rivalry among rental car companies, and, to a degree, this leaves investors at a crossroads when trying to make the best pick for their portfolio.
- 07/11/2022
|
4 Stocks to Buy on Continued Growth in Business Services Activity
- Business services activity has expanded for 25 straight months, helping stocks like ZipRecruiter, Inc. (ZIP), Everi Holdings Inc. (EVRI), Avis Budget Group, Inc. (CAR) and FactSet Research Systems Inc. (FDS).
- 07/08/2022
|
Avis Budget Group To Announce Second Quarter 2022 Results on August 1st
- Conference Call to Discuss Results Scheduled for August 2nd, 2022 Conference Call to Discuss Results Scheduled for August 2nd, 2022
- 07/07/2022
|
3 Reasons Growth Investors Will Love Avis Budget (CAR)
- Avis Budget (CAR) possesses solid growth attributes, which could help it handily outperform the market.
- 07/07/2022
|
Top 5 Value Picks Amid Concerns of Slowing U.S. Economy
- We have narrowed our search to five value stocks. These are: GPI, GEF, GIII, CAR and PSX.
- 07/06/2022
|
Best Growth Stocks to Buy for July 6th
- IMO, CAR and MPC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 6, 2022.
- 07/06/2022
|
Barclays Cuts Price Target For Avis Budget & Hertz Global - Read Why
- Barclays analyst Brian Johnson lowered the price target for Avis Budget Group Inc (NASDAQ: CAR) to $158 (1.7% upside) from $223 while maintaining the Equal Weight rating on the shares. The analyst reduced the price target on Hertz Global Holdings Inc (.
- 07/05/2022
|
Are Investors Undervaluing Avis Budget Group (CAR) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 07/04/2022
|
Best Growth Stocks to Buy for July 1st
- SYY, MPC and CAR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 1, 2022.
- 07/01/2022
|
Best Growth Stocks to Buy for June 29th
- CIB, CC and CAR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 29, 2022.
- 06/29/2022
|
4 Stocks That Boast Impressive Interest Coverage Ratio
- A company that is capable of generating earnings well above its interest expense can withstand financial hardship. Companies such as Dillard's (DDS), Avis Budget (CAR), Wyndham Hotels (WH) and American International Group (AIG) are sound enough to meet financial obligations.
- 06/28/2022
|
Strength Seen in Avis Budget (CAR): Can Its 6% Jump Turn into More Strength?
- Avis Budget (CAR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
- 06/27/2022
|
Best Growth Stocks to Buy for June 27th
- DELL, CAR and AVT made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 27, 2022.
- 06/27/2022
|
Best Growth Stocks to Buy for June 21st
- Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, June 21st:
- 06/21/2022
|
Here is Why Growth Investors Should Buy Avis Budget (CAR) Now
- Avis Budget (CAR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 06/20/2022
|
6 Reasons You Should Invest in Avis Budget (CAR) Stock Now
- Avis Budget (CAR) continues to benefit from acquisitions, technology enhancement and fleet expansion.
- 06/20/2022
|
Best Growth Stocks to Buy for June 16th
- CAR, CLR, and REPYY made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 16, 2022.
- 06/16/2022
|
Avis stock soars on buy rating from Jefferies
- Yahoo Finance's Brian Sozzi discusses Avis stock popping after Jefferies analysts reiterated a Buy rating on the shares.
- 06/15/2022
|
Best Growth Stocks to Buy for June 14th
- CAR, MPC, and AVT made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 14, 2022.
- 06/14/2022
|
5 Lucrative PEG Stocks Ideal for GARP Investors
- Here are five GARP stocks, REPYY, SIG, MPC, CAR and GEF that match the PEG-based screening criteria for a winning strategy.
- 06/14/2022
|
Here Are 4 Stocks With Remarkable Interest Coverage Ratio
- A company capable of generating earnings well above its interest expense can withstand financial hardship. Dillard's (DDS), Avis Budget (CAR), Cadence Design Systems (CDNS) and Univar Solutions (UNVR) are sound enough to meet financial obligations.
- 06/13/2022
|
3 Top-Rated Stocks to Invest in for Stellar Earnings Growth
- Invest in stocks like Archer Daniels Midland (ADM), Commercial Metals (CMC) & Avis Budget Group (CAR) at the moment for superb earnings growth.
- 06/10/2022
|
Ride With Avis Budget Group
- Avis Budget saw a terrible year in 2019 due to the pandemic but has since more than rebounded. Strong domestic travel demand has provided exceptional results for the America segment. On top of this, the International segment is still rebounding, and the company has held down costs.
- 06/09/2022
|
Best Growth Stocks to Buy for June 9th
- LUV, MPC and CAR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 9, 2022.
- 06/09/2022
|
Why Investors Slammed the Brakes on Avis Stock Today
- In anticipation of falling car rental prices, an analyst trimmed his price target on Avis shares.
- 06/08/2022
|
Best Growth Stocks to Buy for June 7th
- IMO, LUV, and CAR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 7, 2022.
- 06/07/2022
|
Here is Why Growth Investors Should Buy Avis Budget (CAR) Now
- Avis Budget (CAR) possesses solid growth attributes, which could help it handily outperform the market.
- 06/03/2022
|
Is Avis Budget Group (CAR) Stock Undervalued Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 06/02/2022
|
5 Top Stocks Likely to Beat Earnings Estimates
- Top-ranked stocks CAR, SQM, CSL, TS and DRVN are likely to beat on bottom line in their next releases.
- 06/02/2022
|
Why Is Avis Budget (CAR) Down 33.3% Since Last Earnings Report?
- Avis Budget (CAR) reported earnings 30 days ago. What's next for the stock?
- 06/01/2022
|
Why Avis Budget Group Stock Tumbled Today
- The auto chip supply shortage might be ending soon, but that's not necessarily good news for everyone who moves the metal.
- 05/31/2022
|
6 Reasons to Add Avis Budget (CAR) Stock to Your Portfolio Now
- Acquisitions, technology enhancement and fleet expansion bode well for Avis Budget (CAR).
- 05/31/2022
|
The 7 Best Mid-Cap Stocks to Buy for June 2022
- While scooping up cheap popular ideas sounds appealing during this selloff, these mid-cap stocks to buy offer a balanced approach. The post The 7 Best Mid-Cap Stocks to Buy for June 2022 appeared first on InvestorPlace.
- 05/28/2022
|
Insiders Buying Coinbase And 2 Other Stocks
- Although the Dow Jones jumped by more than 500 points on Thursday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain.
- 05/27/2022
|
Best Growth Stocks to Buy for May 24th
- CAR, CLR, and ASO made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 24, 2022.
- 05/24/2022
|
5 Transportation Stocks For Your Late-May 2022 Watchlist
- Check out these transportation stocks for your watchlist this week.
- 05/23/2022
|
Here's Why Avis Budget (CAR) is Poised for a Turnaround After Losing 41.7% in 4 Weeks
- Avis Budget (CAR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
- 05/19/2022
|
Bet on 3 Stocks With Momentum Anomaly for a Winning Portfolio
- Avis Budget (CAR), Archer-Daniels-Midland (ADM) and Dillard's (DDS) are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.
- 05/19/2022
|
Why Ford, GM, and Avis Stocks All Crashed Today
- Car sales tumble in Europe -- just like they tumbled in America.
- 05/18/2022
|
Avis Budget Group (CAR) is a Top-Ranked Value Stock: Should You Buy?
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 05/18/2022
|
5 Travel Stocks To Watch After JetBlue Launches Hostile Takeover For Spirit
- Check out these top travel stocks to watch as JetBlue launches hostile takeover for Spirit.
- 05/16/2022
|
5 Top Stocks Likely to Beat Earnings Estimates
- These top-ranked stocks (DRVN, TS, CIB, DDS, CAR) are likely to beat on bottom line in their next releases.
- 05/16/2022
|
5 GARP Stocks Based on Discounted PEG for a Winning Portfolio
- Here are five stocks, CAR, APA, IMO, HUN and PPC that fit our screening criteria.
- 05/13/2022
|
Is Avis Budget Group (CAR) a Great Value Stock Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 05/12/2022
|
How Is the Travel Industry Doing 2 Years Into the Pandemic?
- Plus a look at how to adjust your monthly budget after you get a raise.
- 05/11/2022
|
Looking for a Growth Stock? 3 Reasons Why Avis Budget (CAR) is a Solid Choice
- Avis Budget (CAR) possesses solid growth attributes, which could help it handily outperform the market.
- 05/11/2022
|
Is Avis Budget Group (CAR) Outperforming Other Business Services Stocks This Year?
- Here is how Avis Budget Group (CAR) and CBIZ (CBZ) have performed compared to their sector so far this year.
- 05/06/2022
|
Avis Budget (CAR) Stock Rises 3.8% Since Q1 Earnings Beat
- Avis Budget's (CAR) first-quarter 2022 earnings and revenues increase year over year.
- 05/05/2022
|
Why Avis Stock Topped the Market Today
- The company does an impressive flip on the bottom line for its inaugural quarter of 2022.
- 05/03/2022
|
What Stocks To Buy Today? 3 Travel Stocks For Your List
- Should investors be going the distance for these top travel stocks?
- 05/03/2022
|
Avis Budget Group, Inc. (CAR) CEO Joe Ferraro on Q1 2022 Results - Earnings Call Transcript
- Avis Budget Group, Inc. (NASDAQ:CAR ) Q1 2022 Earnings Conference Call May 3, 2022 8:30 AM ET Company Participants Joe Ferraro – Chief Executive Officer Brian Choi – Chief Financial Officer David Calabria – Treasurer and Senior Vice President of Corporate Finance Conference Call Participants Brian Johnson – Barclays Mario Cortellacci – Jefferies Chris Woronka – Deutsche Bank John Healy – Northcoast Research Ryan Brinkman – JPMorgan Operator Greetings and welcome to the Avis Budget Group, First Quarter 2022, conference call. At this time, all participants are in a listen-only mode, a question-and-answer session will follow the formal presentation.
- 05/03/2022
|
Why Is Avis Budget (CAR) Stock in the Spotlight Today?
- Avis Budget Group just reported positive 2022 Q1 earnings. Here's why that doesn't mean CAR stock is a buy right now.
- 05/03/2022
|
Why Avis Budget Group Stock Is Rising
- Avis Budget Group Inc (NASDAQ: CAR) shares are trading higher Tuesday after the company reported strong financial results. Avis Budget Group said first-quarter revenue increased 77% year-over-year to $2.4 billion, which beat the $2.11 billion estimate.
- 05/03/2022
|
Avis Budget Group (CAR) Surpasses Q1 Earnings and Revenue Estimates
- Avis Budget (CAR) delivered earnings and revenue surprises of 182.20% and 11.31%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 05/02/2022
|
Travel Is Back and These 2 Stocks Are Celebrating
- The stock market had an impressive reversal from deep losses early Monday.
- 05/02/2022
|
Why Avis Budget Group Stock Is Surging After Hours
- Avis Budget Group Inc (NASDAQ: CAR) shares are trading higher in Monday's after-hours session after the company reported strong financial results. Avis said first-quarter revenue increased 77% year-over-year to $2.4 billion, which beat the $2.11 billion estimate, according to data.
- 05/02/2022
|
Earnings Results: Avis Budget stock jumps 12% as car-rental company swings to quarterly profit
- Shares of Avis Budget Group Inc. skyrocketed more than 12% in after-hours trading Monday after the rental-car company reported better-than-expected first-quarter earnings, saying it saw “significantly increasing demand” toward the end of the quarter despite an uptick in COVID-19 cases.
- 05/02/2022
|
Can Avis Budget (CAR) Keep the Earnings Surprise Streak Alive?
- Avis Budget (CAR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 04/29/2022
|
Best Growth Stocks to Buy for April 28th
- OXY, LINC, and CAR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 28, 2022.
- 04/28/2022
|
Best Growth Stocks to Buy for April 25th
- ARCO, JLL, and CAR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 25, 2022.
- 04/25/2022
|
Best Growth Stocks to Buy for April 21st
- CBRE, COP, and CAR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 21, 2022.
- 04/21/2022
|
Three-Stock Lunch: Carter Worth breaks down Roblox, Avis Budget Group and Tesla
- Carter Worth of Worth Charting joins 'Power Lunch' to discuss shares of Roblox, Avis Budget Group and Tesla.
- 04/20/2022
|
Has Avis Budget Group (CAR) Outpaced Other Business Services Stocks This Year?
- Here is how Avis Budget Group (CAR) and Paychex (PAYX) have performed compared to their sector so far this year.
- 04/20/2022
|
Dow transports enjoy unanimous rally, led by Avis Budget, American Airlines
- The Dow Jones Transportation Average DJT, +2.55% powered up 2.6% in midday trading Tuesday, with all 20 components gaining ground. The biggest boost to the index was Avis Budget Group Inc.'s stock CAR, +6.84% , which hiked up 7.0%.
- 04/19/2022
|
Best Growth Stocks to Buy for April 19th
- ARCO, BBQ, and CAR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on April 19, 2022.
- 04/19/2022
|
Dow transports bounces despite broader market selloff, led by Avis Budget and Delta stock rallies
- The Dow Jones Transportation Average DJT, +0.50% bounced 97 points, or 0.7%, with 14 of 20 components gaining ground, to buck the selloff in the broader stock market. The rally comes after the Dow transports closed Friday at a six-month low, following a 13.4% plunge in eight days amid growing fears that rapidly deteriorating market conditions could lead to a freight recession.
- 04/11/2022
|
Avis Budget Group to Announce First Quarter 2022 Results on May 2nd
- Conference Call to Discuss Results Scheduled for May 3 rd , 2022
- 04/08/2022
|
5 Best-Performing Mid-Cap Stocks for 2022
- Avis Budget, Antero Resources, Range Resources, Alcoa, and Devon Energy have stood out for their impressive returns over the past year.
- 04/06/2022
|
Avis Budget Group: Primed For Another Short Squeeze
- Avis' buybacks have led to short squeezes in the past, and the latest $1bn authorization could result in a similar outcome this year.
- 03/29/2022
|
Two lawmakers want Hertz, Avis to answer questions on rising U.S. rental prices
- Two U.S. House Democratic lawmakers on Friday asked Hertz Global Holdings, and Avis Budget Group to answer questions about rising rental car prices and higher industry profits.
- 03/18/2022
|
Avis Budget (CAR) Up 35.3% Since Last Earnings Report: Can It Continue?
- Avis Budget (CAR) reported earnings 30 days ago. What's next for the stock?
- 03/16/2022
|
Avis Budget OKs $1 billion share buyback plan
- Avis Budget Group Inc. CAR, +8.49% said Wednesday its board has approved a $1 billion increase to the car-rental company's existing share buyback authorization. Avis has about $1.16 billion of available share repurchase authorization remaining as of Wednesday.
- 03/16/2022
|
Why Avis Budget Group Accelerated 12% Higher Today
- An article in a prominent newspaper detailed a new California law beneficial for auto-rental agencies.
- 02/24/2022
|
Avis Budget Group's (CAR) CEO Joe Ferraro on Q4 2021 Results - Earnings Call Transcript
- Avis Budget Group's (CAR) CEO Joe Ferraro on Q4 2021 Results - Earnings Call Transcript
- 02/15/2022
|
Avis Budget (CAR) Q4 Earnings & Revenues Beat Mark, Rise Y/Y
- Avis Budget's (CAR) fourth-quarter 2021 earnings and revenues increase year over year.
- 02/15/2022
|
One hedge fund manager made $2 billion last year from a decade-old bet on Avis as the company briefly achieved meme-stock status and soared 456%
- The bet on Avis by Karthik Sarma at SRS Investment helped to roughly triple the hedge fund manager's net worth to $3 billion, according to Bloomberg.
- 02/15/2022
|
Earnings Results: Avis stock sinks as bears focus on revenue per day disappointment over earnings beat
- Shares of Avis Budget Group Inc. took a dive Tuesday, after the car rental company reported upbeat fourth-quarter earnings, but investors focused instead on disappointing revenue per day and rental fleet metrics.
- 02/15/2022
|
Avis Budget Group Stock Plummets Despite Strong Results
- The shares of Avis Budget Group Inc (NASDAQ:CAR) are experiencing a sharp pullback this morning, down 14% to trade at $167.55 at last glance, despite fourth-quarter top- and bottom-line beats.
- 02/15/2022
|
Dow Jones Newswires: Avis Budget earnings and sales continued to benefit from higher car-rental prices in holiday quarter
- Avis Budget Group Inc. reported higher sales in the fourth quarter as revenue per day and rental days continued to increase from the third quarter.
- 02/14/2022
|
4 Top Stock Trades for Tuesday: SE, ABBV, TD, CAR
- Sea Ltd, AbbVie, Toronto Dominion Bank and Avis Budget were our top stock trades for Tuesday. Here's how the charts look now.
- 02/14/2022
|
Dow transports surge on back of Avis Budget's stock strength, to buck the broader-market selloff
- The Dow Jones Transportation Average DJT, +1.04% charged up 157 points, or 1.1%, in afternoon trading, but with just 9 of its 20 components gaining ground, to as the rally in Avis Budget Group Inc.'s CAR, +10.18% stock provided the boost the index needed to buck the selloff in the broader stock market. The car rental company's stock shot up 10.6% in afternoon trading, and the $19.18 price gain added roughly 117 points to the Dow transports' price.
- 02/14/2022
|
What's in the Cards for Avis Budget (CAR) in Q4 Earnings?
- Avis Budget's (CAR) fourth-quarter 2021 earnings and revenues are likely to have increased year over year.
- 02/11/2022
|
Avis Budget Group (CAR) Gains But Lags Market: What You Should Know
- Avis Budget Group (CAR) closed at $187.33 in the latest trading session, marking a +0.21% move from the prior day.
- 02/08/2022
|
Avis Budget Group (CAR) Gains But Lags Market: What You Should Know
- In the latest trading session, Avis Budget Group (CAR) closed at $165.42, marking a +0.56% move from the previous day.
- 01/28/2022
|
Will Avis Budget (CAR) Beat Estimates Again in Its Next Earnings Report?
- Avis Budget (CAR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 01/28/2022
|
Why Avis Budget Stock Zoomed 6.5% Today
- JPMorgan sees value in Avis' cheap stock.
- 01/26/2022
|
Barclays Cuts Price Targets On These Two Car Rental Companies
- Barclays analyst Brian Johnson lowered Hertz Global Holdings Inc (NASDAQ:HTZ) price target to $26 from $28 and maintained an Overweight rating on the shares. The analyst also lowered Avis Budget Group Inc (NASDAQ:CAR) price target to $168 from $217 and maintained an Underweight rating on the shares.
- 01/20/2022
|
Avis Lands After A 215% Spike
- Avis's efforts to expand its rental fleet enables the company to continue growing its top line.
- 01/18/2022
|
Avis Budget Group to Announce Fourth Quarter 2021 Results on February 14th
- Conference Call to Discuss Results Scheduled for February 15th, 2022 Conference Call to Discuss Results Scheduled for February 15th, 2022
- 01/14/2022
|
Best Growth Stocks to Buy for January 13th
- AN, GEF, and CAR made it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 13, 2022.
- 01/13/2022
|
Avis Budget Group (CAR) Gains As Market Dips: What You Should Know
- In the latest trading session, Avis Budget Group (CAR) closed at $199.60, marking a +1.29% move from the previous day.
- 01/10/2022
|
Best Growth Stocks to Buy for January 10th
- TGLS, PFE, and AN made it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 10, 2022
- 01/10/2022
|
Deutsche Bank Upgrades This Mobility Solutions Provider
- Deutsche Bank analyst Chris Woronka upgraded Avis Budget Group Inc. (NASDAQ:CAR) to Hold from Sell, and the price target remained unchanged at $210 (an upside of 3.7%). Woronka mentions that, since a downgrade of the shares post-market on November 2, the stock's estimated 2023 enterprise value to EBITDA multiple has contracted by nearly seven turns, to 9.4 times.
- 01/06/2022
|
Why Avis Budget Stock Stomped on the Gas Today
- Two Wall Street bankers just buddied up to boost Avis stock.
- 01/06/2022
|
The Ratings Game: Avis Budget stock bounces after analyst says investors can stop selling after recent price drop
- Shares of Avis Budget Group Inc. rallied Thursday, after Deutsche Bank analyst Chris Woronka said the stock has fallen enough in the past two months that he no longer recommends investors sell.
- 01/06/2022
|
Avis Budget Group (CAR) Gains As Market Dips: What You Should Know
- In the latest trading session, Avis Budget Group (CAR) closed at $202.53, marking a +0.15% move from the previous day.
- 01/04/2022
|
5 Reasons to Add Avis Budget Group (CAR) Stock in Your Portfolio
- Avis Budget (CAR) remains focused on structurally improving its business amid the pandemic through cost discipline and operational efficiencies.
- 12/31/2021
|
Avis Budget Group (CAR) Stock Sinks As Market Gains: What You Should Know
- In the latest trading session, Avis Budget Group (CAR) closed at $206.56, marking a -1.78% move from the previous day.
- 12/29/2021
|
Buy These 3 Stocks With Momentum Anomaly for Higher Returns
- Avis Budget Group (CAR), Signet Jewelers (SIG) and Fulgent Genetics (FLGT) are currently witnessing a short-term pullback in price. So, make sure you take full advantage of it.
- 12/29/2021
|
Is Avis Budget Group (CAR) Stock Outpacing Its Business Services Peers This Year?
- Here is how Avis Budget Group (CAR) and Information Services Group (III) have performed compared to their sector so far this year.
- 12/29/2021
|
Best Growth Stocks to Buy for December 29th
- ARCB, BERY, CAR, and DDS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 29, 2021
- 12/29/2021
|
Best Stocks To Invest In Right Now? 5 Consumer Discretionary Stocks To Watch
- Should investors be eyeing consumer discretionary stocks in hopes of a Santa rally this week?
- 12/27/2021
|
Avis Budget Stock Slips Despite Higher Rental Rates
- The shares of Avis Budget Group Inc. (NASDAQ:CAR) are slipping today, last seen down 2.8% to trade at $217.56.
- 12/27/2021
|
5 Momentum Stocks Bargain Hunters Would Love Chasing
- Given the prevailing sentiment in the market, Academy Sports (ASO), Avis Budget (CAR), Laboratory Corporation (LH), Penske Automotive (PAG) and West Fraser (WFG) are expected to give handsome returns to momentum investors.
- 12/24/2021
|
7 Great Growth Stocks to Buy for January
- Some growth stocks are still posting big gains and have momentum that will continue into 2022. Here are seven of the best to choose from.
- 12/23/2021
|
5 Lucrative PEG Stocks for GARP Investors
- Here are five GARP stocks, PVH, DOLE, ASO, BERY and CAR, which qualify the screening criteria.
- 12/17/2021
|
Is Avis Budget Group (CAR) Outperforming Other Business Services Stocks This Year?
- Here is how Avis Budget Group (CAR) and Information Services Group (III) have performed compared to their sector so far this year.
- 12/13/2021
|
Implied Volatility Surging for Avis Budget (CAR) Stock Options
- Investors need to pay close attention to Avis Budget (CAR) stock based on the movements in the options market lately.
- 12/13/2021
|
Don't Shun This Car Rental Stock Just Yet
- Avis Budget Group Inc. (NASDAQ:CAR) is down 1.5% at $244.33 this afternoon, likely still reeling from Deutsche Bank and J.P.
- 12/09/2021
|
7 Stocks to Watch as Omicron Takes Aim at the Holiday Travel Recovery Story
- With the omicron variant of the novel coronavirus imposing a dark cloud over the travel industry, these are the stocks to watch. The post 7 Stocks to Watch as Omicron Takes Aim at the Holiday Travel Recovery Story appeared first on InvestorPlace.
- 12/08/2021
|
4 Stocks to Buy as Services Sector Activity Hits Record High
- The services sector has seen steady growth since reopening, helping stocks like The Interpublic Group of Companies (IPG), HeadHunter Group (HHR), Avis Budget Group (CAR) and Robert Half International (RHI).
- 12/07/2021
|
The Ratings Game: Hertz stock jumps after analysts recommend investors buy, while at the same time saying rival Avis Budget is a sell
- Shares of Hertz Global Holdings Inc. surged Monday after JPMorgan recommended investors buy, citing strong industry tailwinds and a number of company-specific drivers that make the car rental company more attractive than its close peer, Avis Budget Budget Group Inc.
- 12/06/2021
|
5 Finest Value Stocks Based on PEG Ratio
- Here are five value stocks, CAR, MODV, LNVGY, PAG and ATCO, which qualify the screening criteria.
- 12/03/2021
|
Why Is Avis Budget (CAR) Down 23.1% Since Last Earnings Report?
- Avis Budget (CAR) reported earnings 30 days ago. What's next for the stock?
- 12/01/2021
|
Heebner's Capital Growth Management Shuffles Top Holdings
- Ken Heebner (Trades, Portfolio)'s Capital Growth Management has revealed its portfolio for the third quarter of 2021. The firm's top trades include an addition to its top holding in Jones Lang LaSalle Inc. ( JLL , Financial), selling out of Philip Morris International Inc. ( PM , Financial) and Dick's Sporting Goods Inc. ( DKS , Financial) positions and new buys into Whirlpool Corp. ( WHR , Financial) and Avis Budget Group Inc. ( CAR , Financial).
- 11/30/2021
|
Avis Budget (CAR) Stock: $170 Price Target From Morgan Stanley
- The shares of Avis Budget Group Inc. (NASDAQ: CAR) have received a price target of $170 from Morgan Stanley. These are the details.
- 11/30/2021
|
Top 5 Picks to Gain From Wall Street's Omicron-Relief Rally
- We have applied our VGM Style Score to narrow the search to the five stocks that have strong growth potential for the rest of 2021. These are: XOM, DVN, BLDR, CAR and WLK.
- 11/30/2021
|
Avis price target raised to $333, Jefferies analyst says, 'pricing power is the number 1 driver'
- Jefferies Equity Analyst Hamzah Mazari joins Yahoo Finance's Brian Sozzi and to discuss the outlook and price target for Avis stock.
- 11/29/2021
|
Electric-Car Fans Are Driving These 2 Unlikely Stocks Higher
- It might seem like a stretch, but investors are excited about these companies.
- 11/29/2021
|
Time to Buy These 5 Relative Price Strength Stocks
- Avis Budget Group (CAR), Builders FirstSource (BLDR), Kronos Worldwide (KRO), Carriage Services (CSV) and PDC Energy (PDCE) are five stocks with explosive relative price strength.
- 11/26/2021
|
Earnings Estimates Rising for Avis Budget (CAR): Will It Gain?
- Avis Budget (CAR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
- 11/25/2021
|
Has Avis Budget Group (CAR) Outpaced Other Business Services Stocks This Year?
- Here is how Avis Budget Group (CAR) and Interpublic Group (IPG) have performed compared to their sector so far this year.
- 11/25/2021
|
Powell's Renomination Confirms Fed Policy Continuity: 5 Picks
- We have selected five stocks that have strong growth potential for the rest of 2021. These are Dow, PSX, BLDR, WLK and CAR.
- 11/23/2021
|
Hertz Vs. Avis Stock: Which Is The Better Buy As Rental Demand Increases?
- Hertz recently re-listed after coming out of bankruptcy. Avis lacks the overhang of private equity shares coming on the market.
- 11/18/2021
|
Top 5 Stocks to Buy at Deep Discount to Boost Portfolio Gains
- We have narrowed our search to five that are currently trading at a deep discount from their 52-week highs.These are: DOW\, CAR, PTC, PSX and DBX.
- 11/18/2021
|
5 Value Stocks You Don't Want to Miss
- Avoid the value trap with stocks such as these.
- 11/16/2021
|
Driving Performance Without CAR: Another Hedged Portfolio Outperforms, This Time Without The Skyrocketing Rental Car Company
- Japanese gameshow contestant versus bear. Image via TMZ.
- 11/15/2021
|
7 New Meme Stocks That Retail Investors Can't Get Enough Of
- As the phenomenon that simply won't die, meme stocks are again lighting up the board. So, here are the latest names to consider.
- 11/12/2021
|
This Top Business Services Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
- Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
- 11/12/2021
|
The massive gains for freshly-minted meme stock Avis are throwing off a 100-year-old indicator that's historically predicted big market moves
- Avis has surged more than 600% this year thanks to retail-trader hype and a tweet from Tesla's Elon Musk.
- 11/11/2021
|
Meet the Next FAANG
- Shares of Avis Budget skyrocket as increased demand for rental cars fuels strong third-quarter profits.
- 11/10/2021
|
Is Avis Budget Group (CAR) Stock Outpacing Its Business Services Peers This Year?
- Is (CAR) Outperforming Other Business Services Stocks This Year?
- 11/09/2021
|
4 Factors Likely to Drive Year-End Wall Street Rally: 5 Picks
- We have narrowed down our search to five large-cap stocks that have strong growth potential for the rest of 2021. These are: DOW, COP, CAR, TRGP and WLK.
- 11/09/2021
|
Short squeezes are pushing these stocks to the moon
- The individual investor army on Reddit that helped push GameStop and AMC to unprecedented heights earlier this year has found some more companies to rally around.
- 11/08/2021
|
Best Momentum Stocks to Buy for November 8th
- BG, CAR, and IT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 8, 2021.
- 11/08/2021
|
The options volume is chasing the big moves in stocks, says Susquehanna's Chris Murphy
- Chris Murphy, Susquehanna co-head of derivative strategy, joins 'Power Lunch' to discuss how much the options market is affecting the overall stock market. Murphy looks at a couple of stocks which have seen big, recent moves and how option trading are affecting their prices.
- 11/05/2021
|
Jim Cramer's advice for hedge funds after the Avis and Bed Bath & Beyond stock surges
- "Mad Money" host Jim Cramer on Wednesday discussed the recent resurgence of retail traders jumping into heavily shorted stocks such as Avis and Bed Bath & Beyond.
- 11/03/2021
|
Avis short-squeeze prompts double downgrade from JPMorgan even as fundamentals 'strongest they have ever been'
- The bank said Tuesday's short-squeeze rally in Avis stock was too far too fast despite the company's best fundamentals ever.
- 11/03/2021
|
Jim Cramer breaks down surging shares of Avis after big earnings beat
- CNBC's Jim Cramer and the 'Squawk on the Street' team discuss shares of car rental company Avis, which more than doubled on Tuesday following the company's huge earnings beat.
- 11/03/2021
|
Avis shares more than double as company hints at EV future
- CNBC's Leslie Picker joins 'Squawk Box' to break down what was behind the 108% surge in shares of rental car company Avis on Tuesday.
- 11/03/2021
|
TD Ameritrade Places Varying Restrictions On Trading In 4 Stocks Including Avis, AMC
- Brokerage firm TD Ameritrade, a unit of Charles Schwab Corp. (NYSE: SCHW), has instituted trading restrictions on four Reddit-favorite stocks — AMC Entertainment Holdings Inc. (NYSE: AMC), GameStop Corp. (NYSE: GME), Avis Budget Group Inc. (NASDAQ: CAR) and Digital World Acquisition Corp. (NASDAQ: DWAC). What Happened: TD Ameritrade said it is limiting certain options strategies and blocking short-selling on the stocks of Avis Budget and Donald Trump-linked special purpose acquisition company (SPAC) Digital World Acquisition.
- 11/02/2021
|
Shares of Avis skyrocket on a big earnings beat and a short squeeze
- Shares of Avis take off on a big earnings beat and short squeeze. With CNBC's Melissa Lee, and the Fast Money traders, Tim Seymour, Dan Nathan, Karen Finerman and Brian Kelly.
- 11/02/2021
|
Stocks Keep Moving Higher: Goldman Breaks Out, Academy Sports Sets Up, Make Avis Stock A Rental
- Stocks Keep Moving Higher: Goldman Breaks Out, Academy Sports Sets Up, Make Avis Stock A Rental Investor's Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market research, education and the latest financial and business news to help investors make more money in the stock market. Learn more.
- 11/02/2021
|
Avis shares soar in meme-like rally as retail traders spark squeeze
- Shares of Avis Budget Group Inc nearly doubled on Tuesday as retail investors rushed to get a piece of the heavily shorted U.S. car rental company after its quarterly results beat Wall Street estimates.
- 11/02/2021
|
Avis Budget (CAR) Q3 Earnings and Revenues Beat Estimates
- Avis Budget's (CAR) third-quarter 2021 earnings and revenues increase year over year.
- 11/02/2021
|
CAR Stock: Why The Price Surged Over 217% Today
- The stock price of Avis Budget Group Inc. (NASDAQ: CAR) increased by over 217% during intraday trading today. This is why it happened.
- 11/02/2021
|
Avis Budget Group, Inc. (CAR) CEO Joseph Ferraro on Q3 2021 Results - Earnings Call Transcript
- Avis Budget Group, Inc. (CAR) CEO Joseph Ferraro on Q3 2021 Results - Earnings Call Transcript
- 11/02/2021
|
Avis Stock Pulls Back After Gaining 200% On Earnings Short Squeeze
- A blowout earnings report and a potential short squeeze has shares of rental car company Avis Budget Group Inc. (NASDAQ:CAR) skyrocketing in an extremely volatile session on Tuesday. What Happened?
- 11/02/2021
|
CAR Stock: The EV News Electrifying Avis Budget Shares Today
- Avis Budget (CAR) stock is charging higher on Tuesday after releasing its earnings report for the third quarter of 2021 and a short squeeze. The post CAR Stock: The EV News Electrifying Avis Budget Shares Today appeared first on InvestorPlace.
- 11/02/2021
|
Avis Budget stock more than tripled on Tuesday: this is why
- Avis Budget Group Inc (NASDAQ: CAR) soared more than 200% in the stock market on Tuesday after reporting quarterly results late last night that beat estimates by a significant margin. A short squeeze at play The massive increase in the share price was attributed to a “short squeeze” after Avis blew past expectations in the […] The post Avis Budget stock more than tripled on Tuesday: this is why appeared first on Invezz.
- 11/02/2021
|
Avis stock more than doubles after strong earnings show no end to rental car boom
- Avis Budget investors didn't really need to try harder to make any money from the stock on Tuesday. The rental car company's shares more than doubled after Avis Budget reported strong earnings Monday evening that easily topped Wall Street's forecasts.
- 11/02/2021
|
Shares of Avis double in single day as huge earnings beat sends hedge fund shorts running
- The company reported $10.74 in earnings per share for the third quarter, trouncing Refinitiv's estimates by more than $4.
- 11/02/2021
|
Why Avis Budget Shares Are Rising
- Avis Budget Group, Inc. (NASDAQ: CAR) shares are trading significantly higher after the company reported better-than-expected third-quarter adjusted earnings per share and sales results. The company also added $1 billion to its buyback.
- 11/02/2021
|
Avis Budget stock is soaring thanks to the rental car boom
- Hertz has made a lot of headlines lately thanks to its deals with Tesla and Uber. Wall Street has noticed, too. But rival rental car company Avis Budget is doing even better.
- 11/01/2021
|
Earnings Preview: What To Expect From Avis Budget Group Today
- Earnings Preview: What To Expect From Avis Budget Group Today. Here is a closer look
- 11/01/2021
|
Earnings Outlook: Avis Budget's earnings report could be ‘as good as it gets,' and stock could still fall
- Avis Budget Group Inc. could crush third-quarter earnings expectations but the stock could still sell off, just like what happened last quarter, as the view “this is as good as it gets” for some on Wall Street seems “logical,” according to Deutsche Bank analyst Chris Woronka.
- 10/29/2021
|
Revving up for a breakdown? The Chartmaster says get out of Avis
- Carter Worth of Worth Charting on whether it's time to sell Avis. With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Tim Seymour, Steve Grasso and Pete Najarian.
- 10/27/2021
|
Avis Budget Group (CAR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Avis Budget (CAR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 10/25/2021
|
4 Top Momentum Stocks Powered by Driehaus Strategy
- CAR, COP, ULTA and ARCB qualified the screen for momentum stocks driven by the Driehaus strategy.
- 10/20/2021
|
Earnings Estimates Rising for Avis Budget (CAR): Will It Gain?
- Avis Budget (CAR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
- 10/19/2021
|
Avis stock falls after Morgan Stanley recommends selling, saying it's too early for the 'mega-fleet bull case'
- Shares of Avis Budget Group Inc. CAR, -2.52% dropped 2.5% in afternoon trading Thursday, after Morgan Stanley analyst Billy Kovanis recommended investors sell, saying it's too early for investors to be betting on the "mega-fleet bull case." The stock has now lost 4.8% since it closed at a record $153.39 on Tuesday, but has still more than doubled (up 103.6%) over the past three months and rocketed 291.6% year to date, while the S&P 500 SPX, +1.70% has advanced just 18.1% this year.
- 10/14/2021
|
3 Reasons To Sell Avis Budget Group
- Avis Budget Group Inc.'s (NASDAQ:CAR) stock has climbed more than 62 percent in the past month. Investors seem to be either assigning more value in the company's nearer-term earnings than its earnings in outer-years, or expecting higher normalized EBITDA, according to Morgan Stanley.
- 10/14/2021
|
Morgan Stanley Downgrades Avis Budget, Sees 23% Downside
- Morgan Stanley analyst Billy Kovanis downgraded Avis Budget Group Inc. (NASDAQ:CAR) to Underweight from Equal Weight and raised the price target to $110 (implying a downside of 23%) from $85. Kovanis says the company faces "peak" cyclical earnings and has an unfavorable risk/reward at the current valuation.
- 10/14/2021
|
Avis and Hertz Stocks Surge as Rental Prices Remain High
- Along with strong rental prices, the prospect of new-car shortages lasting into 2022 means high profitability could continue for rental companies.
- 10/10/2021
|
Avis Budget Group: The Good Times Are Unlikely To Last And I'm Bearish
- There is a global chip shortage and some of the largest beneficiaries are U.S. car rental companies like Avis Budget Group.
- 10/08/2021
|
Should Value Investors Buy Avis Budget Group (CAR) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 10/08/2021
|
Avis Budget stock surges to another record, has nearly doubled over the past three months
- Shares of Avis Budget Group Inc. CAR, +7.94% shot up 7.3% in morning trading Friday, putting them on track for an eighth record close in the past month, and enough to pace the Dow Jones Transportation Average's DJT, +0.74% gainers. The auto rental company's stock has been by far the best performer among the Dow transports components over the past three months (up 92.4%), year to date (up 263.8%) and for the past year (up 335.3%), while the Dow transports has gained 0.9%, 16.8% and 24.2% over the same periods, respectively, and the Dow Jones Industrial Average DJIA, +0.10% has gained 1.0%, 13.6% and 22.3%.
- 10/08/2021
|
Avis Budget Group to Announce Third Quarter 2021 Results on November 1st
- Conference Call to Discuss Results Scheduled for November 2nd, 2021 Conference Call to Discuss Results Scheduled for November 2nd, 2021
- 10/07/2021
|
5 Stocks to Buy on Continued Expansion in Services Activity
- The services sector has witnessed steady growth since reopening. This has seen companies like TransUnion (TRU), YETI Holdings, Inc. (YETI) and Chipotle Mexican Grill, Inc. (CMG) putting up a good show.
- 10/07/2021
|
6 Reasons Why You Should Invest in Avis Budget (CAR) Stock Now
- Avis Budget (CAR) rides on its buyout strategy to expand its global footprint and brand presence. Expansion of connected cars fleet has helped streamline operations and reduce costs.
- 10/01/2021
|
7 Overbought Stocks to Be Very Careful of Right Now
- While the market rally this year has been incredible, worrying developments suggest investors should watch out for overbought stocks. The post 7 Overbought Stocks to Be Very Careful of Right Now appeared first on InvestorPlace.
- 10/01/2021
|
Avis Budget Group's Stock Up On Rental Demand, Will It Sustain?
- Avis Budget Group's stock rose by 26% in the last twenty-one trading days. In comparison, the broader S&P500 index declined by 0.5% over the same period.
- 09/28/2021
|
This Top Business Services Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
- 09/24/2021
|
Is Avis Budget Group (CAR) Stock Undervalued Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 09/22/2021
|
An Airbag For Avis: In Case We (and Bank of America) Are Wrong About The Rental Car Company's Prospects
- Better to have an airbag and not need it than to need one and not have it. Avis Pops On Bullish Bank of America Rating
- 09/17/2021
|
Avis Budget (CAR) Moves 9.8% Higher: Will This Strength Last?
- Avis Budget (CAR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- 09/17/2021
|
Why Avis Budget Group Stock Shot 10% Higher Today
- A big recommendation and price-target upgrade shifted the company into the fast lane.
- 09/16/2021
|
Indexes Finish Off Lows; Avis Budget, eBay, And Macy's In Focus
- Indexes finish off lows Avis Budget, eBay, and Macy's in focus. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market research, education and the latest financial and business news to help investors make more money in the stock market.
- 09/16/2021
|
Avis Budget Stock Surges On BofA's Rating Upgrade, Raised Price Target
- BofA analyst John Murphy upgraded Avis Budget Group Inc. (NASDAQ:CAR) to Buy from Neutral and raised the price target to $125 (implying an upside of 26%), up from $90. Murphy believes 'over-earning' to continue for the company.
- 09/16/2021
|
Analyst Upgrades and Downgrades: Why DASH, CAR and BYND Stocks Are Moving Today
- Due to a few analyst updates, DoorDash (DASH), Avis Budget Group (CAR) and Beyond Meat (BYND) are all seeing their stocks move on Thursday. The post Analyst Upgrades and Downgrades: Why DASH, CAR and BYND Stocks Are Moving Today appeared first on InvestorPlace.
- 09/16/2021
|
Looking for a Fast-paced Momentum Stock at a Bargain? Consider Avis Budget (CAR)
- Avis Budget (CAR) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
- 09/09/2021
|
7 Finest PEG Stocks for GARP Investors
- Here are the stocks, ACI, WLK, OLN, BCC, SNDR, FLEX, and CAR that qualify the screening.
- 09/07/2021
|
Is Avis Budget Group (CAR) Stock Undervalued Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 09/06/2021
|
Avis Budget (CAR) Hits 52-Week High, Can the Run Continue?
- Avis Budget (CAR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 09/06/2021
|
7 Lucrative Value Stocks Based on Discounted PEG
- Here are seven value stocks, PEG ARCB, CAR, JNPR, CLS, LNC, CPRI and TPX satisfying the screening criteria of Zacks Research Wizard.
- 08/20/2021
|
Will Avis Budget (CAR) Gain on Rising Earnings Estimates?
- Avis Budget (CAR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
- 08/19/2021
|
Why Avis Budget Group (CAR) is a Top Momentum Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 08/19/2021
|
Investors Discounting Earnings Growth Potential In These 5 Stocks
- Investors are missing some great earnings growth potential in these stocks.
- 08/17/2021
|
Are You Looking for a Top Momentum Pick? Why Avis Budget Group (CAR) is a Great Choice
- Does Avis Budget Group (CAR) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 08/17/2021
|
The 5 Best Stocks to Buy Now on Relative Price Strength
- Avis Budget Group (CAR), Rent-A-Center (RCII), Petrobras (PBR), Sonos (SONO) and Textron (TXT) are five stocks with explosive relative price strength.
- 08/16/2021
|
6 Lucrative PEG Picks Based on Hybrid Investment Strategy
- Here are six GARP stocks, ACI, CAR, TX, CLS, HCA, and ARCB based on discounted PEG.
- 08/10/2021
|
This Top Business Services Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
- 08/06/2021
|
Services Activity Expands to Record High in July: 5 Winners
- The services sector has witnessed steady growth since reopening. This has seen companies like TransUnion (TRU), Avis Budget Group (CAR) and Sirius XM Holdings putting up a good show.
- 08/06/2021
|
Avis Budget (CAR) Q2 Earnings and Revenues Beat Estimates
- Avis Budget's (CAR) second-quarter 2021 earnings and revenues increase year over year.
- 08/05/2021
|
Avis Budget Group, Inc. (CAR) CEO Joe Ferraro on Q2 2021 Results - Earnings Call Transcript
- Avis Budget Group, Inc. (CAR) CEO Joe Ferraro on Q2 2021 Results - Earnings Call Transcript
- 08/04/2021
|
Top Ranked Momentum Stocks to Buy for August 4th
- CAR, ABG, POWI, and TDY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 4, 2021
- 08/04/2021
|
Avis Budget Group (CAR) Q2 Earnings and Revenues Beat Estimates
- Avis Budget (CAR) delivered earnings and revenue surprises of 161.06% and 13.73%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 08/03/2021
|
Earnings Results: Avis sales triple in Q2 amid rising prices, demand for rental cars
- Avis Budget Group Inc. late Tuesday said it had the best quarter in its history, blowing past Wall Street expectations, with sales tripling thanks to both higher demand for rental cars and higher rental prices as more U.S. residents traveled.
- 08/03/2021
|
Avis Budget Group Reports Record Net Income and Adjusted EBITDA
- PARSIPPANY, N.J., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) today announced second quarter 2021 financial results.
- 08/03/2021
|
The Ratings Game: Avis Budget stock surges ahead of earnings after analyst says ‘big beat' likely
- Shares of Avis Budget Group Inc. surged Monday, after Deutsche Bank analyst Chris Woronka boosted his earning estimate and stock price target a day before the rental car company reveals second-quarter results, saying a "big beat" is likely.
- 08/02/2021
|
3 Stocks to Sell Due to Damaging Supply-Chain Woes
- These three stocks to sell have been struggling immensely with the ongoing supply chain disruptions brought about by the pandemic The post 3 Stocks to Sell Due to Damaging Supply-Chain Woes appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now It doesn't matter if you have $500 in savings or $5 million.
- 07/28/2021
|
Avis Budget Group: Good Growth, Bad Business, Okay Investment
- Avis Budget Group: Good Growth, Bad Business, Okay Investment
- 07/16/2021
|
What's Next For Avis Budget Stock After A 23% Drop In A Month?
- Avis Budget Group's stock, a global car rental provider, has declined around 23% over the last twenty-one trading days (one month) and currently stands at $72. It should be noted that the broader S&P500 returned a 3% growth during the same period.
- 07/15/2021
|
Why Travel Stocks Are Dropping This Week
- COVID-19 is back in the news.
- 07/09/2021
|
Why This Car Rental Stock Sank Today
- Avis Budget Group has a lot to worry about.
- 07/08/2021
|
Avis Budget Group to Announce Second Quarter 2021 Results on August 3rd
- Conference Call to Discuss Results Scheduled for August 4th, 2021
- 07/06/2021
|
3 Top Stocks From the Thriving Business Services Industry
- 3 Top Stocks From the Thriving Business Services Industry
- 06/30/2021
|
Avis Budget board OKs share buyback increase
- Avis Budget Group Inc. board of directors has approved a $325 million increase to the car-rental company's share buyback authorization, the company said in a filing Friday. With that, Avis has about $391 million of available repurchase authorization.
- 06/04/2021
|
5 Stocks to Buy as Services Sector Expands at Record Pace
- The services sector has witnessed steady growth since reopening. This has seen companies like IBEX Limited (IBEX), Avis Budget Group (CAR) and Concentrix Corporation (CNXC) putting up a good show.
- 06/04/2021
|
Why Is Avis Budget (CAR) Up 7.4% Since Last Earnings Report?
- Avis Budget (CAR) reported earnings 30 days ago. What's next for the stock?
- 06/02/2021
|
Avis Budget (CAR) Reports Loss in Q1, Stock Declines 5.8%
- Avis Budget (CAR) first-quarter 2021 revenues decline year over year.
- 05/07/2021
|
Time To Sell Avis Budget Group Stock?
- Avis budget group, a car rental industry company, saw its stock rise by 257% since the end of 2018 compared to the S&P500 which has increased by 69% in the same period.
- 05/07/2021
|
Avis Budget Group, Inc. (CAR) CEO Joe Ferraro on Q1 2021 Results - Earnings Call Transcript
- Avis Budget Group, Inc. (CAR) CEO Joe Ferraro on Q1 2021 Results - Earnings Call Transcript
- 05/04/2021
|
Avis Budget Group down after reporting earnings
- Yahoo Finance's Jared Blikre breask down Avis Budget Group's quarterly earnings report. Watch the 2021 Berkshire Hathaway Annual Shareholders Meeting on YouTube: https://youtu.be/gx-OzwHpM9k
- 05/03/2021
|
Avis Budget Group (CAR) Reports Q1 Loss, Tops Revenue Estimates
- Avis Budget (CAR) delivered earnings and revenue surprises of 80.67% and 10.74%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
- 05/03/2021
|
U.S. rental car firm Avis Budget posts bigger loss
- U.S. rental car company Avis Budget Group Inc on Monday posted a bigger first-quarter loss, as fewer people traveled during the COVID-19 pandemic.
- 05/03/2021
|
Avis' quarterly loss deepens, sales drop 22% in Q1
- Avis Budget Group Inc. late Monday reported another quarterly loss and sales that dropped 22%, but the results were better than expected and the stock fell about 1% in the extended session. Avis said it lost $170 million, or $2.43 a share, in the quarter, compared with a loss of $158 million, or $2.16 a share, in the year-ago quarter.
- 05/03/2021
|
Should You Buy Avis Budget Group (CAR) Ahead of Earnings?
- Avis Budget Group (CAR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 04/30/2021
|
Zipcar Expands Partnership with the City of Philadelphia to Increase Access to Car Sharing
- BOSTON, April 21, 2021 /PRNewswire/ -- Today, Zipcar, the world's leading car-sharing network, is building on its partnership with the City of Philadelphia and the Philadelphia Parking Authority with the addition of nearly 50 Zipcar vehicles to convenient, designated on-street parking spots across the city. Since 2007, Zipcar has been providing members in Philadelphia with access to a vehicle without the cost or hassles of car ownership.
- 04/21/2021
|
Avis Budget Group to Announce First Quarter 2021 Results on May 3rd
- Conference Call to Discuss Results Scheduled for May 4th, 2021 Conference Call to Discuss Results Scheduled for May 4th, 2021
- 04/14/2021
|
Why Is Avis Budget (CAR) Up 61.8% Since Last Earnings Report?
- Avis Budget (CAR) reported earnings 30 days ago. What's next for the stock?
- 03/18/2021
|
Why Shares of Avis Budget Group Fell 7% in Early Trading Today
- The car rental company got pushed lower along with a Wall Street downgrade.
- 03/16/2021
|
Avis Budget Group Announces Pricing of $500 Million of Senior Notes
- PARSIPPANY, N.J., March 09, 2021 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) (the “Company”) announced today that its wholly-owned subsidiaries, Avis Budget Car Rental, LLC and Avis Budget Finance, Inc. (together, the “Issuers”) priced an offering of $500 million aggregate principal amount of 4.75% senior notes due 2028 (the “Notes”) in a private offering, which represents a $150 million increase from the previously announced size of the offering. The Notes will have a maturity date of April 1, 2028. The closing of the offering of the Notes is expected to occur on March 23, 2021, subject to customary closing conditions. The Notes will be issued at par and guaranteed on a senior unsecured basis by the Company and certain of its U.S. subsidiaries.
- 03/09/2021
|
Avis Budget Group Announces Intention to Offer $350 Million of Senior Notes
- PARSIPPANY, N.J., March 09, 2021 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) (the “Company”) announced today that its wholly-owned subsidiaries, Avis Budget Car Rental, LLC and Avis Budget Finance, Inc. (together, the “Issuers”), intend, subject to market and other customary conditions, to offer $350 million aggregate principal amount of senior notes due 2028 (the “Notes”) in a private offering. The Notes will be guaranteed on a senior unsecured basis by Avis Budget Group, Inc. and certain of its U.S. subsidiaries.
- 03/09/2021
|
Avis Budget stock rises toward 6-year high after BofA bumps up price target by 40%
- Shares of Avis Budget Group Inc. hiked 2.5% higher in afternoon trading Wednesday, putting them on track to close at exactly a 6-year high, after BofA Securities analyst Aileen Smith boosted her price target by 40%, saying there's "still good mileage left in this rental." Smith reiterated her buy rating on the rental car company while lifting her price target to $70, which is 15.5% above current levels, from $50.
- 03/03/2021
|
The Past Week's Notable Insider Buys: Agree Realty, Avis Budget, Zoetis And More
- Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Returning buyers and chief executives were among the insiders making purchases this week.
- 02/28/2021
|
What's Driving Avis Budget Group Higher Friday?
- An analyst recently upgraded the rental car giant.
- 02/19/2021
|
Avis Budget Group Announces Pricing of $600 Million of Senior Notes
- PARSIPPANY, N.J., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) (the “Company”) announced today that its wholly-owned subsidiaries, Avis Budget Car Rental, LLC and Avis Budget Finance, Inc. (together, the “Issuers”) priced an offering of $600 million aggregate principal amount of 5.375% senior notes due 2029 (the “Notes”) in a private offering. The Notes will have a maturity date of March 1, 2029. The closing of the offering of the Notes is expected to occur on March 1, 2021, subject to customary closing conditions. The Notes will be issued at par and guaranteed on a senior unsecured basis by the Company and certain of its U.S. subsidiaries.
- 02/17/2021
|
Avis Budget Group, Inc. (CAR) CEO Joe Ferraro on Q4 2020 Results - Earnings Call Transcript
- Avis Budget Group, Inc. (CAR) CEO Joe Ferraro on Q4 2020 Results - Earnings Call Transcript
- 02/17/2021
|
Why Avis Budget Group Dropped 10% After Solid Progress
- Avis is still dealing with COVID-19 headwinds, but the company is well positioned to drive through 2021.
- 02/17/2021
|
Avis Budget Group Announces Intention to Offer $600 Million of Senior Notes
- PARSIPPANY, N.J., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) (the “Company”) announced today that its wholly-owned subsidiaries, Avis Budget Car Rental, LLC and Avis Budget Finance, Inc. (together, the “Issuers”), intend, subject to market and other customary conditions, to offer $600 million aggregate principal amount of senior notes due 2029 (the “Notes”) in a private offering. The Notes will be guaranteed on a senior unsecured basis by Avis Budget Group, Inc. and certain of its U.S. subsidiaries.
- 02/17/2021
|
Avis Budget (CAR) Q4 Earnings Beat Estimates, Revenues Miss
- Avis Budget (CAR) fourth-quarter 2020 earnings and revenues decrease year over year.
- 02/17/2021
|
Avis stock rises on narrower Q4 loss, cost savings
- Shares of Avis Budget Group Inc. rose nearly 1% in the extended session Tuesday after the car-rental company reported a narrower-than-expected fourth-quarter loss and said it reined in costs. Avis said it lost $90 million, or $1.29 a share, in the quarter, contrasting with a profit of $142 million, or $1.90 a share, in the year-ago quarter.
- 02/16/2021
|
Avis Budget Group Removes More than $2.5 billion of Costs Setting the Stage for Future Recovery
- PARSIPPANY, N.J., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) today announced financial results for fourth quarter and full year ended December 31, 2020.
- 02/16/2021
|
5 High-Flying Stocks Set to Move Higher
- These 5 stocks have good reason for further upside.
- 01/29/2021
|
Are Investors Undervaluing Avis Budget Group (CAR) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 01/29/2021
|
3 Reasons Why Avis Budget Shares Could Go Higher
- Shares of car rental company Avis Budget Group Inc. (NASDAQ: CAR) are up more than six-fold since bottoming at $6.35 last March and three catalysts could help lift shares even higher, according to BofA Securities. The Avis Budget Analyst: Aileen Smith initiated coverage of Avis Budget Group's stock with a Buy rating and $50 price target.
- 01/25/2021
|
The Ratings Game: Avis stock rises after BofA says buy, with a $50 target
- Shares of Avis Budget Group Inc. rallied toward an 11-month high on Monday, after BofA Securities analyst Aileen Smith recommended investors buy, targeting about a 20% gain.
- 01/25/2021
|
5 Reasons to Add Avis Budget (CAR) In Your Portfolio Now
- Fleet expansion and impressive share-holder friendly moves bode well for Avis Budget (CAR).
- 01/19/2021
|
Avis Budget Group to Announce Fourth Quarter & Full Year 2020 Results on February 16th
- Conference Call to Discuss Results Scheduled for February 17th, 2021 Conference Call to Discuss Results Scheduled for February 17th, 2021
- 01/14/2021
|
Is Avis Budget Group (CAR) a Great Value Stock Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 01/13/2021
|
Reasons to Retain Avis Budget (CAR) Stock in Your Portfolio
- Avis Budget's (CAR) ability to cater to a wide range of mobility demands helps it expand and strengthen its global foothold through organic growth.
- 12/15/2020
|
Notable Insider Buys Of the Past Week: Avis Budget, Biotech IPOs And More
- Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason -- they believe the stock price will rise and they want to profit from it. So insider buying can be an encouraging signal for potential investors, particularly when there is uncertainty in the markets, as there has been as the pandemic worsens.
- 12/12/2020
|
A New Stakeholder in Avis Budget Group Is Driving Shares 10% Higher Today
- SRS Investment purchased a sizable chunk of Avis stock, the most recent vote of confidence in the vehicle rental company.
- 12/09/2020
|
Last Week's Notable Insider Buys: Avis, Biglari And More
- Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason -- they believe the stock price will rise and they want to profit from it. So insider buying can be an encouraging signal for potential investors, particularly when there is uncertainty in the markets, as there was before and after the elections and as the pandemic worsens.
- 11/21/2020
|
Top Stocks To Short Today Amid COVID Fears And Stimulus Doubts
- Markets continue to churn sideways amid further shutdowns and surging COVID cases. The U.S. seven-day average of daily new COVID-19 infections now stands at 165,029 and is 24% higher than it was a week ago.
- 11/20/2020
|
Top Stocks To Short Today As Post-Election Rally Cools Down
- Despite no clear cut winner in the U.S. election yet, Joe Biden appears to be on the cusp of winning the nomination. Although markets somewhat cooled off today, they are still on pace for their biggest weekly gains since April.
- 11/06/2020
|
Why Avis Budget Group Stock Continues to Fall Monday
- The car rental company's $15 billion debt load is a millstone around its neck.
- 11/02/2020
|
Avis Budget Group, Inc. (CAR) CEO Joe Ferraro on Q3 2020 Results - Earnings Call Transcript
- Avis Budget Group, Inc. (CAR) CEO Joe Ferraro on Q3 2020 Results - Earnings Call Transcript
- 10/30/2020
|
Avis Budget Group beats Q3 estimates but profit and sales hit by pandemic effect on travel
- Avis Budget Group Inc. shares jumped 4% in after-hours trade Thursday, after the rental car company topped earnings estimates for the third quarter, even as profit and revenue slid sharply as travel slowed significantly during the pandemic. The company said it had net income of $45 million, or 63 cents a share, in the quarter, down sharply from $189 million, or $2.50 a share, in the year-earlier period.
- 10/29/2020
|
Avis Budget Group Reports Positive Earnings and Removes an Additional $1 Billion of Expenses in Third Quarter
- PARSIPPANY, N.J., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) today announced third quarter 2020 financial results, with Net income of $45 million and Adjusted net income of $79 million.
- 10/29/2020
|
Wall Street Profits Soar During First Half of 2020
- Wall Street profits jumped 82% in the first half of this year, a rare bright spot for the city and state’s pandemic-ravaged budgets.
- 10/22/2020
|
Global $6+ Billion Military Land Vehicle Electronics (Vetronics) Market and Technologies Forecast to 2028 - ResearchAndMarkets.com
|
Why Hertz Global's Stock Is Up 90%
- Hertz Global (NYSE: HTZ) shares are trading higher on Friday after the company announced it secured commitments of $1.65 billion in debtor-in-possession financing.
Hertz Global...
- 10/16/2020
|
Avis Budget Group to Announce Third Quarter 2020 Results on October 29th
- Avis Budget Group, Inc. (NASDAQ: CAR) announced today that it plans to report its third quarter 2020 results after the market close on Thursday, October 29th,
- 10/13/2020
|
Avis Budget Group to Announce Third Quarter 2020 Results on October 29th
- Conference Call to Discuss Results Scheduled for October 30th, 2020
- 10/13/2020
|
Market Regains Footing On Hopes Of More Stimulus
- The inherent problem of tying your Presidency to the stock market is that it's all fine until it isn't.
- 10/11/2020
|
Albanese surges into Depressionberg Unstimulus vacuum - MacroBusiness
- Here’s Anthony Albanese budget reply speech: ANTHONY ALBANESE MP LEADER OF THE AUSTRALIAN LABOR PARTY MEMBER FOR GRAYNDLER BUDGET IN REPLY 2020 HOUSE OF REPRESENTATIVES PARLIAMENT HOUSE CANBERRA THURSDAY, 8 OCTOBER 2020 My fellow Australians. We live in a great country. Amidst all the chaos and hardship that has shaken our world in 2020 –
- 10/08/2020
|
Mexico's Cancun braced for possibly 'catastrophic' Hurricane Delta
- Mexico's Cancun braced for possibly 'catastrophic' Hurricane Delta
- 10/07/2020
|
Pandemic Budget's tax cuts, cash splash to put Australia in record debt
- Billions of dollars in fast-tracked tax cuts and younger worker wage subsidies underline the Federal Government's budget recovery pitch, as Australia's recession sends debt and deficits to record levels.
- 10/06/2020
|
Detail that should 'concern' all Australians
- Reactions to the Federal Budget are coming thick and fast, with one peak body highlighting the key detail that should "concern" all Australians.
- 10/05/2020
|
Medicrea International : Note en réponse visée | Zone bourse
|
In Colorado, a Sky-High Cabin Compound Goes Midcentury Modern
- The Iuppenlatz couple bought two mining claims in the San Juan Mountains and built a luxurious 3,300-square-foot compound.
- 09/30/2020
|
ASIT biotech présente ses résultats semestriels 2020 et donne un business update jusqu’à la fin de l’année
- Regulatory News: ASIT biotech (ASIT - BE0974289218) (BSE:ASIT) (Paris:ASIT), société biopharmaceutique belge spécialisée dans la recherche et le dével
- 09/30/2020
|
Engineers Gate Manager LP Invests $354,000 in Avis Budget Group Inc. (NASDAQ:CAR)
- Engineers Gate Manager LP acquired a new position in shares of Avis Budget Group Inc. (NASDAQ:CAR) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 15,465 shares of the business services provider’s stock, valued at approximately $354,000. Several other hedge funds and […]
- 09/26/2020
|
UK public borrowing overtakes financial crisis peak
- UK public borrowing overtakes financial crisis peak
- 09/25/2020
|
Vertex présentera de nouvelles données lors de conférences européennes et nord-américaines virtuelles sur la mucoviscidose mettant en évidence l'utilisation à long terme des modulateurs CFTR
- Vertex Pharmaceuticals Incorporated (Nasdaq : VRTX) a annoncé aujourd'hui que les données du portefeuille de médicaments contre la mucoviscidose (FK)
- 09/24/2020
|
Obituary: Avis M. (Genthner) Swift
- PORTLAND - Avis M. (Genthner) Swift, 90 years of age, a lifelong resident of Maine, died peacefully surrounded by her loving ...
- 09/22/2020
|
Australia central bank assessing various monetary policy options, A$ slips
- Australia central bank assessing various monetary policy options, A$ slips
- 09/22/2020
|
Avis Budget Group Inc. (NASDAQ:CAR) Receives Consensus Recommendation of “Buy” from Analysts
- Avis Budget Group Inc. (NASDAQ:CAR) has earned a consensus rating of “Buy” from the eleven ratings firms that are covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price target among brokers that have issued […]
- 09/20/2020
|
Glenmede Trust Co. NA Acquires 27,167 Shares of Avis Budget Group Inc. (NASDAQ:CAR)
- Glenmede Trust Co. NA grew its holdings in shares of Avis Budget Group Inc. (NASDAQ:CAR) by 12,875.4% during the second quarter, HoldingsChannel reports. The institutional investor owned 27,378 shares of the business services provider’s stock after buying an additional 27,167 shares during the period. Glenmede Trust Co. NA’s holdings in Avis Budget Group were worth […]
- 09/18/2020
|
PG&E Continues to Offer Ways to Save Energy During COVID-19
- In response to residents staying home more for school and work due to the COVID-19 pandemic, Pacific Gas and Electric Company (PG&E) shares ways f
- 09/18/2020
|
Charting a holding pattern, S&P 500 asserts the range ahead of the Fed
- U.S. stocks are mixed early Wednesday, largely treading water ahead of the Federal Reserve’s policy statement, due out this afternoon. Against this backdrop,...
- 09/16/2020
|
Flowserve Corporation annonce le lancement d’une Offre publique d’achat pour ses Billets de premier rang à 1,250 % arrivant à échéance en 2022
- Flowserve Corporation (NYSE : FLS) (l’« Offreur »), l’un des principaux fournisseurs de produits et services liés au contrôle des flux, pour les march
- 09/16/2020
|
Bull trend intact: S&P 500, Nasdaq rally from major support
- Technically speaking, the major U.S. benchmarks are back on offense, rising in the wake of an aggressive September downdraft, writes Michael Ashbaugh.
- 09/15/2020
|
Charting a market downdraft, S&P 500 sells off to major support
- Technically speaking, the major U.S. benchmarks have reversed sharply from recent highs, pressured amid the most aggressive selling pressure since June,...
- 09/08/2020
|
CoreLogic and Odonate Therapeutics See Activist Action
- Senator Investment Group and Cannae Holdings revealed a joint stake in property data and analytics firm CoreLogic. Boxer Capital raised its interest in cancer-focused biopharmaceutical firm Odonate by more than one million shares.
- 09/04/2020
|
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2020 Update
- Glenview Capital Management's 13F portfolio value decreased from $3.68B to $3.63B this quarter. The number of positions decreased from 44 to 43.
- 09/04/2020
|
Charting a bullish technical tilt, S&P 500 breaks to record territory
- Technically speaking, the U.S. benchmarks’ already-bullish bigger-picture backdrop continues to strengthen, writes Michael Ashbaugh.
- 08/25/2020
|
Notable Insider Buys Last Week: Avis Budget, Xerox And Many More
- Insider buying can be an encouraging signal for potential investors during periods of uncertainty.
A number of executives and other insiders returned to the buy window last week...
- 08/22/2020
|
Covid-19 drives UK national debt to £2tn for first time
- Pandemic pushes national debt to 100.5% of GDP for first time since March 1961
- 08/21/2020
|
Corporate America Is Choking on Debt and Imperiling the Recovery
- Corporate America Is Choking on Debt and Imperiling the Recovery
- 08/21/2020
|
New York Schools Chief Warns of Teacher Layoffs if State Cuts Aid
- Chancellor Richard Carranza warned that the system might have to lay off 9,000 teachers and call off in-person instruction this year if the state forges ahead with threatened cuts; city and state officials called for federal relief.
- 08/20/2020
|
Mittleman Brothers Q2 2020 Investor Letter
- Mittleman Investment Management, LLC (“MIM”) is an SEC-registered investment adviser that provides discretionary portfolio management to institutional investors and high-net-worth individuals.
- 08/20/2020
|
Californians prepare for life without Uber and Lyft — will taxicabs make a U-turn?
- Ride-hailing giants have until midnight Thursday to comply with law that requires drivers to be classified as employees, but companies say they will suspend operations in California instead
- 08/19/2020
|
Californians prepare for life without Uber and Lyft — can the taxicab business make a U-turn?
- Ride-hailing giants have until midnight Thursday to comply with law that requires drivers to be classified as employees, but companies say they will suspend...
- 08/19/2020
|
Charting a pulling-teeth breakout attempt: S&P 500, Nasdaq challenge record territory
- Technically speaking, the S&P 500 and Nasdaq Composite have registered nominal record highs this week, though a pulling-teeth breakout attempt remains...
- 08/18/2020
|
Why Hertz landed in bankruptcy court when its rivals didn't
- Hertz was a pioneer in car rental and a highly recognized brand. But the company's attempts to address its challenges left it unprepared for the Covid-19 pandemic, unlike its rivals. Now it is in bankruptcy court and struggling to survive.
- 08/17/2020
|
Endless kilometres of beach: summer in southern Sicily
- In the island’s far south-east, locals are making the most of wide sands, buzzy baroque towns – and a lack of foreign tourists
- 08/17/2020
|
Avis Budget Group CFO to Step Down After 18 Months
- John F. North III is stepping down after 18 months in the position to pursue other interests, the car-rental company said. Avis board member Brian Choi will succeed him.
- 08/13/2020
|
Avis Budget's CFO John North to step down after 18 months in the role
- Avis Budget Group Inc. said Thursday that Chief Financial Officer John North will step down from the position "to pursue other interests," after 18 months in the role. The auto rental company's stock fell 1.6% in premarket trading. Avis said current board member Brian Choi will assume the CFO role, effective Aug. 24, at which time Choi will resign from the board, and will no longer have any affiliation with SRS Investment Management, where he is currently a partner. Choi has been on Avis's board since January 2016. Early in his career, Choi worked in the leveraged finance group at Lehman Brothers. "He brings intimate familiarity with our organization and strategy as a member of our board, and I am confident his deep financial management experience will serve us well," said Chief Executive Joe Ferraro. "He will be a great asset as we continue to reshape our company for a post-pandemic world." Avis's stock has slipped 2.3% year to date through Wednesday, while the Dow Jones Transportation Average has gained 0.3% and the Dow Jones Industrial Average has eased 2.0%.
- 08/13/2020
|
Avis Budget Group Announces Chief Financial Officer Transition
- PARSIPPANY, N.J., Aug. 13, 2020 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) today announced that John F. North III will transition from Chief Financial Officer to pursue other interests. Brian Choi will assume the role of Chief Financial Officer on August 24, 2020. As part of the transition, Mr. Choi will resign from the Avis Budget Group Board of Directors and will also no longer have any affiliation with SRS Investment Management. Mr. North will remain with Avis Budget Group as an advisor through the end of the year to help facilitate a smooth transition. Joe Ferraro, Chief Executive Officer of Avis Budget Group, said, “I want to thank John for his leadership and dedicated service to Avis Budget. John has been a tremendous asset to the Company, particularly in recent months, when he has played a key role in delivering on the operational and financial strategies critical in helping navigate the Company through the most challenged time in its history. We are pleased that we will continue to benefit from John’s insights and expertise in his new role as an advisor and wish him well in his future endeavors.” “It has been an intense, yet gratifying experience for me at Avis Budget Group, and I am proud of what we have accomplished amid unprecedented challenges,” said Mr. North. “As we work through the transition, I am confident the Company is well positioned and financially structured to emerge from the pandemic on solid footing. I look forward to working with Joe, Brian and the rest of the management team as we continue to build on our momentum.”Mr. Choi is a highly experienced finance executive with deep analytical, business development and financial acumen in the car rental business. He has served on the Avis Budget Group Board of Directors since January 2016 and as a partner at SRS Investment Management, LLC since 2008. Earlier in his career, he worked in the Leveraged Finance Group at Lehman Brothers.Mr. Ferraro continued, “We are delighted to have Brian join our senior management team. He brings intimate familiarity with our organization and strategy as a member of our Board, and I am confident his deep financial management experience will serve us well. He will be a great asset as we continue to reshape our Company for a post-pandemic world.”With Mr. Choi’s resignation, the Avis Budget Board will be reduced from seven to six members and the cooperation agreement with SRS Management has been amended accordingly.About Avis Budget Group Avis Budget Group, Inc. is a leading global provider of mobility solutions, both through its Avis and Budget brands, which have more than 11,000 rental locations in approximately 180 countries around the world, and through its Zipcar brand, which is the world’s leading car sharing network, with more than one million members. Avis Budget Group operates most of its car rental offices in North America, Europe and Australasia directly, and operates primarily through licensees in other parts of the world. Avis Budget Group is headquartered in Parsippany, N.J.Forward-Looking Statements Certain statements in this press release constitute “forward-looking statements.” Any statements that refer to outlook, expectations or other characterizations of future events, circumstances or results, including all statements related to our future results, the impact of the coronavirus and the timing of and extent to which the travel industry will reopen, are forward-looking statements. Various risks that could cause future results to differ from those expressed by the forward-looking statements included in this press release include, but are not limited to, the severity and duration of the COVID-19 outbreak and related travel restrictions, the ability or desire of people to travel due to travel restrictions and stay-at-home and other similar orders, the possibility of future waves of coronavirus infections and the other factors described in the “Risk Factors” and “Forward-Looking Statements” sections of Avis Budget Group’s Annual Report on Form 10-K for the year ended December 31, 2019 and Quarterly Report on Form 10-Q for the three months ended June 30, 2020. Accordingly, actual results, levels of activity, performance, achievements and events could differ materially from those stated, anticipated or implied by such forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements to reflect subsequent events or circumstances.Contacts Investor Contact: David Calabria IR@avisbudget.comMedia Contact: Sard Verbinnen & Co. David Millar/Tori Goodell (212) 687-8080
- 08/13/2020
|
Avis Budget Rental Car Funding (AESOP) LLC, Series 2019-1 -- Moody's assigns definitive ratings to Avis Budget Series 2020-2 rental car ABS
- Moody's Investors Service (Moody's) has assigned definitive ratings of Aa1 (sf) to the Series 2020-2 Class A fixed rate Rental Car Asset Backed Notes, A3 (sf) to the Series 2020-2 Class B fixed rate Rental Car Asset Backed Notes, and Baa3 (sf) to the Series 2020-2 Class C fixed rate Rental Car Asset Backed Notes, (together with the Class A Notes and the Class B Notes, the Series 2020-2 Notes) issued by Avis Budget Rental Car Funding (AESOP) LLC (the issuer). The issuer is an indirect subsidiary of the sponsor, Avis Budget Car Rental, LLC (ABCR, B2 negative). ABCR is a subsidiary of Avis Budget Group, Inc. ABCR is the owner and operator of Avis Rent A Car System, LLC (Avis), Budget Rent A Car System, Inc. (Budget), Zipcar, Inc and Payless Car Rental, Inc. (Payless).
- 08/12/2020
|
Avis Budget (CAR) Receives a Hold from Barclays - Markets
- In a report issued on August 10, Brian Johnson from Barclays maintained a Hold rating on Avis Budget (CAR –
- 08/12/2020
|
Why Avis Popped 13% Early Tuesday
- Shares of Avis Budget Group (NASDAQ: CAR), a vehicle rental company, jumped over 13% higher Tuesday before giving up some gains in the late afternoon as many transportation and "reopening" stocks rose thanks to vaccine and stimulus hopes. The broader transportation rise also pushed Avis higher Tuesday and almost back to even for the year. It's been a wild ride for Avis investors after the company watched its rental business grind to a near standstill that sent revenue plunging and forced rival Hertz into bankruptcy protection.
- 08/11/2020
|
Dow transports rally toward 10th-straight gain, longest win streak in over 7 years
- The Dow Jones Transportation Average undefined charged up 138 points, or 1.3%, in morning trading Tuesday to ride a 10-day win streak back into a positive...
- 08/11/2020
|
Dow transports rally toward 10th-straight gain, longest win streak in over 7 years
- The Dow Jones Transportation Average charged up 138 points, or 1.3%, in morning trading Tuesday to ride a 10-day win streak back into a positive territory for the year, amid increasing optimism that a new stimulus package will provide a fresh jolt to an improving economy. The Dow transports has soared 13.5% during its current win streak, would be the longest since the 10-day stretch of gains ending Jan. 28, 2013. Avis Budget Group Inc.'s stock surged 11.5% to pace the index's gainers, as new highs in post-COVID-19 travel demand provided a boost for the auto rental company. That also helped lift the stock of all six of the index's airline components, led by the 3.0% surge in Delta Air Lines Inc. and American Airlines Group Inc.'s 2.4% rally. Meanwhile, United Parcel Service Inc.'s stock was the index's biggest decliner, as it shed 2.4% to snap a 5-day win streak that had lifted it to a record close on Monday. The Dow transports, on track for the first close above 11,000 since Feb. 20, is now up 0.9% year to date, while the Dow Jones Industrial Average, which is running up 268 points, or 1.0% on Tuesday, has slipped 1.7% this year.
- 08/11/2020
|
Nisa Investment Advisors LLC Sells 1,960 Shares of Avis Budget Group Inc. (NASDAQ:CAR)
- Nisa Investment Advisors LLC reduced its holdings in shares of Avis Budget Group Inc. (NASDAQ:CAR) by 60.7% in the 2nd quarter, Holdings Channel.com reports. The fund owned 1,270 shares of the business services provider’s stock after selling 1,960 shares during the period. Nisa Investment Advisors LLC’s holdings in Avis Budget Group were worth $29,000 as […]
- 08/11/2020
|
Global Market Outlook for the Food Cans Market to 2027: Profiles of Key Players Ardagh Group, Wells Can Company, CMC Holdings and Kian Joo Group - ResearchAndMarkets.com
|
Avis Makes Germ-Killing Its Latest Marketing Message
- Budget has a new safety pledge that relies on the reputation of Lysol.
- 08/10/2020
|
Global Irrigation Automation Market Outlook to 2027 - Water Conservation and Increased Mechanization in Agriculture are Driving Market Growth - ResearchAndMarkets.com
|
Reps Summon Adeosun, Ahmed, Farouq Over N1.7tn NSIP Fund | Naija News
- The former Minister of Finance, Kemi Adeosun, the current Minister of Finance, Budget and National Planning, Mrs Zainab Ahmed; and the Minister of
- 08/07/2020
|
Global Storage Tank Market, Competition & Outlook 2020-2027 with Profiles of 13 Key Players Including McDermott International, Caldwell Tanks, Crom Corporation, and Tank Connection - ResearchAndMarkets.com
|
Avis Budget Earns Relative Strength Rating Upgrade; Hits Key Threshold
- On Thursday, Avis Budget got a positive adjustment to its Relative Strength (RS) Rating, from 79 to 89. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
- 08/06/2020
|
5 Best Money Saving Apps in India
- We exist in a world where a mobile app is all you need to track and save your money. It is going to be easy to achieve your financial goals by installing a money-saving app on your mobile.
- 08/06/2020
|
COVID-19 Impacts: Electric Car Rental Market Will Accelerate at a CAGR of Over 11% Through 2020-2024|Demand for Rental Cars to Boost Growth| Technavio
- The Global Electric Car Rental Market will grow by USD 7.14 bn during 2020-2024
- 08/06/2020
|
Coronavirus: Rental car cleaning undergoes massive overhaul amid pandemic
- Yahoo Finance speaks with Avis Budget CEO Joseph Ferraro about how he is helping to navigate the company through the COVID-19 pandemic.
- 08/04/2020
|
Avis Budget (CAR) Q2 Loss Wider-Than-Expected, Sales Miss
- Decline in rental days and revenue per day hurts Avis Budget's (CAR) June-end financials.
- 08/04/2020
|
Avis Bond Deal Shows Investor Confidence in Car Travel — and Hunger for Yield
- The sale shows the extent of the recovery in demand for risky debt. Avis is rated at four and five tiers below investment grade by Moody’s and S&P, respectively.
- 08/04/2020
|
Avis Budget Group CEO: 'Leisure travel leads demand for car rentals'
- Joseph Ferraro, Avis Budget Group CEO, joins Yahoo Finance's The First Trade with Alexis Christoforous and Brian Sozzi to discuss safety protocols implemented by the car rental service, how the company adjusted its fleet amid COVID-19, its recent debt offering and much more.
- 08/04/2020
|
Avis Budget Group Announces Pricing of $350 Million of Senior Notes
- PARSIPPANY, N.J., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) (the “Company”) announced today that its wholly-owned subsidiaries, Avis Budget Car Rental, LLC and Avis Budget Finance, Inc. (together, the “Issuers”), priced an offering of $350 million aggregate principal amount of 5.75% senior notes due 2027 (the “Notes”) in a private offering. The Notes will be issued as additional notes under the Indenture, dated as of July 3, 2019, pursuant to which the Issuers previously issued $400 million aggregate principal amount of 5.75% Senior Notes due 2027. The Notes will have a maturity date of July 15, 2027. The closing of the offering of the Notes is expected to occur on August 6, 2020, subject to customary closing conditions. The Notes were priced at 92% of their face value and will be guaranteed on a senior unsecured basis by Avis Budget Group, Inc. and certain of its U.S. subsidiaries. The Company intends to use the net proceeds from the Notes offering to redeem the outstanding $100 million in aggregate principal amount of the Issuers’ 5.50% Senior Notes due 2023, with the remainder to be used for general corporate purposes.The Notes and related guarantees are being offered only to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), or, outside the United States, to persons other than “U.S. persons” in compliance with Regulation S under the Securities Act. The Notes and related guarantees have not been and will not be registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.This press release is for informational purposes only and is not an offer to buy or the solicitation of an offer to sell any securities. Any offers of the Notes will be made only by means of a private offering memorandum.About Avis Budget Group Avis Budget Group, Inc. is a leading global provider of mobility solutions, both through its Avis and Budget brands, which have more than 11,000 rental locations in approximately 180 countries around the world, and through its Zipcar brand, which is the world's leading car sharing network, with more than one million members. Avis Budget Group operates most of its car rental offices in North America, Europe and Australasia directly, and operates primarily through licensees in other parts of the world. Avis Budget Group is headquartered in Parsippany, N.J.Forward-Looking Statements Statements regarding the Notes offering and the expected use of proceeds therefrom are “forward-looking statements” and are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from those expressed in such forward-looking statements. These risks and uncertainties include, but are not limited to, the ability to complete the offering on favorable terms, if at all, and general market conditions (including the COVID-19 pandemic and related economic impact) which might affect the offering. Additional information concerning these and other important risks and uncertainties can be found in the Company's filings with the Securities and Exchange Commission, including under the captions “Forward-Looking Statements” and “Risk Factors” in the Company's Annual Report on Form 10-K for the year ended December 31, 2019 and Quarterly Report on Form 10-Q for the period ended June 30, 2020. The company undertakes no obligation to update any forward-looking statements to reflect subsequent events or circumstances.Contact David Calabria: IR@avisbudget.com PR@avisbudget.com
- 08/04/2020
|
Coronavirus update: U.S. death toll climbs to 155,000, as COVID-19 enters ‘dangerous new phase’
- The U.S. tally for new confirmed cases of the coronavirus that causes COVID-19 continued its march toward 5 million, with the death toll closing in on...
- 08/03/2020
|
Avis Budget Car Rental, LLC -- Moody's assigns B3 to Avis Budget's issuance of senior unsecured notes; B2 CFR and other ratings unchanged. Outlook is negative
- Rating Action: Moody's assigns B3 to Avis Budget's issuance of senior unsecured notes; B2 CFR and other ratings unchanged. New York, August 03, 2020 -- Moody's Investors Service, ("Moody's") assigned a B3 rating to Avis Budget Car Rental, LLC's (Avis) issuance of $350 million of senior unsecured notes. All other ratings are unaffected including Avis: corporate family rating (CFR) at B2; secured credit facility at Ba2; senior unsecured debt at B3; and, Avis Budget Finance PLC: senior unsecured at B3.
- 08/03/2020
|
Avis Budget plans 5.75%, $350 million senior notes offering
- Avis Budget Group Inc. announced Monday that it plans to offer $350 million in senior notes due 2027. The 5.75% notes will be offered as additional notes under the debt dated as of July 2019, in which $400 million in 5.75% senior notes due 2027 were previously issued. The rental car company expects to use the proceeds from the notes offering to redeem $100 million of 5.50% senior notes due 2023, with the rest to be used for general corporate purposes. The company has said last week that it has $1.5 billion in liquidity at the end of the second quarter, and estimated that cash burn would be approximately $900 million, including $100 million in debt retirement. The stock, which edged up 0.1% in premarket trading, has dropped 19.7% year to date through Friday, while the S&P 500 has gained 1.3%.
- 08/03/2020
|
Avis Budget Group Announces Intention to Offer $350 Million of Senior Notes
- PARSIPPANY, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) (the “Company”) announced today that its wholly-owned subsidiaries, Avis Budget Car Rental, LLC and Avis Budget Finance, Inc. (together, the “Issuers”), intend, subject to market and other customary conditions, to offer $350 million aggregate principal amount of 5.75% senior notes due 2027 (the “Notes”) in a private offering. The Notes are being offered as additional notes under the Indenture, dated as of July 3, 2019, pursuant to which the Issuers previously issued $400 million aggregate principal amount of 5.75% Senior Notes due 2027. The Notes will be guaranteed on a senior unsecured basis by Avis Budget Group, Inc. and certain of its U.S. subsidiaries.The Company intends to use the net proceeds from the Notes offering to redeem the outstanding $100 million in aggregate principal amount of the Issuers’ 5.50% Senior Notes due 2023, with the remainder to be used for general corporate purposes. The Notes and related guarantees are being offered only to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), or, outside the United States, to persons other than “U.S. persons” in compliance with Regulation S under the Securities Act. The Notes and related guarantees have not been and will not be registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. This press release is for informational purposes only and is not an offer to buy or the solicitation of an offer to sell any securities. Any offers of the Notes will be made only by means of a private offering memorandum. About Avis Budget Group Avis Budget Group, Inc. is a leading global provider of mobility solutions, both through its Avis and Budget brands, which have more than 11,000 rental locations in approximately 180 countries around the world, and through its Zipcar brand, which is the world's leading car sharing network, with more than one million members. Avis Budget Group operates most of its car rental offices in North America, Europe and Australasia directly, and operates primarily through licensees in other parts of the world. Avis Budget Group is headquartered in Parsippany, N.J.Forward-Looking Statements Statements regarding the Notes offering and the expected use of proceeds therefrom are “forward-looking statements” and are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from those expressed in such forward-looking statements. These risks and uncertainties include, but are not limited to, the ability to complete the offering on favorable terms, if at all, and general market conditions (including the COVID-19 pandemic and related economic impact) which might affect the offering. Additional information concerning these and other important risks and uncertainties can be found in the Company's filings with the Securities and Exchange Commission, including under the captions “Forward-Looking Statements” and “Risk Factors” in the Company's Annual Report on Form 10-K for the year ended December 31, 2019 and Quarterly Report on Form 10-Q for the period ended June 30, 2020. The company undertakes no obligation to update any forward-looking statements to reflect subsequent events or circumstances.Contact David Calabria: IR@avisbudget.com PR@avisbudget.com
- 08/03/2020
|
Why Avis Is Not the Next Hertz | The Motley Fool
- There's a silver lining for investors digging into Avis's second-quarter results.
- 08/03/2020
|
Morgan Stanley Reduces Holdings in Avis Budget Group Inc. (NASDAQ:CAR)
- Morgan Stanley trimmed its position in shares of Avis Budget Group Inc. (NASDAQ:CAR) by 65.0% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 40,635 shares of the business services provider’s stock after selling 75,500 shares during the quarter. Morgan Stanley owned approximately 0.06% of Avis Budget […]
- 08/03/2020
|
Avis Budget Rental Car Funding (AESOP) LLC, Series 2020-2 -- Moody's assigns provisional ratings to Avis Budget Series 2020-2 rental car ABS
- Moody's Investors Service (Moody's) has assigned ratings of (P)Aa1 (sf) to the Series 2020-2 Class A fixed rate Rental Car Asset Backed Notes, (P)A3 (sf) to the Series 2020-2 Class B fixed rate Rental Car Asset Backed Notes, and (P)Baa3 (sf) to the Series 2020-2 Class C fixed rate Rental Car Asset Backed Notes, (together with the Class A Notes and the Class B Notes, the Series 2020-2 Notes) to be issued by Avis Budget Rental Car Funding (AESOP) LLC (the issuer). The issuer is an indirect subsidiary of the sponsor, Avis Budget Car Rental, LLC (ABCR, B2 negative). ABCR is a subsidiary of Avis Budget Group, Inc. ABCR is the owner and operator of Avis Rent A Car System, LLC (Avis), Budget Rent A Car System, Inc. (Budget), Zipcar, Inc and Payless Car Rental, Inc. (Payless).
- 08/03/2020
|
Avis Budget Group Inc. (NASDAQ:CAR) Stock Holdings Lifted by Raymond James Financial Services Advisors Inc.
- Raymond James Financial Services Advisors Inc. raised its position in Avis Budget Group Inc. (NASDAQ:CAR) by 56.6% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 43,829 shares of the business services provider’s stock after purchasing an additional 15,842 shares during […]
- 08/02/2020
|
Why Norwegian Cruise Line, Expedia, and Avis Budget Stocks All Dropped Today
- Shares of cruise and travel industry stocks shrank in end-of-week trading Friday. Car rental stock Avis Budget Group (NASDAQ: CAR) is likewise coasting downhill -- 3.4% -- marking its fifth-straight day of losses. Yesterday, Deutsche Bank kept the bad news coming on that one when it cut its price target on Avis Budget stock by $10, to $24 a share.
- 07/31/2020
|
Avis Stock Higher - Report Reflects Cost Cuts, Smaller Fleet
- Avis reported a narrower-than-expected adjusted loss as the rental-car provider shrank its fleet and cut costs.
- 07/29/2020
|
Avis Budget Group, Inc. 2020 Q2 - Results - Earnings Call Presentation
- The following slide deck was published by Avis Budget Group, Inc. in conjunction with their 2020 Q2 earnings call..
- 07/29/2020
|
Avis Budget Group, Inc. (CAR) CEO Joe Ferraro on Q2 2020 Results - Earnings Call Transcript
- Avis Budget Group, Inc. (NASDAQ:CAR) Q2 2020 Earnings Conference Call July 29, 2020 08:30 AM ET Company Participants David Calabria - Treasurer and Senior Vice President-Corporate Finance Joe Ferraro - Chief Executive Officer John North - Chief Financial Officer Conference Call Participants Ryan Brinkman - JP Morgan Hamzah Mazari - Jefferies Michael Millman - Millman Research Associates Adam Jonas - Morgan Stanley Brian Johnson - Barclays John Healy - Northcoast Research Chris Woronka - Deutsche Bank Presentation Operator Hello and welcome to the Avis Budget Group’s Second Quarter 2020 Conference Call.
- 07/29/2020
|
Avis Rises 11% as Second Quarter Is Both Abysmal and Impressive
- Shares of Avis Budget Group (NASDAQ: CAR), a vehicle rental company, jumped more than 11% higher early Wednesday, despite dismal operating results during COVID-19, as the company's actions to reduce its fleet size and costs could set the stage for positive adjusted EBITDA for the remainder of 2020. Avis' second quarter is really a mixed bag that contains equal parts dismal and impressive results.
- 07/29/2020
|
The battle to avoid becoming the next Hertz - BNN Bloomberg
- Avis Budget is coping much better than Europcar.
- 07/29/2020
|
Stocks making the biggest moves in the premarket: Boeing, GE, GM, Spotify, Eastman Kodak & more
- The stocks making the biggest moves in premarket trading include Boeing, GE, GM, Spotify, Eastman Kodak, and more.
- 07/29/2020
|
The Battle to Avoid Becoming the Next Hertz
- (Bloomberg Opinion) -- Consumers fearful of catching the coronavirus are adapting their transport habits: Crowded airplanes are now unappealing, while being cocooned in a car feels safe.Car rental firms have had a close-up view of this rapid shift in consumer behavior because most generate more than half of their revenue at airports.This dependence looked like it would be disastrous for the entire car rental sector, but on Tuesday evening two of the world’s largest car rental groups — Paris-based Europcar Mobility Group and U.S. operator Avis Budget Group Inc. — gave quite different assessments of their prospects. That has a lot to do with how they’ve managed their large debts and costs.Absent a takeover offer, Europcar which is partly owned by private equity group Eurazeo SE, looks to be heading for a financial restructuring, whereas Avis’s fortunes are rapidly improving. The latter’s shares have more than trebled since their March low. The stock surged another 14% in after-hours trading on Tuesday, after the group said it expects to start generating positive cash flow again.This transatlantic divide is surprising for a couple of reasons. First, unlike in Europe, where the virus has been under fragile control, the coronavirus is still ripping through the southern United States. Second, U.S. car rental firms were denied a bailout from Washington, and Hertz Global Holdings Inc. and Advantage Rent A Car both filed for bankruptcy in May. In contrast, Europcar was able to tap state-backed loans.Europcar has also enjoyed one other big advantage: It can often return unwanted vehicles to their manufacturers. U.S. rental firms have to sell these themselves, since they typically purchase most of their vehicles outright. When used car auctions shut down during the height of the pandemic, the American companies found it difficult to downsize their fleets. Used car prices plunged and became a factor in forcing Hertz to seek bankruptcy protection.Now with showrooms reopening, second-hand car sales have rebounded. Even formerly car-shy New Yorkers have discovered it’s useful to have a vehicle.Hence, Avis has been able to reduce its fleet by around one quarter, and coupled with cost savings and job cuts, it burned through far less cash than expected during the second quarter. Importantly, Avis has also retained access to capital markets: It raised $500 million from debt investors in May, albeit by offering an eye-watering 10.5% coupon. Thanks to the Federal Reserve’s aggressive market interventions and Avis’s own resilient performance, those junk bonds now trade well above par. If only Europcar could say the same. The depressed price of the French group’s 600 million euros of 4.125% coupon bonds due in 2024 reflect worries that holders won’t get all their money back.Maybe they won’t. On Tuesday Europcar reported a first-half loss of 286 million euros and warned its existing capital structure “weighs on its ability to ensure a proper path to recovery.” It is therefore evaluating “short and long-term alternatives” to address its capital structure and “liquidity constraints.”Europcar has 1.7 billion euros of debt, including 320 million euros of state-guaranteed loans and excluding vehicle-related borrowings, but only 400 million euros of unrestricted cash. Following several acquisitions, there’s also 1.2 billion euros of goodwill on the balance sheet, which far exceeds the group’s 235 million-euro market capitalization. The best hope for Europcar shareholders, who’ve lost 90% since the stock’s peak in 2017, is that someone makes a bid for the company. Eurazeo was looking at exiting its remaining 30% stake even before the novel coronavirus emerged. Now Volkswagen AG, which sold Europcar to Eurazeo for 1.3 billion euros in 2006, is exploring an offer for its former subsidiary, Bloomberg reported last month.Acquiring Europcar might help VW expand its range of mobility services, including for renting and leasing electric vehicles. Europcar’s airport outlets are likely to remain depressed for several years, but its commercial vehicle and urban car-sharing businesses are performing better. There are also opportunities in the long-term rental market: Europcar’s “drive safely back to work” marketing effort hopes to persuade commuters nervous of public transport to borrow a car for a few weeks. Still, taking on Europcar’s problems would be a big distraction for VW, which has plenty of its own issues right now. The U.K.’s decision this week to impose a quarantine on holidaymakers returning from Spain doesn’t bode well for overseas tourism bookings.Unless more government help is forthcoming, Europcar’s debt holders may have to cut the rental firm some slack. This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Chris Bryant is a Bloomberg Opinion columnist covering industrial companies. He previously worked for the Financial Times.For more articles like this, please visit us at bloomberg.com/opinionSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
- 07/29/2020
|
Avis Pops 10% In Extended Trading On Q2 Beat, Pick-Up In Rentals
- Shares in Avis Budget Group (CAR) jumped more than 10% in Tuesday’s extended market trading in the US after the rental car company topped sales estimates
- 07/29/2020
|
Avis Pops 10% In Extended Trading On Q2 Beat, Pick-Up In Rentals
- Shares in Avis Budget Group (CAR) jumped more than 10% in Tuesday’s extended market trading in the US after the rental car company topped sales estimates in the second quarter.The stock soared to $30.40 in after-market trading. Avis posted a loss of $481 million, or $6.91 a share, in the second quarter, versus a profit of $62 million, or 81 cents a share year-on-year. On an adjusted basis Avis lost $388 million, or $5.60 a share, in the quarter, with analysts expecting a loss of $5.68 a share. Total revenues dropped 67% to $760 million, beating analysts’ estimates of $719 million.“We quickly [identified] the impact that COVID-19 would have on our business, taking immediate actions to shrink our fleet to match demand, executing a debt financing transaction to build additional liquidity, cutting over $1 billion in expenses across our business,” said Avis CEO Joe Ferraro. “We believe our quick and targeted action has positioned us to both navigate the pandemic and capitalize on consumer demand as it returns.” Avis added that the quarter ended with an adjusted EBITDA loss of $28 million for June, driven by positive adjusted EBITDA of $3 million generated from the Americas. Moreover, liquidity stood around $1.5 billion as of the end of the second quarter. Cash burn during the reported quarter was $580 million down from an estimated $900 million “due to continued vigilance around expense control and stronger than anticipated vehicle fleet disposals”. Looking beyond the reported quarter, Avis said that revenue improvement has been more robust in the rental company’s off-airport locations and is close to pre-pandemic levels. However, the company said that it expects the rate of improvement to moderate in the third quarter but anticipates utilization will continue to improve as it matches car fleet with demand. “Since the beginning of April, we have seen consistent sequential week-over-week increases in rental volume, with both the Americas and International having their best volume to date last week due to increased leisure activity,” said Ferraro. “Coupled with the significant reduction of vehicles as we right size our fleet to current demand, we anticipate both positive cash flow and Adjusted EBITDA for the remainder of 2020.” Barclays analyst Brian Johnson yesterday raised the stock's price target to $24 (13% downside potential) from $18, but maintained a Hold rating, saying that he is "incrementally bearish" in his travel outlook adding that a slower-than-expected travel recovery leads him to lower sales estimates. Overall, Wall Street analysts are sidelined on the stock. The Hold consensus shows 3 Holds, 1 Sell, and 2 Buys. With shares down 14% so far this year, the $28 average price target now indicates a modest 1.5% downside potential in the coming year. (See Avis stock analysis on TipRanks). Related News: Bankrupt Hertz Strikes $650M Deal To Settle Fleet Reduction Plan Tesla Gains 4% After-Hours On Upbeat Q2 Earnings Kimberly-Clark Rises On 2Q Earnings Beat and Upbeat Guidance More recent articles from Smarter Analyst: * Mondelez Reports Mixed Q2; RBC Says Risk/ Reward Skews Positive * Seagate Drops 8% In Extended Trading On Earnings Miss, Weak Outlook * McDonald’s Global Sales Hit By Pandemic; Top Analyst Sticks To Hold * AMD Reassures On Its Chip, GPU Production Amid Intel Delays
- 07/29/2020
|
Avis Budget Group (CAR) Reports Q2 Loss, Lags Revenue Estimates
- Avis Budget (CAR) delivered earnings and revenue surprises of -0.36% and -8.29%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
- 07/28/2020
|
Avis stock jumps more than 10% as company says rental-car market improved
- Shares of Avis Budget Group Inc. undefined rallied nearly 10% in the extended session Tuesday after the car-rental company said it capitalized on the...
- 07/28/2020
|
Avis stock jumps more than 10% as company says rental-car market improved
- Shares of Avis Budget Group Inc. rallied nearly 10% in the extended session Tuesday after the car-rental company said it capitalized on the recovering used-car market to sell more vehicles than planned, shrinking its fleet to match demand dented by the coronavirus pandemic, and that it saw more people renting cars for leisure in recent weeks. Avis said it lost $481 million, or $6.91 a share, in the second quarter, versus a profit of $62 million, or 81 cents a share, in the year-ago period. Adjusted for one-time items, Avis lost $388 million, or $5.60 a share, in the quarter, contrasting with a profit of 79 cents a share a year ago. Sales fell 67% year-over-year to $760 million. Analysts polled by FactSet had expected an adjusted loss of $5.68 a share on sales of $719 million. Avis said it ended the quarter with liquidity around $1.5 billion. It had estimated a cash burn around $900 million, but the quarter's cash burn was $580 million, "due to continued vigilance around expense control and stronger than anticipated vehicle fleet disposals," it said. Avis said rental volumes have shown consistent increases every week since early April, and last week it scored its best volume to date in the U.S. and internationally on "increased leisure activity," Chief Executive Joe Ferraro said in a statement. "Coupled with the significant reduction of vehicles as we right size our fleet to current demand, we anticipate both positive cash flow and adjusted EBITDA for the remainder of 2020," Ferraro said.
- 07/28/2020
|
3 Stocks to Avoid This Week | The Motley Fool
- A car rentals survivor, multiplex operator, and sports wagering leader seem pretty vulnerable this week.
- 07/27/2020
|
Avis Budget Group: Enter Now To Capture Gains Over A Medium-Term Horizon
- Avis Budget Group leadership have demonstrated excellence in working capital management and liquidity preservation this year.
- 07/26/2020
|
Caisse Regionale du Credit Agricole Mutuel d'Ille et Vilaine : Avis financier au 30 juin 2020 | Zone bourse
|
These Personal Finance Apps Can Change Your Life
- Apps that help consumers manage their money are becoming more and more popular
Making smart, calculated, and guided decisions on personal capital is one of the most critical...
- 07/24/2020
|
Avis Budget To Benefit From Increased Private Car Travel
- 1Q20 was soft but 2Q20 should be the bottom as recovery began while lockdown restrictions are being steadily lifted.
- 07/23/2020
|
Volkswagen sees Amazon-built ‘industrial cloud’ as future B2B marketplace
- Volkswagen sees Amazon-built ‘industrial cloud’ as future B2B marketplace
- 07/23/2020
|
SG Americas Securities LLC Sells 91,171 Shares of Avis Budget Group Inc. (NASDAQ:CAR)
- SG Americas Securities LLC reduced its holdings in Avis Budget Group Inc. (NASDAQ:CAR) by 28.0% in the 2nd quarter, Holdings Channel reports. The fund owned 234,494 shares of the business services provider’s stock after selling 91,171 shares during the quarter. SG Americas Securities LLC’s holdings in Avis Budget Group were worth $5,368,000 at the end […]
- 07/22/2020
|
Avis Budget Group (NASDAQ:CAR) Stock Rating Reaffirmed by Morgan Stanley
- Avis Budget Group (NASDAQ:CAR)‘s stock had its “buy” rating reiterated by equities research analysts at Morgan Stanley in a research note issued on Thursday, TipRanks reports. They currently have a $37.00 target price on the business services provider’s stock. Morgan Stanley’s target price suggests a potential upside of 24.37% from the company’s current price. A […]
- 07/18/2020
|
Puis-je quitter la Belgique avec une voiture de location?
- Cet été, vu l’incertitude qui règne, il vaut mieux privilégier les déplacements en voiture plutôt qu’en avion. Mais où trouver un véhicule pour vos vacances?
- 07/18/2020
|
Hertz Is A High-Probability Liquidation Scenario (NYSE:HTZ)
- The unsecured creditors may yield zero recoveries due to poor liquidity and depressed asset valuation.
- 07/17/2020
|
Did Hedge Funds Make The Right Call On Avis Budget Group Inc. (CAR) ?
- The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F […]
- 07/17/2020
|
Hertz Is A High-Probability Liquidation Scenario
- The unsecured creditors may yield zero recoveries due to poor liquidity and depressed asset valuation.
- 07/17/2020
|
Reply reconnu en tant que fournisseur représentatif dans le guide 2020 du marché Gartner pour la gestion des dépôts
- Reply, avec sa suite d'exécution de la chaîne logistique LEA ReplyTM, est fière d'être reconnue comme fournisseur représentatif dans le guide 2020 de
- 07/17/2020
|
Zacks.com featured highlights include: Avis Budget Group, Century Aluminum Company, Diebold Nixdorf, Asbury Automotive Group and Big Lots
- Zacks.com featured highlights include: Avis Budget Group, Century Aluminum Company, Diebold Nixdorf, Asbury Automotive Group and Big Lots
- 07/16/2020
|
UK coronavirus live: 649,000 people lose their jobs during lockdown
- News updates: Unemployment grew by 74,000 in June; Scotland records first Covid-related death in eight days
- 07/16/2020
|
Don’t be misled by today's unemployment figures – a hurricane of job losses is coming | Ben Chu
- We can reasonably expect the number of people in the UK out of work to rise to between three and four million – a far graver toll, at the upper end, than even the mass unemployment of the 1980s.
- 07/16/2020
|
The Breakdown | New Zealand establishes its rugby superiority in battle with Australia
- Is it really the right time for New Zealand to weaken ties with its neighbour after a long history of cooperation?
- 07/16/2020
|
Muncy Bank Financial, Inc. Announces Earnings
- Muncy Bank Financial, Inc., (OTC:MYBF), the parent company of The Muncy Bank and Trust Company (“Bank”), has released its unaudited consolidated finan
- 07/16/2020
|
What Drove Avis and Hertz Higher Early Wednesday?
- Shares of vehicle rental company Avis Budget Group (NASDAQ: CAR) jumped as high as 8% Wednesday morning after new vaccination data from Moderna gave investors hope that consumers and the economy could return to normal sooner rather than later. The news even briefly boosted bankrupt Hertz (NYSE: HTZ), which rose nearly 3% higher before promptly returning to negative territory. Moderna's positive vaccine data brought relief to beaten-down travel stocks, including cruise lines, airlines and rental companies.
- 07/15/2020
|
STELLANTIS : Le nom du nouveau groupe qui sera issu de la fusion de FCA et Groupe PSA
- Regulatory News: Groupe PSA (Paris:UG): AVIS IMPORTANT En lisant cette communication, vous acceptez de fait d’être lié par les limitations et qualific
- 07/15/2020
|
There Is A Reason Avis Budget Group, Inc.'s (NASDAQ:CAR) Price Is Undemanding
- When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 17x, you may...
- 07/14/2020
|
Avis Budget Group to Announce Second Quarter 2020 Results on July 28th
- Conference Call to Discuss Results Scheduled for July 29th, 2020PARSIPPANY, N.J., July 13, 2020 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (NASDAQ: CAR) announced today that it plans to report its second quarter 2020 results after the market close on Tuesday, July 28th, 2020, and to host a conference call for institutional investors to discuss these results on Wednesday, July 29th, 2020 at 8:30 a.m. Eastern time. Investors may access the call at ir.avisbudgetgroup.com, or by dialing (877)-407-2991. Investors are encouraged to dial in approximately 10 minutes prior to the call. A web replay will be available at ir.avisbudgetgroup.com following the call. A telephone replay will be available from 11:00 a.m. Eastern time on July 29th, 2020 until 10:00 p.m. on August 12th, 2020 at (877)-660-6853 using conference code 13706253. About Avis Budget Group Avis Budget Group, Inc. is a leading global provider of mobility solutions, both through its Avis and Budget brands, which have more than 11,000 rental locations in approximately 180 countries around the world, and through its Zipcar brand, which is the world's leading car sharing network, with more than one million members. Avis Budget Group operates most of its car rental offices in North America, Europe and Australasia directly, and operates primarily through licensees in other parts of the world. Avis Budget Group is headquartered in Parsippany, N.J.Contact: David Calabria IR@avisbudget.com
- 07/13/2020
|
Avis Budget Group, Inc. (CAR) Shares March Higher, Can It Continue?
- As of late, it has definitely been a great time to be an investor in Avis Budget Group, Inc. (CAR).
- 07/13/2020
|
Netflix's Hollywood: The 10 Best Outfits Ranked
- Netflix's Hollywood is just another example of Ryan Murphy's amazing attention to detail and styling. Here are 10 of the best outfits on the show.
- 07/12/2020
|
Avis Budget Rental Car Funding (AESOP) LLC, Series 2019-3 -- Moody's downgrades Avis Budget's rental car ABS
- Moody's Investors Service (Moody's) has downgraded the ratings on 32 tranches of rental car asset-backed securities (ABS) issued by Avis Budget Rental Car Funding, LLC (AESOP or the issuer). The issuer is an indirect subsidiary of the transaction sponsor and single lessee, Avis Budget Car Rental, LLC (ABCR, B2 negative). ABCR, a subsidiary of Avis Budget Group, Inc., is the owner and operator of Avis Rent A Car System, LLC (Avis), Budget Rent A Car System, Inc. (Budget), Zipcar, Inc. and Payless Car Rental, Inc. (Payless).
- 07/10/2020
|
Avis Budget Group to Deliver Avis Safety Pledge and Budget Worry-Free Promise Through Agreements With Lysol, Hip Hop Public Health and Renowned Group of Medical Professionals
- PARSIPPANY, N.J., July 09, 2020 -- Avis Budget Group (ABG) today announced the launch of an exciting and forward thinking coalition designed to enhance the cleanliness.
- 07/09/2020
|
Cross-Sector: Market Data Highlights
|
Investors Bet Against Junk Bonds at Their Peril
- (Bloomberg Opinion) -- In the past six months, investors across the globe witnessed the world turn upside down. Then, just as suddenly, sweeping coordinated action by central banks and governments left many major financial markets unchanged at worst — and at record highs at best. Just from looking at asset prices, things appear mostly right-sided, even though millions are unemployed, bankruptcies are piling up and new coronavirus outbreaks raise doubts about reopening efforts.After experiencing such a whipsaw, could you blame investors for heading into the second half of 2020 wanting to bet against something? Anything? While it’s still early days, U.S. high-yield corporate bonds are starting to look like the flashpoint for this anxiety. Investors pulled a whopping $5.55 billion from junk debt funds in the week ended July 1, the fourth-biggest outflow ever and the largest in more than two years, according to data compiled by Refinitiv Lipper. An additional $2.6 billion left exchange-traded funds tracking speculative-grade bonds last week, Bloomberg News’s Katherine Greifeld reported. Generally, high-yield pros are chalking this up to individual investors taking profits after the strongest quarter in more than a decade.Some other troubling signs are starting to crop up, however. Traders are taking bearish options positions on the $27.3 billion iShares iBoxx High Yield Corporate Bond ETF (ticker: HYG), with about $2.5 billion in notional put volume changing hands on July 6, the most since June 11. Total call volume, by contrast, slid to the lowest in a month. Whether for hedging or just outright speculation, these wagers would suggest limited upside and potentially large losses ahead.I admit, this is a tempting narrative. Maybe U.S. stocks can keep climbing thanks to the near-invincible large technology companies. Perhaps total returns on investment-grade bonds should be at a record high with the Federal Reserve buying a broad index of the securities and pledging to keep benchmark interest rates near zero for the foreseeable future, pegging borrowing costs at rock-bottom levels for creditworthy companies. But if the world is in for a slow and uneven recovery, what exactly is the case for junk bonds? They’re a natural asset class to show the first signs of skittishness.Indeed, U.S. bonds and loans trading at distressed levels rose for a second consecutive week through July 2, by 5.9% to $369 billion, according to data compiled by Bloomberg. Before that stretch, that figure hadn’t expanded since April. While it’s still a far cry from the peak of $930 billion in March, this week-by-week chart of bankruptcies from Bloomberg’s Josh Saul shows that corporate America’s struggles are far from over:The superlatives are stunning. More airlines sought U.S. bankruptcy protection this year than at any time since the global financial crisis. Energy filings grew at the fastest pace since oil prices collapsed in 2016. More retail companies turned to court protection in the first half of 2020 than in any other comparable period ever, with Brooks Brothers Group Inc. adding to that tally this week and the owner of the brands Ann Taylor and Lane Bryant reportedly soon to follow. Not all of these companies have unsecured bonds on their books, but the pace is nonetheless ominous.Could the past few months have been a Fed-induced head-fake before the real storm? “Sharp corrections are common in highly volatile distressed cycles, and we think the exuberance may mirror spring 2008’s similar two-month window of calm, which didn’t last,” wrote Philip Brendel, a senior credit analyst at Bloomberg Intelligence. “That correction also reveled in Fed largesse as the central bank stood behind JPMorgan’s Bear Stearns acquisition in March 2008.”Hearing comparisons to the global financial crisis might make an investor rush to a new ETF that Tabula Investment Management introduced this week (ticker: TABS), which effectively bets against 100 high-yield bonds by tracking the performance of the CDX North American High Yield Credit Short Index. “Investors need to review their exposure to high-yield U.S. debt and consider strategies for protecting against any rise in defaults,” said Jason Smith, Tabula’s chief investment officer.For individual investors, it’s one thing to take profits after a blockbuster quarter. It’s quite another to make an outright bet against high-yield bonds. There are several reasons to doubt a full-scale collapse is in the offing, starting with the fact that junk-debt issuance reached $58 billion in June, the busiest month ever. That suggests a large swath of companies, particularly those rated double-B like the preponderance of the CDX index, have successfully raised funds to offset any immediate revenue shortfalls, which in turn lowers the stakes for the coming months if mutual-fund withdrawals persist.Moreover, as I’ve noted before, distressed-debt investors have raised tens of billions of dollars for an opportunity to snap up cheap bonds and loans when companies run into trouble. Some already missed out on the biggest bargains in March; it stands to reason that they’ll be more eager to pounce at the first hint of another selloff, or attractive businesses falling on temporary hard times. On top of that, Bank of America Corp. estimates these investors might sell $200 billion of investment-grade securities in the next several months — money that would likely be deployed into riskier securities.This wall of cash alone won’t save every company from bankruptcy, of course. But one reason that Hertz Global Holdings Inc. went bust while Avis Budget Group Inc. hasn’t is because investors lined up in early May to lend Avis $500 million for five years in exchange for a huge 10.5% coupon. Since then, Avis’s longest-dated bonds have rallied to 84 cents on the dollar from 56 cents, while the new securities trade at 114 cents to yield 6.3%, about the same as the Bloomberg Barclays high-yield index. It went from a company on the brink to an average speculative-grade borrower in just two months.This kind of resolution seems more likely than a 2008 redux. Plus, the Fed wasn’t buying corporate debt and ETFs in 2008, nor was Congress so quick to extend lifelines to businesses and individuals alike. By all accounts, we’re living through a unique economic recession and recovery.Investors shouldn’t assume anything about the behavior of speculative-grade debt in this environment. By all means, take some chips off the table if the persistent drip of bankruptcy filings is unnerving. But bet against the broad junk-bond market at your own risk.This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Brian Chappatta is a Bloomberg Opinion columnist covering debt markets. He previously covered bonds for Bloomberg News. He is also a CFA charterholder.For more articles like this, please visit us at bloomberg.com/opinionSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
- 07/09/2020
|
Why Avis and Hertz Stocks Jumped Wednesday
- Shares of Avis Budget Group (NASDAQ: CAR) and bankrupt rival Hertz (NYSE: HTZ) jumped 11% and 8%, respectively, on Wednesday after news that Melvin Capital Management had opened up a position in Avis. Riding alongside the late-afternoon broader market rally, Avis stock jumped double digits after Melvin Capital disclosed a 5.8% stake in the rental company. It's been a common theme among investors and analysts that Avis will benefit from the Hertz bankruptcy once travel and transportation demand returns, assuming the COVID-19 pandemic will eventually be under control.
- 07/08/2020
|
Why Avis Budget Group Gave Up 29% in the First Half of the Year | The Motley Fool
- The car rental operator's prospects sunk as the pandemic hit.
- 07/08/2020
|
Why American Eagle Outfitters, Avis Budget Group, and Groupon Stocks All Dropped 5% Today
- The five-day-long stock market rally took a breather on Tuesday, with shares of consumer-facing stocks including clothier American Eagle Outfitters (NYSE: AEO), rental car company Avis Budget Group (NASDAQ: CAR), and e-coupon hawker Groupon (NASDAQ: GRPN) falling 5%, 5.1%, and 5.3%, respectively through 3:30 p.m. EDT. There isn't, so far as I can tell, any particular news of note weighing on any of these three shares today -- no negative press releases, earnings warnings, or even analyst downgrades that would explain why American Eagle, Avis, or Groupon in particular should be suffering. What we do have, however, is a new report out from the Organization for Economic Cooperation and Development warning that coronavirus is continuing to depress the economy and threatens to drive unemployment levels up to the highest levels seen since the Great Depression -- and that unemployment won't return to pre-recession levels before 2022.
- 07/07/2020
|
Why Shares of Avis Budget Group Rose as High as 7% on Monday | The Motley Fool
- A glowing analyst recommendation continues to power the company's stock.
- 07/06/2020
|
With consumers hitting the road, this stock could be the best summer travel pick
- Americans are putting the pedal to the metal this summer, and traders Craig Johnson and Nancy Tengler like this auto retail stock.
- 07/06/2020
|
New Mexico Educational Retirement Board Has $188,000 Position in Avis Budget Group Inc. (NASDAQ:CAR)
- New Mexico Educational Retirement Board grew its stake in Avis Budget Group Inc. (NASDAQ:CAR) by 22.7% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 13,500 shares of the business services provider’s stock after purchasing an additional 2,500 shares during the […]
- 07/06/2020
|
Amateur day traders had a field day with Hertz. Now, Morgan Stanley says Avis stock could be next and skyrocket 65%.
|
Stock Markets Gain Ground on Lemonade IPO, Avis Budget Boost
- The stock market continued to gain ground on Thursday, going into the three-day holiday weekend with some strong momentum. Although the gains for the Dow Jones Industrial Average (DJINDICES: ^DJI), S&P; 500 (SNPINDEX: ^GSPC), and Nasdaq Composite waned slightly into the close, investors still showed that they have a strong belief in the power of the U.S. economy to overcome the challenges brought on during the coronavirus crisis. IPO investors got a treat today, as fintech insurance company Lemonade (NYSE: LMND) came public and received huge interest in the secondary market.
- 07/02/2020
|
Avis Budget News: Why CAR Stock Is Driving Higher 13% Today | InvestorPlace
- Avis Budget (CAR) is in the news Thursday after an upgrade from Morgan Stanley analyst Adam Jonas sent CAR stock soaring.
- 07/02/2020
|
Avis Budget Stock Upgraded on Strong Car Sales
- Avis Budget shares were upgraded to overweight at Morgan Stanley, which lifted its price target nearly 50%.
- 07/02/2020
|
Avis Budget Car Rental, LLC -- Moody's confirmed Avis ratings, including CFR at B2 and senior unsecured at B3, outlook is negative
- Moody's Investors Service, ("Moody's") confirmed the ratings of Avis Budget Car Rental, LLC and its guaranteed subsidiaries. The confirmations include: Avis Budget Car Rental, LLC (Avis) -- Corporate Family Rating (CFR) at B2; Probability of Default Rating (PDR) at B2-PD; secured bank facility at Ba2; senior secured notes at Ba2; senior unsecured notes at B3; and, Avis Budget Finance PLC -- senior unsecured at B3.
- 07/02/2020
|
Stocks making the biggest moves midday: Tesla, Avis Budget, Lemonade, Spotify & more
- Take a look at the companies making headlines in midday trading.
- 07/02/2020
|
Why Shares of Avis and Hertz Are Up Today
- Shares of Avis Budget Group (NASDAQ: CAR) soared 29% at the open on Thursday morning after receiving an upgrade from Morgan Stanley. Car sales are holding up better than feared during the pandemic, according to the analyst, and that is good news both for Avis Budget and its bankrupt rival Hertz Global Holdings (NYSE: HTZ). Avis Budget shares gave back some of those gains after the open, but were still up 19% as of 10:30 a.m. EDT.
- 07/02/2020
|
Bourse de Wall Street : Les valeurs à suivre à Wall Street
|
USA-Les valeurs à suivre à Wall Street (actualisé)
- (Actualisé avec ventes de Tesla)
PARIS, 2 juillet (Reuters) - Principales valeurs à suivre
jeudi à Wall Street où les contrats à terme indiquent une
ouverture en hausse de 0,6% à 1% :
* BOEING BA.N - L'administration fédérale de l'aviation
civile américaine (FAA) a annoncé mercredi avoir achevé avec
Boeing les vols de certification du 737 MAX, une étape majeure
en vue de la remise en service de l'appareil, cloué au sol
depuis mars 2019 suite à deux accidents ayant fait 346 morts en
cinq mois
- 07/02/2020
|
Revenue leakage: Senate summons finance minister, Emefiele, Magu
- The Senate, Wednesday, summoned the Minister of Finance, Budget and National Planning as well as heads of other agencies to brief it on the government’s framework to block revenue loss owing to mon…
- 07/02/2020
|
Why did Rishi Sunak fail to help some of the self-employed?
- The Chancellor's largesse to battle Covid-19 has been audacious but when it came to assisting the self-employed, he curiously failed to offer all those affected a hand.
- 07/02/2020
|
NASS dares Buhari, halts 774,000 jobs programme
- The ongoing crisis between federal lawmakers and Minister of State for Labour, Employment and Productivity, Festus Keyamo...
- 07/02/2020
|
Temasek to delay annual reporting to September amid Covid-19 pandemic
- THE annual reporting for Singapore's state investor Temasek Holdings will be delayed from July to September this year amid the Covid-19 pandemic, executive director and chief executive Ho Ching said in a Facebook post on Thursday. Read more at The Business Times.
- 07/02/2020
|
Dylan McDermott and Patti Lupone sex scene cut from Hollywood series
- Dylan McDermott stars as Ernie West, the smooth-talking owner of Golden Tip Gas, in Ryan Murphy's latest Netflix series Hollywood.
- 07/02/2020
|
A Peek Into The Markets: US Stock Futures Gain; All Eyes On Jobs Data
- Pre-open movers
U.S. stock futures traded higher in early pre-market trade, after closing on a mixed note in the previous session. Data on nonfarm payrolls for June, international...
- 07/02/2020
|
Avis and Budget are offering rental car deals and savings for the summer season and beyond — including up to 35% off right now
|
Ganduje orders contractors back to sites
- Kano State Governor, Abdullahi Umar Ganduje, has ordered all contractors working for the state government to return to their project sites with immediate effect. This he said was necessitated by th…
- 07/01/2020
|
When is a Budget not a Budget? | Mortgage Introducer
- It might be deeply unpopular but perhaps now is the time to cut the 3% surcharge that additional homeowners have to pay.
- 07/01/2020
|
Senate moves to block Nigeria’s revenue loss, tax evasion by IOCs - Businessday NG
- The Senate on Wednesday moved to block Nigeria’s revenue loss owing to money laundering, tax evasion by international oil companies operating in the country (IOCs), proceeds of corruption and other criminal activities involving illicit financial flows. The Red Chamber took the decision sequel to the consideration of a motion on “the need to review the […]
- 07/01/2020
|
Strictly's Brendan Cole and wife Zoe to renew vows after 10 years of marriage
- Former Strictly Come Dancing professional Brendan Cole and his beloved wife Zoe will renew their wedding vows to celebrate a decade of marriage
- 07/01/2020
|
That Hamptons Getaway This Summer? Good Luck Renting a Car in NYC - BNN Bloomberg
- Thanks to those who fled during the lockdown, there aren’t enough rental cars now for New Yorkers who stayed behind.
- 07/01/2020
|
FIRS Remits N66 Billion From Stamp Duty in Five Months
- By Chris Agabi The Federal Inland Revenue Service (FIRS) has said it remitted N66 billion as stamp duty revenue into the federation account between January to May this year. The Executive Chairman,…
- 07/01/2020
|
Preferred Hotels & Resorts Launches Loving Local - Rus Tourism News
- Preferred Hotels & Resorts has launched Loving Local, a global travel series designed to facilitate highly localised, luxury hotel experiences
- 07/01/2020
|
Kano 2020 budget: Ganduje to present budget to state assembly for review
- Governor Abdullahi Umar Ganduje of Kano State is to present the state's 2020 budget of over N200 Billion to the state house of assembly for...
- 07/01/2020
|
Buhari presiding over 6th virtual FEC - Vanguard News
- PRESIDENT Muhammadu Buhari is currently presiding over the 6th virtual Federal Executive Council, FEC, meeting.
- 07/01/2020
|
Buhari chairing virtual cabinet meeting
- President Muhammadu Buhari is currently chairing the weekly virtual Federal Executive Council (FEC) meeting. The meeting, being held at the Executive Council Chamber, has the Vice President, Profes…
- 07/01/2020
|
What you should know about buying a used rental car
- With their financial woes, some rental companies are selling off portions of their fleets. Here’s 5 tips for shoppers.
- 07/01/2020
|
Barloworld taking austerity measures
- Heavy equipment, automotive and logistics group anticipates rough trading conditions for at least 18-24 months
- 07/01/2020
|
Centre’s net tax receipts down 71% in April-May; deficit at 59% of FY21 estimate
- The year-on-year growth in the Centre’s total budgetary expenditure fell 0.2% year-on-year to Rs 5,11,841 crore in April-May 2020 compared with a growth rate of 21% in April.
- 07/01/2020
|
Nigeria working towards meeting World Bank’s FX unification requirement - finance minister - Businessday NG
- Nigeria’s Finance Minister Zainab Ahmed said on Tuesday that the country was working towards meeting the single exchange rate window requirement for accessing an agreed $1.5 billion loan support from the World Bank. Ahmed made the announcement during a webinar organised by the Federal Ministry of Finance, Budget and National Planning, OSSAP-SDGs and UNDP Nigeria […]
- 07/01/2020
|
FIRS generates N66bn from stamp duty in five months
- The Federal Inland Revenue Service (FIRS) has said it remitted N66 billion as stamp duty revenue into the federation account between January to May this year. The Executive Chairman, Mr. Muhammad N…
- 07/01/2020
|
Car Leasing Market 2020-2024 | Rising Technological Obsolescence of Older Cars to Boost Growth | Technavio
- The Global Car Leasing Market will grow by 18.38 mn units during 2020-2024
- 07/01/2020
|
Boris Johnson's deal rehashing old policies is not enough to save jobs
- The Labour leader has said the PM’s £5bn of infrastructure projects, ranging from roads to schools and hospital repairs, is nowhere near enough to tackle the looming crisis
- 06/30/2020
|
Barloworld to cut more than 2 500 jobs
- Will exit logistics and has put its automotive arm under 'business review'.
- 06/30/2020
|
FG generates N66bn from stamp duty in five months
- The Federal Inland Revenue Service (FIRS) has said it has remitted N66bn stamp duty revenue into the federation account between January and May 2020. The FIRS Executive Chairman, Mr Muhammad Nami d…
- 06/30/2020
|
Nigeria to embrace integrated financing for SGDs, as funding gaps hit $100bn - Businessday NG
- The Nigeria government has introduced the integrated financing framework to fund the financial gap in meeting sustainable development...
- 06/30/2020
|
No longer riding 2019’s wave, the PM fights to keep his head above 2020’s tsunami
- The Prime Minister’s speech in Dudley today sounded a lot like the election roadmap he unveiled here almost a year ago. But the honeymoon is over
- 06/30/2020
|
Lawmakers, Festus Keyamo Engage in Shouting Match over 774,000 Jobs ⋆
- The lawmakers then turned to Festus Keyamo and accused him of taking over the programme from the NDE. This resulted in a shouting match
- 06/30/2020
|
Bank of China, Sinosure to finance $2.6bn AKK gas pipeline ― FG
- The FG disclosed that funding for the $2.6bn Ajaokuta-Kaduna-Kano (AKK) gas pipeline would be provided by the Bank of China and SINOSURE
- 06/30/2020
|
Boris Johnson vows to uncover Britain’s Covid mistakes saying he owes it 'to the tens of thousands who died'
- BORIS Johnson has vowed to uncover Britain’s Covid mistakes saying he owes it “to the tens of thousands who died before their time”. In a strong hint that a public inquiry will be held into the pan…
- 06/30/2020
|
U S House of Representatives Committee on Bud : Chairs Yarmuth, Lowey, and Maloney Press OMB and Agencies to Comply with GAO Inquiries into WHO Funding
|
China, Sinosure to finance $2.6bn AKK gas pipeline - FG
- The Nigerian National Petroleum Corporation (NNPC), Monday, disclosed that financing for the Ajaokuta-Kaduna-Kano (AKK) gas pipeline
- 06/30/2020
|
Nigeria working towards meeting World Bank’s FX unification requirement, says finance minister - Businessday NG
- Nigeria’s Finance Minister Zainab Ahmed said on Tuesday that the country was working towards meeting the single exchange rate window requirement for accessing an agreed $1.5bn loan support from the World Bank. Ahmed made the announcement during a webinar organised by the Federal Ministry of Finance, Budget and National Planning, OSSAP-SDGs and UNDP Nigeria with […]
- 06/30/2020
|
LIVE updates as PM details £5bn build Britain out of coronavirus pandemic plans
- Live updates as the Prime Minister is making his first major speech since lockdown in Dudley
- 06/30/2020
|
Boris Johnson unveils bumper £5bn 'new deal' recovery plan with a third off 1,500 homes for first-time buyers
- BORIS Johnson today promised at least 1,500 discounted homes for first-time buyers in a multi-billion pound package to help Britain “build, build build” our way out of the coronavirus c…
- 06/30/2020
|
Le parquet national financier en 4 questions
- Créé en 2014 à la suite de l'affaire Cahuzac, le Parquet national financier est éclaboussé depuis début juin par plusieurs scandales. La juridiction est violemment critiquée pour des décisions prises, notamment dans le cadre des affaires Fillon, Kohler et Sarkozy. CQFD fait le point.
- 06/30/2020
|
Die wichtigsten Antworten zum Saisonauftakt der Formel 1 - Blick
- Ab Freitag dröhnen in Spielberg endlich wieder die Formel-1-Motoren! Das müssen Sie zum Auftakt alles wissen.
- 06/30/2020
|
Budget Insurance launches R6m small business relief fund
- Budget Insurance has launched a R6 million small business relief fund to help small businesses that have been impacted by the coronavirus pandemic.
- 06/30/2020
|
6 Tipps für Mietauto im Ausland: Checkliste bei Autovermietung
- Ein fremdes Land mit einem Mietauto selbst zu entdecken, ist verlockend, kann aber auch für Ferienverdruss sorgen. BLICK hat Tipps für den ungetrübte Roadtrip.
- 06/30/2020
|
Ford Mustang rental car sets ‘crazy’ speed record
- The driver of a daring high-speed record “Cannonball Run” across America says video evidence of his pursuit “would probably land me in jail”.
- 06/30/2020
|
Nigeria: Looking ahead to a planned future under PMB - Vanguard News
- WILL the world and its economy return to normal after the coronavirus pandemic? The answer to the above question will probably be in the...
- 06/30/2020
|
Avis Budget Group adopts one-year shareholder rights plan
- Avis Budget Group Inc. CAR, -4.24% said Tuesday a special committee formed by its board to manage its engagement with shareholder SRS Investment Management has agreed to adopt a one-year shareholder rights plan.
- 01/28/2020
|
Avis Budget Group Adopts Short-Term Shareholder Rights Plan to Protect the Company and its Shareholders
- SRS Investment Management Refuses to Renew Cooperation Agreement on Acceptable Terms SRS Investment Management Refuses to Renew Cooperation Agreement on Acceptable Terms
- 01/28/2020
|
Avis Budget Group and Fiat Chrysler Automobiles Sign New Connected Car Agreement, Giving a More Streamlined, Self-Serve and On-Demand Rental Experience in Europe
- BRACKNELL, United Kingdom, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc . (NASDAQ: CAR) today announces a new agreement with Fiat Chrysler Automobiles (FCA) Group to connect more than 22,000 Fiat vehicles in Avis Budget Group’s European fleet.
- 01/23/2020
|
Final Trades: BAC, TBT, CAR & NEM
- The Fast Money traders offer their final trades of the week.
- 01/10/2020
|
Avis Budget Appoints Joe Ferraro as Interim Chief Executive
- Ferraro succeeds Larry De Shon, whose planned departure as announced in May, as the interim CEO of Avis Budget (CAR).
- 01/02/2020
|
Avis Budget Group names Joe Ferraro interim CEO
- Avis Budget Group Inc. CAR, -0.86% said Monday that it has named Joe Ferraro, the car rental company's Americas president, to the interim chief executive post.
- 12/30/2019
|
Avis Budget Group Provides Leadership Update
- Joe Ferraro Named Interim Chief Executive Officer Joe Ferraro Named Interim Chief Executive Officer
- 12/30/2019
|
Final Trades: TRGP, FB, and more
- The "Fast Money" Traders share their first moves for the opening bell, including TRGP, FB, and more
- 12/19/2019
|
Lyft announces car rental service; Hertz and Avis shares plunge
- Lyft said on Thursday that it's launching a car rental service within its main app.
- 12/12/2019
|
Avis Named World’s Leading Car Rental Company at World Travel Awards 2019
- BRACKNELL, United Kingdom, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Leading car rental brand, Avis, has been named the world’s leading car rental company for the second year in a row at the World Travel Awards 2019 Grand Final. The award was announced at an awards ceremony in Muscat, Oman on 28th November 2019.
- 12/10/2019
|
Final Trade: EEM, Oil, CAR & MRO
- The Fast Money traders offer their final trades of the week.
- 12/06/2019
|
